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CHAPTER I 
 
INTRODUCTION 
 
Regulation of Proliferation and Differentiation 
Cell proliferation and differentiation are two processes that require 
exquisite control during development to produce mature functional organs in the 
growing organism.  Any misregulation of these processes can lead to altered cell 
division, which in turn, may result in formation of tumors or congenital 
malformations. Interestingly, each set of tissues has its own controls for these 
processes, since each tissue has its own unique niche and functions. The 
mechanisms controlling these functions are being elucidated, and we are just 
starting to understand the regulation of proliferation and differentiation during 
organogenesis and embryogenesis.  
For the purposes of this document, the heart will be used as the model 
organ. Cells that comprise the functioning heart muscle, cardiomyocytes, do not 
retain the ability to proliferate after terminal differentiation. This is in contrast to 
other organs, for example epithelial cells of the digestive system. Enterocytes 
retain the ability to divide throughout their lifetime and have a continuous stem 
cell population to replenish lost and dead cells (Ross et al., 1995).  
Cardiomyocytes have the ability to differentiate as they proliferate during 
cardiogenesis. A cascade of transcription factors has been identified, including 
Mesp1, 2, Nkx2.5, GATA 4, 5, 6, Mef2c, and the Tbx family of proteins, that 
regulate the proliferation of the cardiac cell lineage (reviewed in Solloway and 
Harvey, 2003). Several studies have identified differential gene expression in 
mature cardiomyocytes, including genes that encode myosin heavy chain and 
light chain family of proteins, cardiac α-actin, tropomyosin, α-actinin, titan, and 
desmin (Franco et al., 1998; Lyons et al., 1995; Ross et al., 1996; Solloway and 
Harvey, 2003; Wang and Stockdale, 1998; Yutzey and Bader, 1995). The factors 
that control the balance of these processes are not yet well understood. For the 
purposes of our studies, the Retinoblastoma (Rb) family of genes is implicated in 
the regulation of proliferation and differentiation, at least in part, of the 
cardiomyocyte maturation pathway (Novitch et al., 1996; Papadimou et al., 
2005).  
In the developing mouse, cardiomyocytes continue to proliferate and 
differentiate until the first postnatal week. At this time, there are poorly defined 
signals that direct the exit of proliferating cells from the cell cycle and then initiate 
terminal differentiation. It is commonly speculated that this results in the inability 
of cells to reenter the cell cycle. Recently, what has become an area of great 
debate within the field (Barlucchi et al., 2003; Beltrami, 2003). It is unresolved 
whether or not a resident stem cell population exists within the heart, even 
though no clear stem cell population has yet been identified. Needless to say, the 
processes that regulate cardiomyocyte proliferation and terminal differentiation 
are poorly understood. Myocardial infarction is the leading cause of death in 
Americans (American Heart Association). If we were able to determine the 
underlying mechanisms of cardiomyocyte proliferation and differentiation, it may  
 2
3Figure 1: Summary of mouse heart development. 1) Cardiac crescent (E7.5). 2) Linear heart 
tube (E8). 3) Looping heart (E8.5-9.5). 4) Chamber formation (E10-12). 5) Maturation and 
septation (E12-birth) (Bruneau et al., 2002). 
one day be possible to treat infarctions by reprogramming cells to proliferate and 
heal the damaged heart. Therefore, it is critical that we study and decipher the 
molecular regulators of cardiomyocyte proliferation and also for differentiation 
during development for basic scientific value and better treatment options. 
 
Heart Organogenesis 
Although it has been one of the most extensively studied processes, regulation of 
cardiac muscle development is still not well understood.  Fate mapping studies 
during gastrulation have shown that two sets of cells migrate from the primitive 
streak to two bilateral areas forming cardiac mesodermal sheets in the 
developing embryo (Garcia-Martinez and Schoenwolf, 1993). These cells commit 
to a cardiac fate (Gonzalez-Sanchez and Bader, 1990), and it is thought, at least 
in part, that signals from the surrounding endoderm are responsible for their 
committment (Jacobson and Duncan, 1968; Linask and Lash, 1986; Nascone 
and Mercola, 1995).  The mesodermal layer, or the cardiac crescent, folds 
toward the ventral midline to form the linear heart tube (DeHann, 1967; Linask 
and Lash, 1986).  Two cell types are specified at this time, the cells of the inner 
lining of the heart, or endocardium, and the cells that will develop into the muscle 
structure, or the myocardium (Garcia-Martinez and Schoenwolf, 1993; Inagaki et 
al., 1993). As seen in Figure 1, the linear heart tube consists of a single ventricle 
and a single atrium. The tube soon contorts into an S-shaped tube, and with 
extensive remodeling, eventually develops into a four-chambered heart (Carlson 
et al., 1981). 
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5Figure 2. Trabeculation. Conceptualization of the development of ventricular trabeculae after E8 
in the developing mouse heart. (Sedmura et al., 2000)
Maturation of the Heart Wall 
The bilateral heart crescent fuses at murine E8. At this stage, the heart consists 
of three layers: an inner layer of endothelial cells, a middle layer of extracellular 
matrix, and an outer layer of myocardium that is 1-2 cells thick (Inagaki et al., 
1993).  Cardiac myocytes in the heart tube are actively dividing at a much higher 
rate in the single ventricle than those in the atrium.  Finger-like projections, 
termed trabeculae, start to form in the ventricle at murine E10.5 and will form at a 
later time in the atrium (Figure 2; Challice and Viragh, 1974; Icardo, 1996; Icardo 
and Fernandez-Teran, 1987).  Dividing cells exist in the base of the trabeculae 
and are “pushed” up to form the projections (Luo et al., 2001; Radice et al., 
1997).  As cardiomyoctes move up the trabeculae, they cease proliferation and 
differentiate, as defined by the expression of structural and contractile specific 
genes and cessation of mitosis (Challice and Viragh, 1974; Mikawa et al., 1992; 
Thompson et al., 2002).    As trabeculae mature, they compact to form the thick 
myocardial wall of the adult heart (Mikawa et al., 1992).  Data suggest that 
neuregulin signaling from the endocardium and the erbB2 and erbB4 receptors of 
the ventricular trabeculae are involved in myocardial compaction and maturation 
(Birchmeier and Zhao, 1995; Gassmann, 1995; Kasahara et al., 1998; Lee et al., 
1993).  Proliferation continues in the maturing myocardium, and contractile and 
structural gene expression occurs throughout heart development.  All myocytes 
cease proliferation and permanently withdraw from the cell cycle, or terminally 
differentiate, a few days after birth (myocyte development reviewed in Sawyer et 
al., 1998). Rb family members are thought to have a regulatory role in 
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cardiomyocyte proliferation and terminal differentiation (Kablar et al., 1998; 
Pexieder et al., 2000; Zacksenhaus et al., 1997). 
 
The LEK Family of Proteins 
Our laboratory discovered Lek1, the murine member of the LEK family of 
proteins. The identified members of the family include Lek1, CMF1, only found in 
the chicken, and the human protein, CENP-F/Mitosin. The name of the family 
comes from the amino acid composition of the proteins comprising of 
approximately 40% leucine (L), glutamic acid (E), and lysine (K). All the proteins 
are relatively large in size (> 300 KD) and have similar domain structures. The N-
terminus is comprised of numerous leucine zippers.  The central region contains 
a spectrin repeat along with leucine zippers and is predicted to fold into a coiled 
coil structure (Goodwin et al., 1999).  The C-terminus contains a functional 
nuclear localization sequence (NLS), leucine zippers, an atypical Rb binding site, 
a helix-loop-helix (HLH) dimerization domain, and a farnesylation domain (Figure 
3; Goodwin et al., 1999; Liao et al., 1995; Redkar et al., 2002; Zhu et al., 1995a). 
Even though the family members all share structural similarities and are relatively 
large in size, their subcellular localizations and functions during cellular 
processes are diverse. 
The human members of the LEK family are CENP-F/Mitosin, and initially, 
two laboratories used different methods to identify the same protein (Liao et al., 
1995; Zhu et al., 1995b). Mitosin was identified first because of its ability to bind 
Rb, while CENP-F was identified as a human autoimmune antigen in patients 
with systemic autoimmune diseases. They are two proteins that are nearly  
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Figure 3. Structure of LEK family of proteins. The family includes Lek1 (mouse), CENP-
F/Mitosin (human), and CMF1 (chicken). All are relatively large in size and share similar domain 
structures, yet they display divergent functions.
identical in sequence, but they have divergent C and N termini. They will be 
referred to as CENP-F/Mitosin for the purposes of this document. CENP-
F/Mitosin expression is cell cycle dependent and one of the earliest proteins to 
assemble at the kinetochore. Protein accumulates in late S phase and peaks in 
early M phase (Zhu et al., 1995b) and is highly expressed in various 
malignancies (Landberg et al., 1996). Such an expression pattern makes it a 
useful cancer marker (de la Guardia et al., 2001; Erlanson et al., 1999; Rattner et 
al., 1997; Shigeishi et al., 2005). CENP-F/Mitosin demonstrates dynamic 
subcellular localization patterns during mitosis. It is a nuclear protein that 
associates at the kinetochore plate and spindle apparatus in early M phase, 
localizes to the spindle midzone in anaphase, the midbody in telophase, and then 
is completely absent at the end of cell division (Liao et al., 1995; Zhu et al., 
1995a; Zhu et al., 1995b). The protein also contains a farnysalation site, a CAAX 
domain required for proper nuclear envelope and kinetochore localization. The 
domain is required for proper M phase progression and protein degradation 
(Ashar et al., 2000; Hussein and Taylor, 2002). Some oncogenes, for example 
the Ras protein, also undergo farnesylation, which is important for the protein’s 
biological activity. Regulation at such sites is being investigated for possible 
therapeutic development (Russo et al., 2004). 
CENP-F/Mitosin associates with the kinetochore through a core region 
that all LEK family members have, at least to some degree (Zhu, 1999). The 
kinetochore is required for microtubule (MT) attachment and proper M phase 
progression during the cell cycle (Biggins and Walczak, 2003; Cleveland et al., 
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2003; Maiato et al., 2004). Kinetochores are macromolecule structures 
composed of many different proteins that assemble into a highly organized 
complex at the centromeres of chromosomes during mitosis. They are important 
for MT attachment and maintance during chromosome segregation. Proper cell 
division is dependent upon accurate kinetochore assembly. As a result, 
kintochores are critical at the G2/M checkpoint. Studies over the last few 
decades have begun to define and characterize the molecular composition of the 
kinetochore-centrosome complex during mitosis and describe the segregation 
event. 
Several reports demonstrate chromosome condensation or misalignment 
when Cenp-F/Mitosin is depleted (Bomont et al., 2005; Holt et al., 2005; Yang et 
al., 2005). Reports show that altering endogenous CENP-F/Mitosin function 
delays cell cycle progression, because microtubule (MT) dynamics and 
attachment at the kinetochore are affected (Bomont et al., 2005). Studies differ in 
what checkpoint is activated to cause the delay. In relation to our studies, CENP-
F/Mitosin also interacts with Nudel/NudE, a protein that associates with dynein 
and the MT network through the Lis1 pathway (Soukoulis et al., 2005; Yan et al., 
2003). Studies have identified this interaction as being critical for MT dynamics. 
Lastly, during interphase, mitosin remains nuclear and appears to sequester 
and/or activate certain transcription factors (Zhou et al., 2005). CENP-F/Mitosin 
is a multifunctional LEK protein that has a dynamic localization pattern 
throughout the cell cycle and is vital for cell cycle progression. It has critical 
functions in cell cycle progression, which is a MT-based process. 
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The chicken family member, CMF1, shares similar structural properties as 
the other LEK family members but demonstrates a divergent expression pattern 
from that of other LEK proteins. CMF1 was identified from a chicken expression 
library utilizing an antiserum to the basic helix-loop-helix domain of MyoD, an 
essential muscle transcription factor (Wei et al., 1996). Like other family proteins, 
it also contains a functional Rb binding domain (Redkar et al., 2002). Unlike other 
LEK roteins, the distribution of CMF1 appears to be restricted to skeletal and 
cardiac muscles during development, as it is highly expressed during early 
stages of embryogenesis and drops dramatically after embryonic day 7 (Pabon-
Pena et al., 2000). It has not been detected in the adult, so it is postulated that 
the protein is critical for myocyte development, a shared function of mouse Lek1 
(Papadimou et al., 2005). 
CMF1 has been determined to have a functional nuclear localization 
sequence (NLS) by utilizing chimera reporter proteins (Redkar et al., 2002). Yet, 
it is observed predominantly in the cytoplasm during myocyte proliferation and 
differentiation. In vitro studies have shown nuclear CMF1 in primary myoblast 
and then a cytoplasmic distribution after differentiation (Dees et al., 2000; Pabon-
Pena et al., 2000), however one group does report nuclear CMF1 in the 
developing embryo (Redkar et al., 2002). Analyses examining CMF1 expression 
patterns also show that it precedes the expression of sarcomeric myosin heavy 
chain, a marker for differentiated myocytes (Bader et al., 1982). Notably, 
inhibition of the endogenous protein results in a substantial decrease in 
sarcomeric heavy chain expression, indicating an inhibition of myocyte 
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~160 KD cytLEK1
~110 KD nucLEK1
Available 
Antibodies
Figure 4. Lek1 undergoes a post-translational modification. The event produces an N-terminal 
cytLEK1 that localizes to the cytoplasm, while the C-terminal nucLEK1 immediately localizes to 
the nucleus. We have four available antibodies to cytLEK1, while we have three for nucLEK1. 
These antibodies are important for characterizing the Lek1 knock-out (Chapter V).
differentiation (Dees et al., 2000; Wei et al., 1996). Therefore, it is proposed that 
CMF1 plays an important role in the proliferation and differentiation of skeletal 
and cardiac myocytes, which is also a proposed function of the mouse family 
member Lek1 (Papadimou et al., 2005).  
 The mouse member of the LEK family of proteins is Lek1. It differs from 
other family members in its expression pattern and appears to have divergent 
cellular functions. Lek1 was originally cloned utilizing reverse transcriptase 
polymerase chain reaction (RT-PCR). Degenerative primers based on conserved 
sequences of the LEK family were used against an E9.5 mouse heart library 
(Goodwin et al., 1999). The resulting clone fragments were then used to screen a 
E8.5 whole mouse cDNA library. Southern blot analyses demonstrated that there 
was a single copy of Lek1 in the mouse genome, while northern blot analysis 
showed two bands approximately 10 kB, indicating that the mRNA may be 
alternatively spliced. Unique to the family, Lek1 undergoes post-translational 
modification. Previous studies in our laboratory have demonstrated that there is a 
post-translational cleavage event by an unknown enzyme at an unknown site that 
produces an N-terminal nucLEK1 and a C-terminal cytLEK1 (Figure 4). Early 
studies concentrated on nucLEK1 function in the nucleus (Ashe et al., 2004; 
Goodwin et al., 1999).  
 Northern blot and immunolabeling experiments demonstrated the 
expression pattern of Lek1 in the developing embryo (Figure 5). The highest 
levels of mRNA expression are at E8.5 in the whole embryo, and E9.5 in the 
head and caudal regions posterior to the heart. Interestingly, Lek1 message 
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E11.5
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C D
Figure 5. mRNA expression during development. A) Northern blot analysis demonstrates that 
Lek1 mRNA expression is highest at E9.5 in the developing mouse. It also shows that the heart and 
liver retain high levels of expression at E16.5. B) Transcript expression is high until N4 and is then 
severely down regulated and not found in the adult (A-B: Goodwin et al., 1999). C-D) In situ
analyses at E11.5: The control sense-probe shows no significant background (C), while the
antisense-probe demonstrated high expression in the developing heart and in the brain.
increases in the heart and liver through development, while in other organs it 
decreases as the embryo ages. In the heart specifically, Lek1 transcript is 
detected at high levels until P4 and then disappears by P7. nucLEK1 protein 
expression demonstrates a similar pattern and is not found in the heart post N5 
(Goodwin et al., 1999). Coincidently, this is the same time in which 
cardiomyocytes permanently exit the cell cycle and terminally differentiate 
(Soonpaa and Field, 1998; Soonpaa et al., 1996). From these initial data, we 
postulated that Lek1 has a role in the regulation of proliferation and differentiation 
during cardiogenesis.  
 In order to test our hypothesis for a Lek1 function in cardiomyocyte 
proliferation and/or differentiation, the Rb binding domain of nucLEK1 was 
examined because of Rb’s role in these processes (Ashe et al., 2004).  
NucLEK1, like other LEK family members (Redkar et al., 2002; Zhu et al., 
1995b), binds all Rb family members, Rb, p107, and p130. NucLEK1 was found 
to associate with both transiently expressed and endogenous Rb proteins, 
through the “pocket domain” of nucLEK1 (Ashe et al., 2004). Other proteins, such 
as the viral oncogenes E1A, E7, and T-antigen, and E2Fs, have been found to 
interact with Rb proteins through their pocket domain (Knudsen and Wang, 
1997). Rb regulators bind the pocket region of Rb to interfere with protein 
interaction (Resnitzky et al., 1994). Rb family proteins have important functions in 
cell cycle regulation, and its roles in the control of differentiation and apoptosis 
are being elucidated (Yee et al., 1998). We propose that nucLEK1 binds Rb 
family proteins, therefore inhibiting their function. The interaction maintains cells 
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in a proliferative, non-differentiative state during embryogenesis. nucLEK1 is then 
downregulated, Rb can bind proliferative factors, and differentiation proceeds. 
 To test our hypothesis, experiments were conducted that disrupted Lek1 
function. Morpholino (MO) antisense oligomer technology was utilized to test 
knock-down of Lek1. NIH 3T3 fibroblasts were depleted of Lek1, presumably 
activating Rb family member function, and the cell population arrested in G1/S 
(Ashe et al., 2004). Therefore, we conclude that Lek1 is required for NIH 3T3 cell 
proliferation. Evidence also suggests that Lek1 is required for C2C12 
differentiation. C2C12 cells express Lek1 in their proliferative, non-differentiated 
state. In C2C12 cells that are depleted of Lek1, cells form myotubes and 
accumulate sarcomeric myosin heavy chain expression, indicating that the cells 
have differentiated (Ashe and Bader, unpublished data). These data on Lek1 
support a role for its interaction with Rb family proteins resulting in regulation of 
proliferation and differentiation during embryogenesis. 
 
cytLek1, Nde1, and the Microtubule Network 
 cytLEK1 is the N-terminal portion of Lek1 that immediately localizes to the 
cytoplasm (Pooley et al., 2006; Soukoulis et al., 2005). It contains a spectrin 
repeat that has been shown to be important for cytoskeletal interaction (Djinovic-
Carugo et al., 2002). Since cytLEK1 contains this repeat and the function(s) of 
this cleavage product were unknown, it was initially hypothesized that cytLEK1 
may have a role with the cytoskeletal network. A yeast-two hybrid (Y2H) screen 
was performed utilizing the spectrin repeat region and 5’ and 3’ flanking 
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sequences of cytLEK1 as bait to screen an E17.5 embryonic mouse heart library. 
Out of several sequenced clones, Nde1 (formally NudE), a member of the Lis1 
pathway, was identified most often (Soukoulis et al., 2005). 
 Nde1 and Nudel are protein isoforms and mammalian homologs of the 
nude gene in A. nidulans and are members of the Lis1 pathway (Efimov and 
Morris, 2003). They are highly conserved among mammals, demonstrate similar 
expression patterns, and have overlapping functions. Yet it is unclear what their 
separate roles may be. Only Nde1 will be referred to for the purposes of this 
document. Studies examining Nde1 mRNA and protein expression patterns show 
that it is found at high levels in the developing brain, heart, skeletal muscle, and 
testes (Feng et al., 2000; Niethammer et al., 2000; Sasaki et al., 2000; Yan et al., 
2003). Expression is first detected during embryogenesis at E11 and peaks five 
days later when it slowly decreases and is found at low levels in the adult (Feng 
et al., 2000). Data suggest that Nde1 function is important during embryogenesis, 
and its function in the adult remains elusive. Lek1 has a similar expression 
pattern, and since we identified it as a cytLEK1 interacting protein in our Y2H 
screen, we initially speculated that cytLEK1 and Nde1 may function together in a 
common pathway.  
Nde1 was originally discovered by a Y2H screen utilizing Lis1 as bait 
(Feng et al., 2000). It is also interesting to note that Y2H screens conducted by 
other groups utilizing the LEK family protein CENP-F/Mitosin as bait also 
identified Nde1 as an interacting protein (Feng et al., 2000; Yan et al., 2003). 
Subsequent studies on the Nde1-Lis1 interaction revealed additional interaction 
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with the microtubule associated motor dynein (Feng et al., 2000; Niethammer et 
al., 2000; Sasaki et al., 2000).  
In most cells, Nde1 has a cytoplasmic distribution with high perinuclear 
expression pattern and significant localization at the centrosome (Feng et al., 
2000). It must be pointed out that Nde1 localization is not exclusive to the 
centrosome, as it does localize throughout the perinuclear region and in the cell 
periphery, similar to cytLEK1. Nde1 has also been co-immunoprecipitated with γ-
tubulin, a key component of the centrosome (Feng et al., 2000). cytLEK1 
colocalizes to a high degree with the Lis1 pathway members Nde1, Lis1, and 
dynein (Figure 6; Soukoulis et al., 2005). Colocalization between the proteins is 
not absolute, and this result is expected given that all these proteins have been 
shown to have multiple functions. Further subcellular localization experiments 
showed that Nde1 colocalized with dynein on mitotic spindles and on the 
kinetochore (Feng et al., 2000; Yan et al., 2003).  Overexpression of Nde1 in 
mammalian cells significantly disorganizes the microtubule network, while the 
centrosome is altered and dispersed (Feng et al., 2000). From these data, it is 
speculated that Nde1 association with Lis1 and dynein functions in microtubule 
processes and centrosome formation. Even though the microtubule network, 
dynein, and associated Lis1 pathway proteins are well-studied, precise regulation 
of the network remains poorly understood.  
Since it is postulated that Nde1 functions in MT based processes through 
the Lis1 pathway, such activities were further characterized. Dynein is MT motor 
that is essential for the positioning of many organelles, vesicles, proteins, and 
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Figure 6. cytLEK1 colocalizes with Lis1 pathway proteins. Confocal microscopy was utilized to 
examine endogenous proteins in 3T3 fibroblasts. CytLEK1 is in green, while colocalizing proteins 
are visualized in red. A) CytLEK1 and dynein have a cytoplasmic distribution along with a high
perinuclear distribution. The merged image demonstrates a high degree of colocalization between 
cytLEK1 and dynein. B) CytLEK1 is more diffuse than that of Lis1, but they still share a high 
degree of overlap, especially in the perinuclear region. C) Both cytLEK1 and Nde1 (formally 
named NudE) demonstrate significant colocalization as seen in the merged image. D)
Deconvolution analysis of confocal data shows a more detailed localization of cytLEK1 and Nde1 
(NudE1). Figure adapted from Soukoulis et al., 2005.
RNAs near the nucleus. Mitosis is a key process that is dependent on dynein. 
During the cell cycle, it has a wide set of functions including chromosome 
alignment, spindle orientation, and the movement of chromosomes toward 
opposite poles (Banks and Heald, 2001; Gibbons, 1996; Hirokawa et al., 1998). 
Important for our studies in characterizing Lek1 function in the following chapters, 
dominant-negative experiments have shown that altering proteins in the Lis1 
pathway fragment and disperse lysosomes, endosomes, and Golgi. These 
effects were specific to dynein-mediated processes, because vesicles relying on 
kinesin motors were unaffected. Knock-down of Nde1 by RNAi supported these 
results (Liang et al., 2004b). Further experiments utilizing RNAi also show 
accumulation of MT near the nucleus, implying that the Lis1 pathway is required 
for MT transport to the periphery. The MT network also forms a connection from 
the cell cortex to the centrosome and nucleus. During cell migration, cells 
depleted of Nde1 have an increased distance between the nucleus and 
centrosomes (Shu et al., 2004; Smith, 2000). It is now apparent that Nde and the 
Lis1 pathway are required for such MT-based processes. It must also be noted 
that extensive studies have characterized the pathway in neuronal development 
and have shown that it is critical for proper neuronal development and function. 
In fact, mutations to this pathway are responsible for “smooth brain”, or 
lissencephaly (Reiner et al., 1993). Studies describing Lis1 function in other 
tissues are more obscure.  
 The cytLEK1-Nde1 binding domains have been defined in each protein 
utilizing Y2H and coimmunoprecipitation studies. The necessary and sufficient 
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region in cytLEK1 to bind Nde1 is amino acids (aa) 2071-2149 and is referred to 
as myc-C (refer to Figure 3; Soukoulis et al., 2005). Interestingly, myc-C 
colocalized with Nde1 and γ-tubulin at the centrosome. This is of great interest, 
since Nde1 appears to have a function in establishing and maintaining 
centrosome integrity, a known function of the LEK family of proteins. When 
transfected into mammalian cells, myc-C acted as a dominant-negative protein. 
Experiments demonstrated that cells had a collapsed MT network, therefore also 
having a rounded-up phenotype. Interestingly, these results phenocopy what is 
observed in knock-down studies of Lis1 pathway members (Shu et al., 2004; 
Smith, 2000). As one might expect, myc-C transfected cells showed altered 
distribution of endogenous dynein, Lis1, and Nde1, confirming a cytLEK1 
function in the pathway. Myc-C conferred detergent resistance and remained 
attached to the cytoskeleton, further demonstrating association with the MT 
network. Overexpression of myc-C also inhibited microtubule repolymerization 
after addition of nocodazole, while knock-down of cytLEK1 resulted in tight 
perinuclear focusing of microtubules around the nucleus. Both phenotypes are 
seen when altering proteins of the Lis1 pathway. From these data, we postulate 
that the myc-C region of cytLEK1 is responsible for its association and functions 
with the MT network through Nde1 and the Lis1 pathway.  
 
SNAREs 
 Studies over the last 30 years have described the molecular mechanisms 
responsible for intracellular protein transport. Proteins traffic between 
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membranous organelles which include the endoplamic reticulum, Golgi 
apparatus, endosomes, lysosomes, and the plasma membrane. In order for 
proteins to move between these membrane bound compartments, a series of 
budding and fusion events must occur between donor and acceptor membranes. 
 The soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
(SNAREs) family of proteins is responsible, at least in part, for membrane 
targeting and fusion (Figure 7; Sollner et al., 1993b). The SNARE superfamily is 
comprised of at least 24 known yeast members and more than 35 proteins in 
mammals (Bock et al., 2001). The SNARE hypothesis is proposed to explain how 
membrane proteins can traffic specifically from one compartment to the other; 
each type of transport organelle carries a v-SNARE and binds to particular t-
SNARE on the apposing membrane. SNARE proteins can function in multiple 
trafficking steps, some members can substitute for other family members, and 
multiple SNAREs are found at any particular compartment (Brandhorst et al., 
2006; Darsow et al., 1997; Gerrard et al., 2000; Liu and Barlowe, 2002; 
Thorngren et al., 2004).  
 Most of the SNARE family of proteins are from the SNAP (Synaptosomal-
associated protein of 25KD), VAMP (vesicle-associated membrane proteins), or 
the syntaxin subfamilies. They all vary widely in size and structure, but they all 
share one characteristic in that they contain a SNARE motif (Bock et al., 2001). 
The SNARE motif contains 60-70 amino acids (aa) that include eight heptad 
repeats typical for coiled coils. Most SNAREs have a C-terminal transmembrane 
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Figure 7. The SNARE complex. Formation of the SNARE complex probably requires interaction 
between the helical domains of  SNAP-25, VAMP, and syntaxin. Immediately following complex 
formation, apposing membranes fuse (Molecular Biology of the Cell, 4th Edition). 
domain (syntaxins and VAMPs), and others have a post-translational 
modification that anchors them to the membrane (SNAP). 
 As membranes fuse, SNARE proteins on opposite membranes associate 
into a core complex. It is mediated by SNAP motifs and when they come into 
contact, large conformational changes result. A SNARE complex is formed by the 
interplay of four SNAP motifs in parallel direction; two of the motifs are supplied 
by a SNAP protein, one by syntaxin, and the last by VAMP (Figure 7; Fasshauer 
et al., 1997; Sutton et al., 1998). Assembly is thought to proceed in a zipper-like 
fashion as SNAREs in the apposing membranes pull the membranes closer 
together and form an extremely stable complex (Hanson et al., 1997; Lin and 
Scheller, 1997). Other regulators, such as NSF and soluble NSF- attachment 
proteins are responsible for the subsequent disassembly of the SNARE complex 
(Sollner et al., 1993a). In vitro data show that SNAREs are not predetermined in 
their appropriate binding partners. There appears to be some degree of 
promiscuity, as some SNARE complexes are more stable than others 
(Fasshauer et al., 1997; McNew et al., 2000; Parlati et al., 2002; Paumet et al., 
2002; Yang et al., 1999). To date, it is under debate in the specificity of SNARE 
complex formation in various membrane fusion events and exactly which proteins 
bind with one another in vivo. Important questions remain on the complex’s 
function: Is the complex involved in only recognition of the apposing 
membranes? Or, is it required for the entire fusion event? SNARE proteins on 
one membrane may or may not encode in themselves which SNAREs they bind 
on the opposite membrane. Also, SNAREs may or may not be confined to 
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specific compartment(s). Even though enormous progress has been made, many 
important questions remain.  
Not surprisingly, numerous accessory and regulatory proteins to SNAREs 
have been identified. Tethers link fusing membranes before SNARE protein 
interaction (Guo et al., 1999). These include COG complexes and golgins of the 
Golgi apparatus and EEA1 of early endosomes (Christoforidis et al., 1999; Whyte 
and Munro, 2003). Tethers function with Rab family GTPases to promote the 
initial association of fusing membranes. Just as with SNARE proteins, multiple 
Rabs have been identified at different steps of trafficking (Jahn et al., 2004). As 
we have now begun to understand, SNAREs, tethers, and Rabs all have critical 
roles in the intricate details of membrane fusion and protein trafficking within the 
cell. 
 
SNAP-25 
SNAP-25 is most well understood for its role in neurotransmitter 
exocytosis. It is a member of the same family of proteins as SNAP-23 
(Ravichandran et al., 1996) and SNAP-29 (Steegmaier et al., 1998). Classically, 
SNAP-25 is thought to be predominantly neuronal, whereas the other two 
members are their supposed non-neuronal counterparts. Important for our 
studies, there is an emerging field of evidence that shows SNAP-25 functions in 
intracellular membrane trafficking of non-neuronal cell types.  
 SNAP-25 is a hydrophilic protein that consists of 206 aa (Figure 8). 
Palmitic fatty acid groups are added to four central cysteine residues, and it is 
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Figure 8. SNAP-25 and syntaxin 4 structure. SNAP-25 (A) is a protein of 206 aa, while syntaxin
4 (B) consists of 298 aa. The four cysteine residues are labeled on SNAP-25 and are the sites for
palmitoylation. Amino acids 2-82 are responsible for syntaxin binding, while the N-terminal 107 aa
of syntaxin 4 are required for SNAP-25 association.  The areas in gray are intramolecular coiled 
coil regions of the proteins. The yellow region of syntaxin 4 is the transmembrane domain. These 
coiled coil regions of SNAP-25 and syntaxin 4 bind together, along with VAMP, and form the 
stable SNARE complex.
responsible for the association of SNAP-25 with membranes (Loranger and 
Linder, 2002).  The amino and carboxy-terminal domains of SNAP-25 form an 
intramolecular coiled coil complex that associates with a VAMP and a syntaxin 
family member during membrane fusion (Chapman et al., 1994). An important 
tool in studying SNAP-25 function was the identification of botulinum neurotoxins 
A and E as SNAP-25 cleaving compounds. They have been beneficial in the 
studies of SNARE function in membrane fusion as a way to study SNAP-25 loss-
of-function (Sakaba et al., 2005). SNAP-25 consists of 8 exons, and alternative 
splicing of exon 5 creates two variants, SNAP-25A and B. SNAP-25B is the 
predominant adult isoform (Bark et al., 1995). 
  Even though more than 35 mammalian SNARE proteins exist, only a few 
are involved in exocytosis and the rapid release of neurotransmitters. SNAP-25 
was identified from neuronal specific mRNA, and with functions in neurons being 
the most well-studied. For neurotransmitter release to occur, cytosolic synaptic 
vesicles (SV) must dock and fuse with the presynaptic membrane after nerve 
membrane depolymerization. VAMP 1 and 2 are integral SV proteins, while 
syntaxins 1 and 2 are bound to the presynaptic membrane. SNAP-25 associates 
with syntaxins at the cytosolic face of the nerve membrane. SNAP-25, VAMP, 
and syntaxins provide the four coiled-coils to form the SNARE complex during 
membrane fusion (Montecucco et al., 2005). With only a few SNAREs identified 
as being functional components of neurotransmitter release, other SNARE 
proteins have also shown to be critical for intracellular membrane fusion events 
in other cell types. 
 27
 SNAP-23 is considered to be the predominant non-neuronal SNAP family 
member (Ravichandran et al., 1996), but additional studies identify SNAP-25 as 
also being important for intracellular vesicle organelle fusion events. Outside of 
the brain and neurons, SNAP-25 has been identified in gastric parietal cells 
(Karvar et al., 2002), osteoblasts (Bhangu et al., 2003), melanocytes (Scott and 
Zhoa, 2001), adipocytes (Jagadish et al., 1996), cells from kidney collecting 
ducts (Shukla et al., 2001), and relevant for our studies, in myocytes of the heart 
and muscle (Jagadish et al., 1996; Ma et al., 2005; Sevilla et al., 1997). More 
importantly, these studies describe intracellular SNAP-25 localization and 
function as being important for vesicle trafficking. 
SNAP-25 is mostly located at the membrane in neurons, but a large 
intracellular pool of SNAP-25 still exists. SNAP-25 has been localized to sorting 
vesicles (SVs), along with the early endosomes marker EEA1 (Waite et al., 
1998), indicating a function in proper trafficking and localization of 
neurotransmitter carrying SVs to the plasma membrane (Selak et al., 2004; 
Walch-Solimena et al., 1995). Reports also state that SNAP-25 binds directly 
with the Hrs protein in the early endosomes of neuronal cells (Komada and 
Soriano, 1999; Sun et al., 2003; Tsujimoto et al., 1999). Hrs has been shown to 
interact with numerous proteins implicated in membrane trafficking (Bean et al., 
2000; Bean et al., 1997; Chin et al., 2001). The SNAP-25-Hrs association 
appears to be a negative regulator of homotypic early endosome fusion (Sun et 
al., 2003). Studies show that SNAP-25 has a role in vesicle trafficking from the 
plasma membrane to the sorting and recycling endosomes, and finally to the 
 28
Golgi in an ARF6-endocytic pathway (Aikawa et al., 2006; Prekeris et al., 1998). 
Critical for our studies, SNAP-25 was shown to associate with Rab11a and 
TGN38, markers for the recycling endosomes and trans-Golgi network (TGN), 
respectively. The role of SNAP-25 in exocytosis of neurotransmitters remains the 
most well studied and understood aspect of SNAP-25 function, but it is becoming 
evident that SNAP-25 also has a significant role in intracellular membrane and 
vesicle trafficking. 
 Our laboratory has created the conditional Lek1 allele for protein ablation 
in a tissue specific and/or temporal manner (Chapter V). Therefore, results 
obtained from other knock-out studies conducted with Lek1 interacting proteins 
are beneficial in postulating the roles Lek1 may have in given molecular 
pathways. The SNAP-25 knock-out mouse was created by Washbourne et al 
(2001) that gave intriguing results for SNAP-25 function during mouse brain 
development. Knock-out mutant mice were not observed at birth, and as a result, 
they examined E17.5-18.5 mice. At this stage, mice were in a tucked position, 
were smaller in size, and failed in both spontaneous movement and reflexes in 
response to stimuli. The heart and other organs appeared normal. From their 
data, they concluded that SNAP-25 was not required for nerve-outgrowth and 
stimulus independent neurotransmitter release, which are functions dependent 
on the SNARE complex during membrane fusion events in the brain. Brain 
development proceeded normally, and the phenotypes were observed in fetus 
musculature, which are tissues that we have also shown to contain high levels of 
Lek1 expression. They speculate other SNARE proteins may be able to 
 29
compensate for SNAP-25 loss-of-function in the brain. They conclude that SNAP-
25 is critical for evoked action potential synaptic transmission. 
 
Syntaxin 4 
 Syntaxin 4 is one of 15 identified syntaxin proteins (Hong, 2005). It is a 
298 aa protein, and along with SNAP-25, it is a SNARE protein involved in 
membrane docking and fusion. The syntaxin 1A and 1B isoforms were originally 
identified by their interaction with the synaptic vesicle protein synaptotagmin 
(Bennett et al., 1992). Soon, numerous non-neuronal family members were 
identified in various secretory and endosomal pathways (Bock et al., 2001). 
Syntaxins localize to multiple intracellular membranes functioning at membrane 
fusion interfaces (Figure 9). Syntaxin 4 was originally identified as being a cell-
surface syntaxin (Bennett et al., 1993), but more recently has been identified in 
intracellular locations, such as Rab11a positive vesicles (Band et al., 2002; 
Torrejon-Escribano et al., 2002). All syntaxin proteins, except syntaxin 11, are 
transmembrane proteins anchored by C-terminal tails. The proteins contain 
several hydrophobic regions that form coiled coil structures. Most importantly for 
our studies, the ~60 aa long coiled coil SNARE region closest to the 
transmembrane domain is responsible for syntaxin association with SNAP-25 
(Figure 6; Weimbs et al., 1997).  
 Through their SNARE domains, syntaxins and SNAP-25 proteins form t-
SNARE complexes at target membranes. The t-SNARE complexes then interact 
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Figure 9. Syntaxin localization. Syntaxin family proteins (labeled STX) are found at multiple 
compartments throughout the cell. Syntaxin 4 was initially characterized by its localization at the 
cell membrane, but has been since localized to intracellular compartments. This is a diagram 
demonstrating the complexity of defining syntaxin localization, because they do function in 
multiple pathways. Not only does syntaxin 4 function at the cell surface, but it also localizes to 
intracellular Rab11a positive endosomes. Figure adapted from Chen et al., 2001.
with VAMP family members at vesicle membranes (Sollner et al., 1993b). 
Together they form the four coiled-coil helices of the SNARE complex. 
 Syntaxin 4 localizes to the basal lateral membrane in pancreatic β- cells 
and Madin-Darby kidney cells and is involved in plasma membrane trafficking 
from the trans-Golgi network (TGN) to basal lateral surface (Spurlin and 
Thurmond, 2006). Relevant for this document, syntaxin 4 has been localized to 
Rab11a positive recycling endosomes in NRK cells, a myeloma cell line (Band et 
al., 2002). Interestingly, it is a cell line that also highly expresses Lek1 
(unpublished data).  
GLUT4 vesicle fusion with the plasma membrane is an instrumental step 
in insulin-regulated glucose internalization and transport. In response to elevated 
blood sugar levels, the pancreas secretes insulin. Insulin-responsive tissues, 
suchas the liver, muscle, and adipose tissue, then internalize glucose in an 
insulin-dependent manner (Figure 10). GLUT4 primarily functions in cells that are 
responsive to insulin stimulation, namely adipocytes and muscle cells (Charron et 
al., 1989; James et al., 1989). In a non-induced environment, GLUT4 is localized 
to intracellular pools (Birnbaum, 1989; James et al., 1988; James et al., 1989). 
After a meal, GLUT4 positive vesicles quickly redistribute to the plasma 
membrane to function in uptake of glucose. 
Data suggest the existence of an insulin-sensitive compartment: the 
GLUT4 storage vesicle (GSV). Exactly how these GSVs traffic to the cell 
membrane is under debate. Under basal conditions, the GSV pool colocalizes 
with TGN markers, and once stimulated, GSVs traffic to the cell membrane and 
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Figure 10. GLUT4 trafficking. Insulin released by β-cells stimulates an increase in muscle 
and adipocyte glucose uptake. Insulin binds to the cell surface Insulin Receptor (IR) that 
initiates a signaling cascade which results in trafficking of GLUT4 vesicles to the cell 
membrane. This catalyzes the uptake of glucose into the cell, and GLUT4 is recycled through 
intracellular membrane compartments. Rab11a is implicated in the recycling of GLUT4. 
Figure adapted from Pessin et al., 1999.
localize with VAMP2. Markers for early and late endosomes and lysosomes are 
largely devoid from the GSVs (Martin et al., 1998). Compartments that contribute 
to GSVs and the timing of such events in GSV trafficking are not well understood. 
There is evidence that once these specialized compartments arise from the TGN, 
GLUT4 cycles through recycling endosomes under basal conditions until they 
localize to the plasma membrane upon insulin stimulation (Bryant et al., 2002). 
An alternative model states that GSVs develop in a post-endosomal 
compartment derived from Rab11a-positive recycling endosomes (Malide et al., 
1997; Zeigerer et al., 2002). What has become clear is that the Rab11a plasma 
membrane recycling pathway is important in GLUT4 trafficking (Kessler et al., 
2000; Larance et al., 2005; Millar et al., 1999; Uhlig et al., 2005). 
The importance of syntaxin 4 in vesicular transport is exemplified by the 
regulation of GLUT4-containing vesicles in skeletal muscle, cardiomyocytes, and 
adipose tissue after insulin stimulation (Bryant et al., 2002; Pessin et al., 1999). 
Of the non-neuronal syntaxin proteins, syntaxin 4 is the only member that 
interacts with VAMP2 (Cheatham et al., 1996; Kawanishi et al., 2000; Martin et 
al., 1998; Randhawa et al., 2000), and it is the VAMP family member implicated 
in GLUT4 trafficking to the cell surface. 3T3-L1 adipocyte treatment with 
dominant-negative peptides significantly reduces GLUT4 trafficking and glucose 
uptake. These data support that syntaxin 4 is the major syntaxin protein to 
function in insulin-dependent GLUT4 trafficking (Cheatham et al., 1996; 
Macaulay et al., 1997; Olson et al., 1997; Tellam et al., 1997; Volchuk et al., 
1996). 
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The syntaxin 4 knock-out mouse line has been created (Yang et al., 
2001). Similarly to the SNAP-25 knock-out, homozygous syntaxin 4 mutants are 
embryonic lethal, therefore experiments utilizing heterozygous mutants were 
examined. As with SNAP-25 mutant mice, the phenotypes in syntaxin 4 mutants 
were observed in muscle tissues. Surprisingly, no defects in insulin stimulated 
GLUT4 trafficking were seen in adipose tissue, a major reservoir of syntaxin 4 
and model of its function (Charron et al., 1989; James et al., 1988; James et al., 
1989). In contrast, a 50% reduction in skeletal muscle glucose transport was 
observed, while GLUT4 trafficking was also significantly reduced (Yang et al., 
2001). These data show that no other SNARE proteins appear able to 
compensate for knock-down of syntaxin 4. Therefore, protein levels may be 
critical for glucose uptake in myocytes. Even with reduced levels of syntaxin 4 in 
heterozygous mutants, adipocytes appear to function. There still may be 
sufficient amounts of syntaxin 4 for glucose uptake in mutant cells, or another 
SNARE may replace lost syntaxin 4 function.  
Interestingly, Spurin et al (2006) also performed studies utilizing 
pancreatic β-cells from heterozygous syntaxin 4 mutant mice, a cell type that has 
high syntaxin 4 expression (Jacobsson et al., 1994). Results from their 
experiments demonstrate that syntaxin 4 also functions in insulin release from β-
cells. There are two phases to insulin release. First phase release is the 
membrane fusion of insulin containing granules already at the cell surface. 
Second phase incorporates insulin release from intracellular pools that need to 
be trafficked to the cell surface. Data show that mutant cells had a 50% reduction 
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in first phase insulin release, and a trend in reduction in second phase insulin 
secretion was also found. The most intriguing aspect of these studies, in 
relationship to our work with Lek1, is that β-cells also express high levels of 
SNAP-25 (Sadoul et al., 1995). Both SNAP-25 and syntaxin 4 have known 
interactions with cytLEK1 (Chapters II and III).  
From the data that will be presented in the following chapters, we are able 
to make the following hypotheses on Lek1 function. Through the interaction of 
Lek1 with SNAP-25 and syntaxin 4, Lek1 is the first identified bridge that links 
recycling endosomes with the MT network. We have also created the conditional 
Lek1 allele, which has given intriguing results. It appears that ablating Lek1 
functon early in heart development alters cardiomyocyte proliferation. These data 
support a role for the protein as a regulator of proliferation and differentiation. 
Mutant hearts also have a defect in electroconductivity. Therefore, we postulate 
that protein trafficking and recycling to the cell membrane may be affected in 
mutant cardiomyocytes.  We show that Lek1 may be a critical regulator of protein 
trafficking and of proliferation and/or differentiation during heart development. 
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CHAPTER II 
 
CYTLEK1 IS A REGULATOR OF PLASMA MEMBRANE RECYCLING 
THROUGH ITS INTERACTION WITH SNAP-25 
 
 
Introduction 
The trafficking of proteins between organelles and the plasma membrane 
is mediated by transport vesicles that originate from a series of budding and 
fusion events between donor membranes and acceptor membranes. Vesicle 
docking and fusion is regulated, in part, by SNAREs (soluble N-ethylmaleimide-
sensitive fusion protein attachment protein receptors), a class of coiled-coil 
proteins (Chen and Scheller, 2001; Jahn and Sudhof, 1999; Sollner et al., 
1993b). SNARE proteins form coiled-coil aggregates that help link two opposing 
membranes for fusion (Chen and Scheller, 2001; Jahn and Sudhof, 1999; Sollner 
et al., 1993b). Endosome membrane fusion is also dependent on SNAREs 
(Braell, 1987; Gruenberg et al., 1989; Mullock et al., 2001; Salzman and 
Maxfield, 1988). The SNARE protein SNAP-25 (Synaptosomal-associated 
protein of 25 KD) is a member of this complex and participates in vesicle 
membrane docking and fusion. A role for SNAP-25 in membrane fusion of early 
endosomes has been previously documented, as disruption of SNAP-25 inhibits 
early endosome fusion (Braun et al., 2004; Sun et al., 2003). But, functions in 
other endosomal pathways, such as the recycling pathway, have not been well 
established. 
 37
In mammalian cells, the plasma membrane recycling system is critical in 
the maintenance and regulation of membrane proteins. Pumps, channels, 
receptors, and other membrane proteins are delivered to and removed from the 
membrane through this system. Studies have established that along with SNARE 
proteins, the Rab GTPase family is critical in this process. This family contains 
over 50 protein members and has been implicated in the formation, targeting, 
and fusion of transport vesicles (Casanova et al., 1999; Novick and Zerial, 1997; 
Ullrich et al., 1996; Wang et al., 2000). One member, Rab11a, is important in 
transferrin (Tf) receptor recycling through the perinuclear recycling system in 
nonpolarized cells (Green et al., 1997; Ren et al., 1998; Ullrich et al., 1996). 
The Tf receptor is a glycoprotein that associates with the cell membrane 
and is critical in the regulation of iron uptake in a variety of cell types. Iron is 
indispensable for life in both heme and non-heme iron proteins in a wide range of 
cellular processes, including oxygen transport, electron transport, DNA synthesis, 
and nitrogen fixation. With the exception of mature erythrocytes and some 
terminally differentiated cells, Tf receptor is expressed in all cells but at varying 
degrees. Cells that express the highest levels of protein include immature 
erythrocytes, placental tissue, and rapidly proliferating cells (reviewed in Ponka 
and Lok, 1999). The Tf receptor is 85 KD and contains 760 aa, and each binds 
one Tf molecule. Diferric Tf has the greatest affinity for the receptor, monoferric 
Tf an intermediate affinity, and apotranferrin has the least (Young et al., 1984). A 
model of tranferrin-iron uptake is depicted in Figure 11. Once internalized, early
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Figure 11. Transferrin uptake. In the first step, diferric Tf preferentially binds to the Tf
receptor. Bound receptors then cluster into clathrin-coated pits. Second, the Tf receptor 
complexes are internalized. Third, iron is released from the receptor in endosomes by a 
temperature and energy-dependent process, which requires the lowering of pH within the 
vesicles. Tf receptor and apotransferrin are then recycled to the plasma membrane, with 
Rab11a and recycling endosomes (RE) having roles in the process. Figure adapted from
Magadan et al., 2006.
(Jin and Snider, 1993), late (Sakai et al., 1998), and recycling endosomes (Ullrich 
et al., 1996) have all been shown to contain intracellular pools of the internalized 
Tf receptor complex. It remains unclear how the different intracellular pools vary 
in function. Rabs 4 (Daro et al., 1996), 5 (Bucci et al., 1992), 11 (Ullrich et al., 
1996), and 22 (Magadan et al., 2006) have functions in endocytosis of the 
complex. Rab11a participates in recycling of the apotransferrin and the receptor 
from the perinuclear recycling endosome network to the plasma membrane. 
Rab11a also regulates transcytosis and apical recycling of polymeric IgA 
receptor through the apical recycling system in polarized cells (Casanova et al., 
1999; Wang et al., 2000). Furthermore, Rab proteins play a well-established role 
in docking of vesicles to their target compartment and in vesicle association with 
the actin cytoskeleton (Apodaca et al., 1994; Lapierre et al., 2001; Ullrich et al., 
1996). 
Previous studies have identified a number of Rab11a interacting proteins, 
one of which is myosin Vb, an unconventional myosin that is implicated as a 
motor protein for the transit of vesicles out of the plasma membrane recycling 
endosome pathway (Lapierre et al., 2001; Reck-Peterson et al., 2000). This is of 
particular interest because expression of a myosin Vb-tail chimera, which lacks 
the myosin motor and neck domains, colocalizes with Rab11a in perinuclear 
vesicles in HeLa cells and causes retardation of Tf trafficking, a model of plasma 
membrane recycling (Hales et al., 2002; Lapierre et al., 2001). Similar to 
transfection with myosin Vb chimeras, the expression of Rab11a mutants and 
truncations of Rab11a-interacting proteins block exit of Tf from the recycling 
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endosome vesicles (Hales et al., 2002; Junutula et al., 2004; Lapierre et al., 
2001; Lindsay and McCaffrey, 2002; Ren et al., 1998). 
Our laboratory has discovered Lek1, a relatively large protein of over 300 
KD, which is a member of the LEK family of proteins (Goodwin et al., 1999; 
Mancini et al., 1995; Pabon-Pena et al., 1999). These proteins share similar 
structures that include numerous leucine zippers, a central spectrin repeat, an 
atypical Rb binding domain, and a nuclear localization sequence domain in its C-
terminus (Ashe et al., 2004; Dees et al., 2000; Goodwin et al., 1999; Pabon-Pena 
et al., 1999). Even though the LEK family of proteins displays similar homology, 
they contain divergent domains and have varying expression patterns and 
functions.   
Lek1 undergoes post-translational cleavage that produces two peptides: a 
C- terminal peptide that immediately localizes to the nucleus, termed nucLEK1, 
and an N- terminal peptide named cytLEK1 that distributes throughout the 
cytoplasm (Ashe et al., 2004; Soukoulis et al., 2005). Until now, studies on Lek1 
function have focused on two areas: the role of nucLEK1 in cell division and 
differentiation (Ashe et al., 2004; Goodwin et al., 1999; Papadimou et al., 2005), 
and the function of cytLEK1 in regulation of cell shape through its association 
with Nde1 (formally NudE) and the microtubule network (Soukoulis et al., 2005). 
Important to the current study, Nde1 has been shown to bind Lis1 and dynein 
(Faulkner, 2000; Morris and Xiang, 2000; Smith, 2000). Both Lis1 and dynein 
interact with the microtubule network through the Lis1 pathway regulating 
membrane trafficking, organelle positioning, migration, and mitosis (Banks and 
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Heald, 2001; Gibbons, 1996; Terada et al., 1998). Our laboratory has previously 
shown that dominant-negative protein expression and morpholino suppression of 
cytLEK1 function severely alters cell shape by interfering with the microtubule 
network (Soukoulis et al., 2005). Together, these data indicate a role of cytLEK1 
with the Lis1 pathway and the microtubule network. However, the functions of 
cytLEK1, the Lis1 pathway, and the microtubule network in membrane trafficking 
and organelle positioning remain poorly understood. 
In an effort to further define cytLEK1 function, the highly coiled N- terminal 
portion of cytLEK1 was used in a Y2H screen to identify novel interacting 
proteins. One of the binding proteins identified was SNAP-25. This interaction 
was consistent with the hypothesis that cytLEK1 plays a role in the dynamics of 
the cytoskeleton and in membrane trafficking. In the present study, we define the 
interaction domains within cytLEK1 and SNAP-25 that are responsible for 
association between the two proteins. Immunofluorescence and 
immunoprecipitation studies demonstrate that both transiently expressed and 
endogenous cytLEK1 and SNAP-25 proteins interact in a complex that also 
includes Rab11a, and myosin Vb, which are partners in plasma membrane 
recycling. The SNAP-25 interacting SNARE proteins vesicle-associated 
membrane protein 2 (VAMP2) and syntaxin 4 were also identified in this 
complex. Finally, we show that disruption of cytLEK1 function inhibits Tf 
trafficking, a model for plasma membrane recycling. Taken together with our 
previous data, the present study suggests that cytLEK1 provides a critical link 
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between recycling endosomes and the microtubule network through its 
association with SNAP-25. 
 
Materials and Methods 
 
Yeast Two-Hybrid Screen  
The N-terminus of cytLEK1 (aa 1-689) was PCR amplified using a full-
length cytLEK1 clone (aa 1-2210) containing restriction sites and ligated into 
pGBKT7 for use in the Matchmaker Y2H System 3 (BD Biosciences Clontech). 
The bait containing yeast were mated with a yeast strain pretransformed with a 
whole mouse embryonic day 17.5 cDNA library. Yeast colonies that survived on 
Quadruple Dropout Medium (QDO; SD/-Ade/-His/-Leu/-Trp/X-a-Gal) and 
exhibited lacZ expression were subjected to further testing. Colonies were then 
streaked several times to ensure plasmid segregation. Library plasmids were 
isolated and the inserts sequenced by the Vanderbilt Sequencing Core Facility 
and identified using NCBI Blast (Altschul et al., 1990). For each identified protein 
product, false positive tests involving empty vector and random protein matings 
were conducted to eliminate spurious interactions according to the 
manufacturer’s recommendations. 
 
Cell Culture and Transfection 
COS-7, NIH 3T3, and C2C12 cells (ATCC) were maintained in Dulbecco’s 
modified Eagle’s medium supplemented with 10, 10, and 20% FBS respectively, 
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100 ug/mL penicillin/streptomycin, and L- glutamine, in a 5% CO2 atmosphere at 
370C. Cells were grown to 50-75% confluency and transfected with DNA using 
FuGENE 6 (Roche) according to the manufacturer’s recommendations. 
 
Immunostaining and Microscopy 
For transient protein experiments, cells were grown on glass chamber 
slides and transfected 24 h after passage. Cells for transient and endogenous 
studies were gently washed with 1X PBS and fixed with either Histochoice or 4% 
paraformaldehyde for 20 min. Cells stained for γ-tubulin were fixed with methanol 
at -20oC for 15 mins. Cells were washed with 1X PBS, permeabilized with 0.25% 
Triton X-100 in 1X PBS for 10 min, and blocked for at least 1 h in 2% BSA in 1X 
PBS. Primary antibodies were diluted in 1% BSA and incubated overnight at 4oC. 
Cells were washed 3 times in 1X PBS; secondary antibodies were added for 1 h 
at room temperature. Cells were again washed 3 times with 1X PBS and 
coverslips mounted with AquaPoly/Mount (PolySciences). Cells were visualized 
by fluorescence microscopy with an AX70 (Olympus), or for confocal analysis, 
with an LSM510 (Ziess) microscope. Images were captured and processed using 
Magnafire (Olympus) and Photoshop (Adobe).  For deconvolution analysis, 
confocal Z stacks (0.5 um optical thickness) were utilized, using a blind 3D 
deconvolutional algorithm (AutoQuant Imaging). All images of control and 
experimental cells were processed identically. 
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Coimmunoprecipitation Using Transient Transfections 
COS-7 cells were grown on 10 cm plates; proteins were harvested 48 h 
post transfection. The ProFound Mammalian c-Myc Tag Co-IP Kit (Pierce) was 
utilized according to manufacturer’s protocol.  Briefly, cells were washed once 
with ice-cold TBS, incubated with M-Per Extraction Reagent (Pierce) containing 
protease inhibitor (Sigma), and centrifuged at 16,000 X g for 20 min at 4oC. 
Lysate protein concentration of the supernatant was determined using a 
bicinchoninic acid solution assay (Pierce). 100 μg total lysate was incubated for 2 
h at 4oC with 10 μl anti-c-myc agarose slurry with gentle shaking at 4oC. Columns 
were washed 3 times with 1X TBS-Tween. Protein was eluted with 2X non-
reducing sample buffer (Pierce) at 95oC for 5 min. To reduce proteins for SDS-
PAGE analysis and western blot analysis, 2 μl 2-mercaptoethanol was added. 
Ten μl of total lysate supernatant was used to confirm protein expression. Blots 
were developed using NBT-BCIP (Roche) and scanned into digital images 
(Hewlet-Packard). 
 
Deletional Analysis 
The cytLEK1 5’LCR (aa 1-689) and SNAP-25 yeast deletion constructs 
were created using a PCR approach and transformed into AH109 and Y187 
yeast, respectively, for matings. The 5’ LCR was further truncated into the N-
terminal 5’LSD. Deletion constructs were created that combined various regions 
of these domains as shown in Fig. 12A and B. Colonies were grown on QDO 
Medium and tested lacZ expression to determine viable interactions. In order to 
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confirm results by coimmunoprecipitation in mammalian cells, the relevant 
cytLEK1 and SNAP-25 yeast plasmid inserts were cloned into the pCMV-myc 
and EGFP-C3 expression vectors (BD Biosciences Clontech) and used for 
transfection studies in COS-7 cells. Truncations of cytLEK1 appear in Fig. 10A 
and B as follows: aa 1-689, 1-540, 1-474, 1-364, 1-170, 171-689, 365-689, and 
171-364. Truncations of SNAP-25 are as follows: aa 1-207, 1-102, 103-207, 1-
75, 1-27, 20-102, 28-102, and 15-75. 
 
Coimmunoprecipitation of Endogenous Protein Complexes Containing 
cytLEK1 
 
NIH 3T3 cells were lysed with Nonidet P-40 buffer with gentle sonication. 
Whole cell lysates were recovered and samples containing 2-3 mg total protein 
were precleared with GammaBind Plus Sepharose (Amersham Biosciences) for 
20 min at 4oC with gentle rotation. Cell lysates were collected and incubated 
overnight with 3 μg of a monoclonal SNAP-25 antibody (Sigma). GammaBind 
Plus Sepharose was added to bind the antibody-protein complex.  Beads were 
washed 3 times with cold 1X PBS and proteins were eluted with Laemmli sample 
buffer at a boiling temperature for 5 min. Proteins were resolved on a 6% SDS-
PAGE gel and analyzed by Western blot analysis.   
 
Nocodazole Treatment 
Cells were transfected with the appropriate plasmids and exposed to 100 
μM nocodazole (Sigma) for 30 min at 4oC in the appropriate serum conditions 
(Soukoulis et al., 2005). Cells were then immunostained as described above. 
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Morpholino (MO) Antisense Oligomer Treatment 
Methods used and the production and use of MO that specifically inhibits 
production and accumulation Lek1 have been previously reported (Ashe et al., 
2004; Soukoulis et al., 2005). 
 
Tf Trafficking 
For Tf internalization studies, COS-7 cells were cotransfected with the 
binding domains of cytLEK1 and SNAP-25. 5’LSD was ligated into pVenus (Ibata 
et al., 2002) and SNAP-25 was ligated into pCerulean (Rizzo et al., 2004); both 
gifts from Dr. Piston, Vanderbilt Univeresity). Cells coexpressing both proteins 
could be analyzed. 24 h post transfection, cells were serum starved for 2 h with 
DMEM containing 0.2% BSA at 37oC in CO2. Cells were then incubated for 30 
min with serum media containing 50ug/ml Alexa-633 Tf (Molecular Probes) at 
4oC to allow binding (Time-0). Labeled Tf was then allowed to internalize for 5, 
10, and 20 min. Cells were then washed with 1XPBS, trypsinized, and 
resupended. The fluorescence intensity of cell-associated Alexa-633 Tf was 
measured by flow cytometry utilizing a BD LSRII (BD Biosciences; Vanderbilt 
Flow Cytometry Core). The mean intensity of each cell population (5000 cells) 
was recorded at each time point. The intensity of Alexa-633-conjugated Tf was 
gated by expression of Venus and Cerulean in cotransfected cells. Control mock 
transfected cells expressed EGFP (Clontech). The mean flourescense intensity 
was compared between cotransfected and mock transfected cell populations. 
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 For the Tf recycling analysis, MO and Standard Control (SC) cell 
populations were allowed to bind and internalize labeled Tf for 30 min (described 
above). After internalization (Time-0), pulse labeled Tf was chased by addition of 
normal DMEM containing 10% FBS and analyzed at 5, 10, and 20 min after 
labeled Tf internalization. The mean fluorescence intensity was compared 
between MO and SC cell populations 
 
Antibodies 
cytLEK1, Rab11a, and myosin Vb antibodies were previously described 
(Lapierre et al., 2001; Soukoulis et al., 2005). Anti-cytLEK1 specificity has been 
tested by immune peptide competition and by selective loss of reactivity in 
conditional knockout of the Lek1 gene in the developing mouse heart (Pooley 
and Bader, manuscript in preparation). Also, screening of lambda GT11 libraries 
with this antiserum identified only Lek1 transcripts (Pabon-Pena and Bader, 
unpublished data). SNAP-25, syntaxin 4, and γ-tubulin antibodies were obtained 
from Sigma. Golgin, p58, and giantin antibodies were obtained from Molecular 
Probes. α-myc and α-GFP antibodies were obtained from BD Bioscience. 
VAMP2 and VAMP3 antibodies were purchased from StressGen, and VAMP8 
antibody was from Abcam. Alexa Fluor 488- and 568- conjugated secondary 
antibodies were utilized (Molecular Probes). For triple labeled 
immunofluorescence studies, polyclonal anti-myc (Novus) was directly labeled 
with the Zenon Alexa-647 labeling kit (Molecular Probes). Alkaline phosphatase-
conjugated secondary antibodies for western blot were purchased from Sigma. 
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Results 
 
Identification of SNAP-25 as a cytLEK1 interacting protein 
A Y2H screen was used to identify novel cytLEK1 binding partners and 
further characterize cytLEK1 function. The region chosen as bait to screen an 
embryonic whole mouse cDNA library consisted of the N-terminal most 689 aa of 
cytLEK1 beginning at the translation start site (base pairs 1-2067; termed 5’ LCR 
for cytLEK Coil Region; Figure 12). A PROSITE domain search of this region 
identified a highly coiled structure with a leucine zipper (Rutkowski et al., 1989). 
From the Y2H screen, four independent clones were found to contain the full 
coding sequence of SNAP-25, and all clones passed the false screening 
process. No other region of cytLEK1 tested thus far has shown interaction with 
SNAP-25. Since we have previously demonstrated that cytLEK1 has a function 
with the microtubule network (Soukoulis et al., 2005), and SNAP-25 is important 
for vesicular transport (Braun et al., 2004; Sun et al., 2003), we pursued this 
protein interaction to test whether cytLEK1 is involved in membrane trafficking. 
 
Identification of cytLEK1 and SNAP-25 binding domains 
In order to define the domain within the 5’LCR region of cytLEK1 that 
associates with SNAP-25, we employed a Y2H approach. A series of truncations 
of the 5’LCR region revealed a minimal region of cytLEK1 that was sufficient to 
bind the full-length SNAP-25. We termed this binding region as 5’LSD, for 
cytLEK SNAP-25 Binding Domain (aa 1-474; Figure 12A-B). While all constructs 
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Figure 12. Identification of cytLEK1/SNAP-25 interaction and characterization of 
binding domains. A) Our initial Y2H screen identified SNAP-25 as having a direct interaction 
with cytLEK1. 5’LCR was used as bait and associates with SNAP-25. A series of truncations 
were constructed by PCR and then transformed into appropriate yeast strains. Yeast were then 
grown and plated on QDO medium. Positive associations grew and exhibited blue color upon 
Gal testing. As a control, growth was indicated by yeast transformed with pGBKT7-53 and 
pGADT7-T. The negative control utilized yeast expressing pGBTK-53 and the empty vector 
pGADT7. Positive cytLEK1 and SNAP-25 interactions must contain the 5’LSD and SNLD 
regions of the proteins to associate and grow on QDO medium.  B) This is a summary of the 
5’LCR deletion constructs that were tested for interaction with full-length SNAP-25 by Y2H 
analysis.  (+) indicates interaction between the constructs.  The N-terminal 474 aa of cytLEK1, 
5’LSD, is required and sufficient for association with SNAP-25.  A similar deletion series was 
constructed with SNAP-25 sequences. The N-terminal 75 aa, SNLD, was found to be required 
and sufficient for cytLEK1 binding. C) COS-7 cells were transfected with 5’LCR and GFP-
SNAP-25 or with GFP-SNAP-25 alone. An immunoprecipitation was conducted with α-myc
antibody, and blots were probed with α-GFP antibody. Input lanes show transfected protein 
expression in the lysate. GFP-SNAP-25 was precipitated in the presence of 5’LCR, but not 
without 5’LCR. D) COS-7 cells were transfected with both 5’LSD and GFP-SNLD, and GFP-
SNLD was found to immunoprecipitate with 5’LSD. As a negative control, cells were
transfected with 5’LSD and GFP-3’SN25, which demonstrates no interaction between the 
proteins. Thus, we have identified the 5’LSD of cytLEK1 and the SNLD of SNAP-25 as being 
required for association.
containing this region were found to bind SNAP-25 in yeast matings, further 
truncations of 5’LSD eliminated all interactions with full length SNAP-25 (Figure 
12A-B). Therefore, we determined that 5’LSD was critical for cytLEK1/SNAP-25 
interaction. Of note, 5’LSD association does not appear to extend to all members 
of the SNAP family of proteins, as SNAP-23 did not interact with 5’LSD in Y2H 
analysis. 
 Next, we analyzed the region within SNAP-25 that was responsible for 
cytLEK1 interaction. SNAP-25 deletion studies revealed that the N-terminal 75 aa 
of the protein, termed SNAP-25 Lek1 binding Domain (SNLD), were sufficient 
and required for the interaction of the 5’LSD domain of cytLEK1 (Figure 12A-B). 
Further truncations of SNLD eliminated all protein interactions. Interestingly, this 
binding region within SNAP-25 contains two coil domains critical for its 
interactions with VAMP/Synaptobrevin and syntaxin (Chapman et al., 1994). Both 
VAMP/Synaptobrevin and Syntaxin are important for membrane docking and 
fusion (Chapman et al., 1994; Hong, 2005; Stoichevska et al., 2003). 
 To determine whether cytLEK1 and SNAP-25 interact within mammalian 
cells, COS-7 cells were then cotransfected with both 5’LCR and a GFP-SNAP-25 
fusion construct. As seen in Figure 12C, coimmunoprecipitations of GFP-SNAP-
25 revealed interaction with myc-tagged 5’LCR. Control experiments 
demonstrated no precipitation of SNAP-25. In order to confirm the interacting 
domains, we performed coimmunoprecipitation analyses with the minimal 
interacting domain, 5’LSD, and either the GFP-SNLD or the 3’ domain of SNAP-
25, termed GFP-3’SN25. While interaction was confirmed for 5’LSD and GFP-
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SNLD, GFP-3’SN25 did not form a complex with the 5’LSD of Lek1 (Figure 12D). 
These results demonstrate that the 5’LSD region of cytLEK1 is required for 
SNAP-25 interaction and confirm our Y2H results.   
 
Endogenous cytLEK1 colocalizes and associates with its interacting 
partner SNAP-25 in murine cells 
 
We next examined the endogenous colocalization and association of 
cytLEK1 and SNAP-25. Cell lines previously shown to express both cytLEK1 
(Soukoulis et al., 2005) and SNAP-25 (Sevilla et al., 1997) were used in these 
studies. As seen in confocal and deconvolution images in Figure 13, there was 
significant colocalization of cytLEK1 with SNAP-25 in NIH 3T3 fibroblast and 
C2C12 myoblast cells. Images show a strong overlap of intense perinuclear 
distribution of the proteins, with further colocalization extending away from the 
nucleus. Cytoplasmic distribution of SNAP-25 has been previously described 
(Aikawa et al., 2006; Blasi et al., 1995; Catsicas et al., 2002; Kataoka et al., 
2000; Sun et al., 2003; Yan et al., 2003). Our data reveal that the colocalization 
of the proteins is not absolute in these cell lines, as overlap in staining was 
greatest surrounding the nucleus and became less apparent in the cell periphery. 
Since both endogenous proteins have multiple and varied functions, absolute 
colocalization was not expected. The staining pattern seen in these cell lines was 
not an artifact, as colabeling studies with other markers, such as the cytoplasmic 
proteins β-catenin and Bves, showed no significant colocalization (data not 
shown). Even though SNAP-25 is considered most predominantly neuronal in
 52
53
Figure 13. Endogenous cytLEK1 and SNAP-25 colocalize in murine cells. CytLEK1 
expression is shown in red, while SNAP-25 is shown in green. A) CytLEK1 and SNAP-25 
demonstrated significant overlap in expression throughout the cytoplasm in NIH 3T3 
fibroblasts (merge).  They share a high degree of colocalization in the perinuclear region, but 
SNAP-25 has a broader distribution extending into the cell periphery. B) C2C12 myoblasts
demonstrated a similar distribution pattern to that seen in the NIH 3T3 fibroblasts. C)
Deconvolution analysis of proteins in C2C12 myoblasts was conducted to show a high degree 
of colocalization. All images are from confocal microscopy. (Bar, 10 μm). D) CytLEK1 forms 
an endogenous complex with SNAP-25. Endogenous protein complexes were analyzed using 
NIH 3T3 cell lysates for coimmunoprecipitation analysis with α -SNAP-25 antibody,
Sepharose beads alone, or IgG antibody alone. After precipitation, elution, and western 
blotting, the blot was probed with α-cytLEK1 antibody. Lane 1 demonstrates the presence of 
cytLEK1 in the lysate.  Lane 2 shows that cytLEK1 precipitates with SNAP-25.  Lanes 3 and 
4 demonstrate the lack of precipitation with beads and non-immune IgG.
expression, numerous non-neuronal cell types have been documented that 
express SNAP-25 (Bhangu et al., 2003; Jagadish et al., 1996; Karvar et al., 
2002; Macaulay et al., 1997; Scott and Zhoa, 2001). 
 We next tested whether endogenous cytLEK1/SNAP-25 complexes could 
be isolated from cells. A series of coimmunoprecipitation studies, with the same 
NIH 3T3 cell line that demonstrated immunofluorescent colocalization, was 
conducted with an antibody previously used to recover SNAP-25 and its 
interacting partners (Kolk et al., 2000). As seen in Figure 13D (lane 2), SNAP-25 
forms an endogenous complex containing cytLEK1. In contrast, neither 
Sepharose beads nor α-IgG antibodies alone were able to precipitate cytLEK1 
(Figure 13D, lanes 3 and 4). Thus, along with our genetic, biochemical, and 
transient protein localization and interaction studies, we demonstrated that 
cytLEK1 and SNAP-25 associate and form an endogenous complex. 
 
5’LSD redistributes with SNAP-25 expression 
Our previous data showed that the 5’LSD of cytLEK1 and SNAP-25 
interact at a biochemical level. We next confirmed that, similar to the endogenous 
proteins, the transfected protein constructs colocalized in mammalian cells. 
Immunochemical reagents used in this study do not detect endogenous cytLEK1 
or SNAP-25 in COS-7 cells. COS-7 cells were transfected with either 5’LSD or 
SNAP-25. In cells expressing 5’LSD alone, a cytoplasmic localization with a 
distinct punctate perinuclear distribution was observed (Figure 14A). Cells 
transfected with GFP-SNAP-25 also demonstrated a perinuclear distribution, in
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Figure 14. Transfected 5’LSD and GFP-SNAP-25 distribution in COS-7 cells. COS-7 cells 
were transfected individually with either 5’LSD or GFP-SNAP-25 (A and B), or cotransfected
with both constructs (C-E). α-myc immunostaining (blue) is shown in A and C. GFP fluorescence 
(green) is observed in B and D. A) Cells singly transfected with 5’LSD demonstrated a high
perinuclear distribution. B) GFP-SNAP-25 expressing cells also showed a cytoplasmic
distribution with high levels of fluorescence observed in the perinuclear region and at the cell 
periphery. (C-E) Cotransfected cells demonstrated relocalization and redistribution of both 
proteins to a perinuclear ring with extensive overlap seen in the merged image (E). Control cells 
show no redistribution of 5’LSD with EGFP expression (F-G). (*) denotes cotransfected cells. All 
images are from confocal microscopy. (Bar, 5 um)
 addition to high levels of expression at the cell periphery (Figure 14B). This 
pattern of SNAP-25 overexpression has been reported previously (Xiao et al., 
2004). 
 Interestingly, when COS-7 cells were cotransfected with 5’LSD and GFP-
SNAP-25, a dramatic redistribution of transiently expressed protein localization 
was observed. Immunoreactivity of 5’LSD overlapped extensively with that of 
GFP-SNAP-25 at a distinct perinuclear focus (Figure 14, C-E). Importantly, this 
overlap was not observed when EGFP was cotransfected with 5’LSD, as EGFP 
remained expressed throughout the cytoplasm and nucleus (Debily et al., 2004) 
with minimal colocalization and no redistribution of 5’LSD distribution (Figure 14, 
F-G). These findings demonstrate a specific interaction between 5’LSD and GFP-
SNAP-25, which is not a consequence of simple protein overexpression.      
 
5'LSD and SNAP-25 interact with components of the recycling endosomal 
pathway 
 
Coexpression of 5’LSD and GFP-SNAP-25 demonstrated an intense 
overlap in a perinuclear locus. This perinuclear localization is similar to the 
pattern seen in HeLa cells transiently expressing either the myosin Vb-tail or a 
truncated form of the plasma membrane recycling endosome associated Rab11-
family interacting protein 2 (Hales et al., 2002; Lapierre et al., 2001). To 
determine whether components of the endosomal recycling pathway were also 
present in the 5’LSD/GFP-SNAP-25 complex, we assessed the distribution of 
Rab11a in cotransfected cells (Green et al., 1997; Ullrich et al., 1996). As seen in 
Figure 15A, redistribution of Rab11a to the same perinuclear region in 5’LSD and 
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Figure 15. Rab11a colocalization with 5’LSD and GFP-SNAP-25. 
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Figure 15– cont. COS-7 cells were cotransfected with 5’LSD and GFP-SNAP-25 or GFP-
SNAP-23. In A-G, cells were triple imaged as labeled with α -myc (blue), GFP fluorescence 
(green), and as labeled in red. Cells coexpressing 5’LSD and GFP-SNAP-25 colacalize to a
perinuclear foci. A) Cells co-expressing 5’LSD and GFP-SNAP-25 showed a high degree of 
localization with endogenous Rab11a. B) p58, a Golgi marker, does not colocalize in
cotransfected cells, but there was redistribution of the protein that is excluded from the
perinuclear focus of the transfected proteins. C-D) Both endogenous Syntaxin 4 and VAMP2 
localize and have high expression at the perinuclear focus containing 5’LSD and GFP-SNAP-
25. E-G) VAMP3, Syntaxin 13, and VAMP8 do not show strong localization of the proteins at 
the perinuclear focus. H) Cotransfection of 5’LSD and GFP-SNAP-25 relocalize around the
centrosome, as indicated by γ-tubulin staining in red. Dapi staining is indicated in blue.  I) As 
a control, GFP-SNAP-23 was cotransfected with 5’LSD. Interstingly, the trasfected proteins 
did not redistribute to a perinuclear focus as observed with cotransfection of SNAP-25 and 
5’LSD, and there was no dramatic redistribuation of endogenous Rab11a (red). Images in A-
G, and I were taken by confocal microscopy. (Bar, 4 μm)
GFP-SNAP-25 coexpressing cells was readily observed. In order to test whether 
this phenotype was specific for 5’LSD and SNAP-25 interaction, we tested 
overexpression of 5’LSD and SNAP-23. Interestingly, coexpression of the two 
proteins did not form the tight perinuclear focus and did not redistribute 
endogenous Rab11a into that structure (Figure 15I). Analysis of colocalization 
with the Golgi showed minimal colocalization with the transfected proteins at the 
perinuclear focus, here shown with the Golgi marker p58 (Figure 15B). It is of 
interest to note though, that Golgi proteins showed redistribution to a position 
adjacent to and at the center of the perinuclear 5’LSD and GFP-SNAP-25 locus. 
As indicated by γ-tubulin staining, the 5’LSD and GFP-SNAP-25 ring focus 
encircled the centrosome (Figure 15H). 
 Other SNARE proteins have been shown to be associated with recycling 
endosomes.  The vesicular SNARE proteins VAMP2, VAMP3, syntaxin 4, and 
syntaxin 13 have all been reported to localize in Rab11a containing recycling 
endosomes (Band et al., 2002; Calhoun and Goldenring, 1997; McMahon et al., 
1993; Prekeris et al., 1998). We next examined whether these proteins were also 
in the perinuclear focus in cotransfected cells. We examined and detected both 
VAMP2 and Syntaxin 4 at the perinuclear focus in cells coexpressing 5’LSD and 
GFP-SNAP-25 (Figure 15, C-D). Surprisingly, neither endogenous VAMP3 nor 
Syntaxin 13 protein expression redistributed with coexpression of the transfected 
proteins (Figure 15, E-F). As an internal control, VAMP8, shown to be expressed 
in early endosomes (Nagamatsu et al., 2001), was examined for localization at 
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the perinuclear focus and was not found to be redistributed to the 5’LSD/GFP-
SNAP-25 focus (Figure 15G). 
To test whether Rab11a is contained within the same 5’LSD/GFP-SNAP-
25 complex, whole protein lysates from cotransfected COS-7 cells were collected 
and analyzed. Lysates containing transfected 5’LSD and GFP-SNAP-25 proteins 
were probed for Rab11a and were subsequently found to contain endogenous 
Rab11a in the 5’LSD/GFP-SNAP-25 complex (Figure 16). Myosin Vb, a key 
regulator of Rab11a-containing recycling vesicles (Lapierre et al., 2001), was 
also found in the complex (Figure 16).  Notably, further Y2H analyses showed no 
direct interaction between 5’LSD and either Rab11a or myosin Vb, therefore 
suggesting an indirect association between these proteins and cytLEK1. The 
membrane bound SNARE protein VAMP2 has also been reported to be present 
on Rab11 containing vesicles (Calhoun and Goldenring, 1997). We 
coimmunoprecipitated the same lysates and identified VAMP2 to be associated 
in the complex (Figure 16). From these data, we have thus characterized critical 
proteins in the complex that links 5’LSD with recycling endosomes. 
 
The 5’LSD/GFP-SNAP25 complex is formed independent of the microtubule 
network 
 
Previous studies have shown that endosomal recycling is dependent on 
an intact microtubule network and that vesicles are dispersed upon microtubule 
disruption with the depolymerizing agent nocodazole (Apodaca et al., 1994; 
Casanova et al., 1999; Lapierre et al., 2001). Gross alteration of microtubule
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Figure 16. Rab11a, myosin Vb, and VAMP2 are in the same complex as 5’LSD/GFP-
SNAP-25. COS-7 cells were cotransfected with 5’LSD and GFP-SNAP-25 or transfected with 
GFP-SNAP-25 alone, and lysates were obtained. Immunoprecipitations were conducted 
utilizing α-myc antibody, and the blots were probed with either α-Rab11a, α-myosin Vb, or α-
VAMP2 antisera to detect endogenous proteins. Input lanes show presence of transfected
proteins in the lysate. Precipitation of 5’LSD/GFP-SNAP-25 demonstated the presence of 
Rab11a, myosin Vb, and VAMP in the complex, but neither Rab11a, myosin Vb, nor VAMP2
immunoprecipitate in lysates expressing GFP-SNAP-25 alone. 
network organization after cotransfection of 5’LSD and GFP-SNAP-25 was not 
observed (Figure 17). Interestingly, 5’LSD/GFP-SNAP-25 coexpressing cells did 
not demonstrate redistribution of the complex after challenge with nocodazole 
(Figure 17, D-F). Therefore, we postulate that the recycling complex is stable and 
is independent of the microtubule network after disruption with the microtubule- 
depolymerizing agent. Immunostaining for Rab11a in cotransfected cells showed 
that the recycling vesicle protein continued to associate at the distinct perinuclear 
focus after treatment with nocodazole (Figure 17F, arrow). In nontransfected 
cells, nocodazole treatment resulted in a diffuse distribution of Rab11a 
throughout the cytoplasm (Figure 17F, arrowhead), which is similar to that seen 
in MDCK cells after disruption of the microtubule network (Casanova et al., 
1999). Since 5’LSD does not contain the Nde1 binding domain, we propose that 
the lack of redistribution of the vesicle components in cells expressing 5’LSD and 
GFP-SNAP-25 was due, in part, to the inability of 5’LSD to interact with the 
microtubule network. These results suggest that the 5’LSD/SNAP-
25/Rab11a/myosin Vb/VAMP2/Syntaxin 4 containing complex in cotransfected 
cells is not associated with the microtubule system. Furthermore, the expression 
of 5’LSD and GFP-SNAP-25 results in a redistribution of the recycling endosome 
pathway. Therefore, it would be expected that endosomal recycling would be 
altered. 
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Figure 17. Morphological effects of cotransfected COS-7 cells. Cells were cotransfected with 
5’LSD and GFP-SNAP-25, as previously shown (A-C), or treated with nocodazole for 30 min 
(D-F). 5’LSD is immunostained with α-myc antibody in white, GFP fluorescence in green, and α-
Rablla is indicated in red. Cells demonstrated colocalization of 5’LSD/GFP-SNAP-25/Rab11a 
with no treatment as expected (A-C), but cotransfected cells treated with nocodazole also showed 
no redistribution of any of the proteins (D-F). Nontransfected cells in panel F showed a 
dispersion of Rab11a throughout the cytoplasm (arrowhead). Cotransfected cells are indicated 
with arrows. G-H) Cells were cotransfected with 5’LSD and GFP-SNAP-25 as previously shown. 
Cells were then preextracted and stained for β-tubulin (red) to visualize the microtubule network. 
Cells never demonstrated 5’LSD nor GFP-SNAP-25 localization after preextraction. Therefore, 
the perinuclear focus that contains 5’LSD and GFP-SNAP-25 in cotransfected cells is washed out 
in the soluble fraction and is not bound to the microtubule network. DAPI is in blue. (Bar, 10 μm)
cytLEK1 functions in Tf recycling 
Tf receptor trafficking is known to depend on the plasma membrane 
recycling pathway (Bilan et al., 2004; Ghosh et al., 1994; Sonnichsen et al., 
2000). Disruption of the recycling endosomal pathway by mutants of Rab11a, 
Rab11a-FIP2, and myosin Vb inhibits Tf recycling (Hales et al., 2002; Lapierre et 
al., 2001; Ren et al., 1998). In order to determine whether disruption of cytLEK1 
function by expression of 5’LSD and GFP-SNAP-25 inhibits vesicle transport, Tf 
recycling was examined in cotransfected COS-7 cells by utilizing flow cytometry.   
Cells were cotransfected and cells expressing both 5’LSD and SNAP-25 
were analyzed for Tf uptake (Figure 18A). After a 30 min time period allowing 
Alexa-633 labeled Tf to bind the cells, the amounts of internalized labeled Tf 
were measured at 5, 10, and 20 min time points. Tf uptake is diminished in 
coexpressing cells, as they demonstrated ~13% reduction in labeled Tf 
internalization at all timepoints compared to control cells. The rates of recycling 
were not affected in cotransfected cells which mirrors the results of Nakamura et 
al. (2005) in Tf internalization. Taken together, the coexpression of the binding 
partners 5’LSD and SNAP-25 forms a dominant-negative complex and results in 
the redistribution of recycling endosome network and an inability of the cells to 
recycle Tf properly. 
 In order to further define the function of cytLEK1 and determine whether 
the protein alone has a role in Tf recycling, we examined Lek1 knock-down by 
MO antisense oligomers in NIH 3T3 fibroblasts (Figure 18B). We have previously
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Figure 18. cytLEK1 functions in Tf recycling. A) Cos-7 cells were cotransfected with 5’LSD 
and SNAP-25 (squares) or with the vector only expressing EGFP (circles) and allowed to bind
Alexa-633 Tf for 30 min at 4oC. After labeled Tf was allowed to bind the cells (Time-0), 
internalized, labeled Tf was measured in cells at 5, 10, and 20 min time points post binding.
Cotransfected and mock transfected cells were analyzed by flow cytometry and measured for 
mean fluorescence intensity. B) Lek1 MO oligomers were utilized to knock-down protein 
expression in NIH 3T3 fibroblasts. SC oligomers were used as controls. Cells were examined 48 
h after treatment. Cells were allowed to internalize labeled Tf and then chased with unlabeled Tf. 
Mean fluoresnce intensity was measured by flow cytometry in MO and SC treated cells at 0, 5, 
10, and 20 min after Alexa-633 Tf internalization. MO treated cells demonstrate a significant 
decrease in rate of Tf recycling. After a 20 min chase period, Lek1 knock-down cells retain 26% 
more labeled Tf than SC cells. Data are means + SE from three independent experiments. (*) 
ANOVA , P<0.01 vs. control. C) Lek1-specific MO treated cells demonstrate a significant, but 
not complete, knock-down of endogenous cytLEK1 compared to SC treated cells. (Bar, 10 μm)
confirmed the effectiveness and specificity of this Lek1 knock-down technology 
(Ashe et al., 2004; Soukoulis et al., 2005). Briefly, knock-down cells and standard 
control (SC) cells were allowed to bind Alexa-633 Tf for 30 min and then allowed 
to internalize labeled Tf for 30 min. After the internalization of labeled Tf, media 
containing unlabelled Tf was added to the cells (Time-0). Flow cytometry was 
used to measure the levels of Alexa-633 Tf retained in knock-down and SC cell 
populations at 5, 10, and 20 min after internalization. As expected, Lek1 knock-
down cells recycled labeled Tf at a significantly slower rate than SC cells and had 
a higher level of labeled Tf retained in the cells. These results further 
demonstrate that cytLEK1 function is critical for endosome recycling. 
 
Discussion 
 Lek1 is a member of a family of proteins that exhibits functional diversity, 
demonstrating roles in regulation of the cell cycle, myocyte differentiation, and 
microtubule dynamics. The human family member Mitosin/CENP-F has been 
shown to associate with the kinetochore, and its localization pattern is dependent 
on the cell cycle and also appears to play a role in cell division (Liao et al., 1995; 
Mancini et al., 1995). The chicken protein CMF1 has a function in chick myocyte 
differentiation in the developing embryo (Dees et al., 2000; Pabon-Pena et al., 
1999; Wei et al., 1996).  The mouse family member, Lek1 has a role in cell 
division and differentiation (Ashe et al., 2004; Dees et al., 2005). Recently, Lek1 
has been implicated in specification of the cardiac lineage from embryonic stem 
cells (Papadimou et al., 2005). Of interest for the current study, we have recently 
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identified cytLEK1 as a Nde1 binding protein (Soukoulis et al., 2005). Nde1 is a 
member of the Lis1 pathway and has been shown to associate with the 
microtubule network. Lek1 knock-down and dominant-negative experiments have 
profound effects on the microtubule network and cell morphology (Soukoulis et 
al., 2005).  
We have identified SNAP-25, a member of the SNARE family, as a novel 
cytLEK1 interacting protein. Expression of 5’LSD of cytLEK1 and SNAP-25 leads 
to the redistribution of the endosomal recycling system with relocalization of 
Rab11a, myosin Vb, and the membrane associated SNARE proteins VAMP2 and 
Syntaxin 4 into a perinuclear focus. SNAP-25 is well established in its direct 
interaction with VAMP2 (Chapman et al., 1994; Jahn and Sudhof, 1999). To date, 
most work has concentrated on VAMP3 and syntaxin 13 as being SNARE 
proteins localized to recycling endosomes. Data has been reported linking 
VAMP2 and syntaxin 4 as being proteins localized to recycling endosomes (Band 
et al., 2002; Calhoun and Goldenring, 1997). We have now identified VAMP2 and 
syntaxin 4 as being SNARE proteins in recycling endosomes in COS-7 cells. 
Emerging data continues to identify multiple SNAREs operating in trafficking 
steps and interacting with multiple protein complexes. Thus, characterizing 
SNARE complexes is critical to understand regulation of vesicle trafficking.  
An important link between the Lis1 pathway and recycling endosomes has 
now been identified. Cotransfected cells were studied since it established a 
stable protein complex that acts as a dominant-negative in COS-7 cells. Our data 
phenocopies previous patterns reported in transfection studies of dominant-
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negative myosin Vb-tail and the mutant Rab11-FIP2 (129-512) (Hales et al., 
2002; Lapierre et al., 2001), further implicating a role for cytLEK1 in the 
regulation of vesicular transport. Because studies have shown that docking and 
fusion of vesicle membranes within endosomal pathways are dependent on 
SNARE proteins (Foletti et al., 1999; Kodrik et al., 1998; Liang et al., 2004a; 
Mullock et al., 2001), cytLEK1 association with SNAP-25 predicts a function in 
the recycling pathway. Additionally, the microtubule network has been shown in 
the regulation of plasma membrane recycling (Apodaca et al., 1994; Casanova et 
al., 1999), yet proteins responsible for vesicle interaction with microtubules 
remain largely unknown. Our data indicate that cytLEK1 belongs to a new class 
of proteins that link recycling vesicles with the microtubule network and has 
implications for regulation of endosomal trafficking in a broad spectrum of 
developmental and cell biological processes.  
 
Identification of cytLEK1 and SNAP-25 interaction provides a physical link 
between recycling endosomes and the microtubule network 
 
The microtubule network is important in plasma membrane recycling (De 
Brabander et al., 1988; Gibbons, 1996; Lapierre et al., 2001; Sakai, 1991). These 
studies have established that depolymerization of the microtubule cytoskeleton 
by nocodazole treatment disperses the recycling system (Apodaca et al., 1994; 
Hales et al., 2002; Lapierre et al., 2001). Matanis et al. (2003) identified Bicaudal-
D as the link between microtubules and Rab6a positive vesicles, but proteins 
regulating plasma membrane recycling through the microtubule network remain 
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more obscure. Additional protein regulators of vesicle/microtubule association 
likely exist. 
From our data, we postulate that expression of 5’LSD, which lacks the 
Nde1 binding domain and therefore does not interact with the microtubule 
network, results in separating the 5’LSD/GFP-SNAP-25/Rab11a/myosin 
Vb/VAMP2/Syntaxin 4 perinuclear complex from the microtubule cytoskeleton. 
5’LSD would represent a dominant-negative form of cytLEK1 that alters its 
function in vesicle recycling. As seen in Figure 17, treatment of cotransfected 
COS-7 cells with nocodazole has no noticeable redistribution of Rab11a as 
compared to wild-type cells. This is in contrast to Lapierre et al. (2001), where 
myosin Vb and Rab11a positive vesicles partially dispersed after nocodazole 
treatment, suggesting that an intact microtubule network was needed for 
recycling endosome function and movement. We demonstrate that the 
perinuclear complex is independent of the microtubule network and is part of the 
soluble fraction of cells, further implicating a role for cytLEK1 in recycling 
endosome trafficking. It is interesting to note that the cytLEK1 binding partner 
Nde1 influences microtubule based Golgi trafficking, demonstrating that the Lis1 
pathway is involved in organelle transport (Liang et al., 2004b). We propose that 
cytLEK1 may be the bridge between Rab11a-containing recycling vesicles and 
the microtubule network through cytLEK1 binding to both SNAP-25 and Nde1.  
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5’LSD and SNAP-25 expression disrupt protein recycling 
Once we established cytLEK1 as a possible bridge between recycling 
vesicles and the microtubule network, we tested the effects of 5’LSD on Rab11a 
and Tf recycling. Expression of 5’LSD and GFP-SNAP-25 leads to relocalization 
of the Rab11a-containing vesicles into a perinuclear focus. As seen in Figure 18, 
Tf can enter transfected cells, but at significantly reduced amounts. We postulate 
that there is a reduction of Tf receptor at the cell surface, but Tf can still be 
internalized by early endosomes (Sheff et al., 2002). The retardation of Tf 
recycling has also been observed when dominant-negative constructs of Rab11a 
or its binding partners are expressed in nonpolarized cells (Hales et al., 2002; 
Lapierre et al., 2001; Mammoto et al., 1999; Valetti et al., 1999; Zeng et al., 
1999). Furthermore, knock-down of Lek1 expression significantly reduces Tf 
recycling and exit from the cell (Figure 18B). Our data demonstrate that 
expression of the SNAP-25 binding domain, 5’LSD, alters endosomal recycling, 
placing cytLEK1 as an essential member in an established recycling process. 
Therefore, we postulate that cytLEK1 and its association with an intact 
microtubule network are vital for recycling endosome trafficking. 
 To date, our studies demonstrate that cytLEK1 associates with both 
SNAP-25 and Nde1. Whereas previous studies have established a link between 
Rab11a-positive recycling endosomes and the actin cytoskeleton through 
association with myosin Vb, no proteins responsible for the interaction between 
recycling endosomes and the microtubule network have yet to be identified. The 
present data demonstrate that cytLEK1, SNAP-25, Rab11a, myosin Vb, VAMP2, 
 70
and syntaxin 4 can form a complex in association with plasma membrane 
recycling vesicles. Supporting our studies, Calhoun et al. (1997) and Peng et al. 
(1997) have also identified the SNARE protein VAMP2 in Rab11a containing 
recycling endosomes, while Band et al. (2002) has characterized syntaxin 4 at 
Rab11a positive endosomes. Therefore, we propose as a model that this 
complex acts as a bridge for recycling vesicles to the microtubule network 
through the ability of cytLEK1 to bind SNAP-25 and Nde1. cytLEK1 is a newly 
identified protein that links recycling endosomes with the Nde1/Lis1 pathway and 
the microtubule network. Similarly, the myosin Vb/Rab11a complex would bridge 
to the actin cytoskeleton. Thus, we have defined a multi-protein complex 
coordinating the dynamic interaction of recycling system membranes with both 
the microtubule and actin cytoskeleton. 
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CHAPTER III 
 
CYTLEK1 FUNCTIONS WITH SYNTAXIN 4 IN PLASMA MEMBRANE 
TRAFFICKING 
 
 
Introduction 
Plasma membrane trafficking is mediated by a series of budding and 
fusion events between donor and acceptor membranes. The SNARE (soluble N-
ethylmaleimide-sensitive fusion protein attachment protein receptors) family of 
proteins is responsible, at least in part, for regulation of intracellular membrane 
events. Apposing SNARE proteins, which consist of vesicle associated proteins 
(VAMPs), syntaxins, and synaptosomal-associated protein of 25KD (SNAP-25), 
form coiled-coil aggregates that are important in regulating membrane fusion 
events. Plasma membrane trafficking between cellular compartments is critical 
for localization of proteins to the cell surface (Chen and Scheller, 2001; Jahn and 
Sudhof, 1999; Sollner et al., 1993b). Trafficking of plasma membranes between 
the Golgi and recycling endosome network is implicated but not well described 
(Mallard et al., 2002; Wilcke et al., 2000). The regulators of this process are 
largely unknown.  
Syntaxin 4 is a SNARE protein that is localized to the plasma membrane 
and is also found in intracellular compartments, such as recycling endosomes 
(Bajohrs et al., 2005; Band et al., 2002). Plasma membrane trafficking to the cell 
surface involves the SNARE family proteins, but little is known about the potential 
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function of syntaxin 4 at recycling endosomes. Interestingly, even though no 
function has been identified for syntaxin 4 at the Golgi, transfected syntaxin 4 is 
found in that compartment (Takuma et al., 2002). Rab11a, a marker of recycling 
endosomes, functions in plasma membrane recycling in both polarized and 
nonpolarized cell lines (Ullrich et al., 1996; Urbe et al., 1993). Also, plasma 
membrane recycling endosomes have been shown to contain SNAP-25 and 
syntaxin 4 (Aikawa et al., 2006; Band et al., 2002; Pooley et al., 2006).  
The importance of syntaxins in vesicular transport is exemplified by the 
regulation of GLUT4-containing vesicles in skeletal muscle, cardiomyocytes, and 
adipose tissue after insulin stimulation (Bryant et al., 2002; Pessin et al., 1999). 
In these cell types, fusion of GLUT4 vesicles at the cell membrane is the key step 
in insulin-regulated glucose transport and is mediated by SNARE proteins (see 
Chapter I). Both syntaxin 4 and VAMP2 localize to GLUT4-positive vesicles and 
regulate trafficking to the cell membrane (Cain et al., 1992; Martin et al., 1996; 
Pessin et al., 1999; Volchuk et al., 1996). Even though most studies have 
concentrated on the function of SNAP-23 in GLUT4 trafficking, SNAP-25 has 
been isolated from GLUT4 positive cells (Jagadish et al., 1996), however a 
potential role for SNAP-25 in GLUT4 trafficking remains obscure. Rab11a also 
localizes in GLUT4-positive vesicles in insulin responsive tissues (Kessler et al., 
2000; Larance et al., 2005; Millar et al., 1999; Uhlig et al., 2005). The interaction 
of this system with the cytoskeleton and its significance are not well understood.   
Lek1 is the murine member of the LEK/CENPF/mitosin family of proteins 
(Goodwin et al., 1999).  This family of proteins displays sequence homology, yet 
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each family member contains unique domains and have varying expression 
patterns in cells and organisms (Ashe et al., 2004; Dees et al., 2000; Goodwin et 
al., 1999; Liao et al., 1995; Pabon-Pena et al., 2000; Zhu et al., 1995a; Zhu et al., 
1995b). Lek1 is a relatively large protein that contains 2998 amino acids (aa; 
NCBI accesion number DQ642022). There is a post-translational modification 
that produces the N-terminal peptide, cytLEK1, which is distributed throughout 
the cytoplasm (Pooley et al., 2006; Soukoulis et al., 2005). Recently, we have 
described cytLEK1 interaction with Nde1 of the Lis1 pathway (Soukoulis et al., 
2005). In turn, Nde1 interacts with Lis1 and dynein to regulate the microtubule 
network (Faulkner, 2000; Morris and Xiang, 2000; Smith, 2000). The association 
of Nde1, Lis1, and dynein through the Lis1 pathway have critical roles regulating 
membrane trafficking, positioning, cell migration, and mitosis (Banks and Heald, 
2001; Gibbons, 1996; Terada et al., 1998). Important for the current study, the 
Lis1 pathway functions with the Golgi network and in membrane trafficking 
(Kondratova et al., 2005; Liang et al., 2004b). By utilizing dominant-negative 
protein expression and Morpholino (MO) induced suppression of Lek1 
expression, we have demonstrated that altering cytLEK1 function severely alters 
the microtubule network (Soukoulis et al., 2005). The role of cytLEK1 in 
membrane trafficking remains unresolved.   
Our most recent data demonstrates that cytLEK1 physically associates 
with SNAP-25, and together these proteins complex with Rab11a, myosin Vb and 
VAMP2. Furthermore, disruption of endogenous Lek1 function by dominant-
negative protein expression or protein knock-down severely retards the recycling 
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endosome network and transferrin trafficking (Pooley et al., 2006). We postulate 
that cytLEK1 establishes a link between recycling endosomes and the 
microtubule network through its ability to bind both Nde1 and SNAP-25 (Pooley 
et al., 2006; Soukoulis et al., 2005). However, the functions of cytLEK1, SNAP-
25, Nde1, and the microtubule network in membrane trafficking and organelle 
positioning remain poorly understood. 
In the current study, we demonstrate that syntaxin 4 and cytLEK1 
physically interact. These data are consistent with the hypothesis that cytLEK1 
plays a role in the dynamic regulation of plasma membrane trafficking through its 
association with Nde1, the microtubule network, and SNARE proteins. Using 
genetic, immunolocalization, and immunoprecipitation studies, we demonstrate 
that both transiently expressed and endogenous cytLEK1 directly associates with 
syntaxin 4 at recycling endosomes. This complex also contains VAMP2 and 
SNAP-25. Finally, we show that disruption of Lek1 function inhibits GLUT4 
trafficking, a model of syntaxin 4 function in membrane trafficking, thus 
demonstrating the essential nature of syntaxin 4-cytLEK1 interaction. The 
present study suggests that cytLEK1 provides a physical link between syntaxin 4-
positive membranes and the microtubule network, and that these interactions are 
critical in membrane trafficking.  
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Materials and Methods 
 
Yeast Two-Hybrid Screen 
The screen was previously described in Pooley et al., 2006. Briefly, The 
N-terminus of cytLEK1 (aa 1-689) was utilized in the Matchmaker Y2H System 3 
(BD Biosciences Clontech). Library plasmids were isolated from yeast colonies 
that survived on Quadruple Dropout Medium (QDO; SD/-Ade/-His/-Leu/-Trp/X-a-
Gal) and exhibited lacZ expression. The inserts were then sequenced by the 
Vanderbilt Sequencing Core Facility and identified using NCBI Blast (Altschul et 
al., 1990). For each identified protein product, false positive tests involving empty 
vector and random protein matings were conducted to eliminate spurious 
interactions according to the manufacturer’s recommendations. 
 
Cell Culture and Transfection 
COS-7, 3T3-L1, and C2C12 cells (ATCC) were maintained in Dulbecco’s 
modified Eagle’s medium supplemented with 10, 10, and 20% FBS respectively, 
100 ug/mL penicillin/streptomycin, and L- glutamine, in a 5% CO2 atmosphere at 
37oC. 3T3-L1 preadipocytes were differentiated by treatment with insulin, 
dexamethasone, and isobutylmethlxanthine as previously described (Frost and 
Lane, 1985), and cells were used for experimentation 9-12 days after initiation of 
differentiation. For transfection, cells were grown to 50-75% confluency and 
transfected with DNA using FuGENE 6 (Roche) according to the manufacturer’s 
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recommendations. Full-length cytLEK1 was constructed by placing the N-
terminal 2210 aa with a FLAG-tag into pCI-neo (Promega). 
 
Immunostaining and Microscopy 
Cells for transient and endogenous studies were gently washed with 1X 
PBS and fixed with either 4% paraformaldehyde, to visualize endogenous 
proteins, methanol, to visualize transient protein, or Histochoice (Amresco), to 
visualize the microtubule network, for 20 min. Cells were washed with 1X PBS, 
permeabilized with 0.25% Triton X-100 in 1X PBS for 10 min, and blocked for at 
least 1 h in 2% BSA in 1X PBS at room temperature. Primary antibodies were 
incubated overnight at 4oC. Cells were then washed 3 times in 1X PBS and 
secondary antibodies were added for 1 h at room temperature. Cells were again 
washed 3 times with 1X PBS and coverslips mounted with AquaPoly/Mount 
(PolySciences). Cells were visualized by fluorescence microscopy with an AX70 
(Olympus), or for confocal analysis, with a LSM510 (Ziess) microscope. Images 
were captured and processed using Magnafire (Olympus) and Photoshop 
(Adobe). All images of control and experimental cells were processed identically. 
 
Coimmunoprecipitation Using Transient Transfections 
COS-7 cells were grown on 10 cm plates; proteins were harvested 48 h 
post transfection. The ProFound Mammalian c-Myc Tag Co-IP Kit (Pierce) was 
utilized according to the manufacturer’s protocol.  Briefly, cells were washed 
once with ice-cold TBS, incubated with M-Per Extraction Reagent (Pierce) 
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containing protease inhibitor (Sigma), and centrifuged at 16,000 X g for 20 min at 
4oC. Lysate protein concentration of the supernatant was determined using a 
bicinchoninic acid solution assay (Pierce). 100 μg total lysate was incubated for 2 
h at 4oC with 10 μl anti-c-myc agarose slurry with gentle shaking at 4oC. Columns 
were washed 3 times with 1X TBS-Tween. Protein was eluted with 2X non-
reducing sample buffer (Pierce) at 95oC for 5 min. To reduce proteins for SDS-
PAGE analysis and Western blot analysis, 2 μl 2-mercaptoethanol was added. 
Ten μl of total lysate supernatant was used to confirm protein expression. Blots 
were developed using NBT-BCIP (Roche) and scanned into digital images 
(Hewlett-Packard). 
 
Coimmunoprecipitation of Endogenous Protein Complexes Containing 
cytLEK1 
 
C2C12 cells were lysed with Nonidet P-40 buffer with gentle sonication. 
Whole cell lysates were recovered and samples containing 2-3 mg total protein 
were precleared with GammaBind Plus Sepharose (Amersham Biosciences) for 
20 min with gentle rotation at 4oC. Cell lysates were collected and incubated 
overnight with 3 μg of a polyclonal syntaxin 4 antibody (Sigma). GammaBind 
Plus Sepharose was added to bind the antibody-protein complex.  Beads were 
washed 3 times with cold 1X PBS and proteins were eluted with Laemmli sample 
buffer at a boiling temperature for 5 min. Proteins were resolved on a 6% SDS-
PAGE gel and analyzed by Western blot analysis. Twenty μg of protein lysate 
was loaded to visualize cytLEK1 in whole cell lysate. 
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MO Antisense Oligomer Treatment 
Production of and methods utilizing MO to specifically knockdown 
endogenous Lek1 have been previously reported (Ashe et al., 2004; Pooley et 
al., 2006; Soukoulis et al., 2005). 
 
2-Deoxy-D-Glucose Transport Assay 
48 h after MO addition, 3T3-L1 were starved of serum for 1 h. The cells 
were then incubated with 100nM insulin in KRH buffer for 20 min. Glucose 
transport was initiated by addition of 0.5 mM 2-deoxy-D-[1,2-3H] glucose 
(0.25μCi). After 10 min, transport was terminated by washing the cells 3X with 
cold KRH buffer. Cells were then solubilized with 0.5% SDS, and the 
incorporated radioactivity was measured by liquid scintillation counting. All 
quantitative data are representative of three separate experiments conducted 
over three days, each with n=6-8. A one sample Student’s t-test was used after 
normalization to standard control (SC) cell populations.  
 
Antibodies 
cytLEK1 and Rab11a (a gift from Dr. James Goldenring, Vanderbilt 
University) antibodies were previously described (Pooley et al., 2006; Soukoulis 
et al., 2005). SNAP-25, syntaxin 4, and β-tubulin antibodies were obtained from 
Sigma. Golgin-97 was obtained from Molecular Probes. Syntaxin 4, EEA1, α-myc 
and α-GFP antibodies were obtained from BD Bioscience. VAMP2 and VAMP3 
antibodies were purchased from StressGen. Alexa Fluor 488- and 568- 
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conjugated secondary antibodies were utilized (Molecular Probes). For triple 
labeled immunofluorescence studies, polyclonal anti-myc (Novus) was directly 
labeled with the Zenon Alexa-647 labeling kit (Molecular Probes). Alkaline 
phosphatase-conjugated secondary antibodies for Western blot were also 
purchased from Sigma. 
 
Results 
 
Identification of syntaxin 4 as a cytLEK1 interacting protein 
Syntaxin 4 was identified as a cytLEK1 interacting protein using 5’ LCR as 
bait. Both syntaxin 4 and the previously identified cytLEK1 interacter SNAP-25 
are members of the SNARE family of proteins (Chen and Scheller, 2001; Jahn 
and Sudhof, 1999; Sollner et al., 1993b). Also utilizing Y2H analysis, 5’LSD (aa 
1-474) was found to be the minimal domain of cytLEK1 required for syntaxin 4 
interaction (Figure 19), just as it was for SNAP-25 (Pooley et al., 2006). Since we 
have previously established interactions of cytLEK1 with the microtubule network 
(Soukoulis et al., 2005) and SNAP-25 in the membrane trafficking system 
(Pooley et al., 2006; Soukoulis et al., 2005), the association of cytLEK1-syntaxin 
4 was investigated further.  
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Figure 19. Identification of syntaxin 4 as cytLEK1 interacting protein. A) A Y2H screen was 
conducted and described previously [Pooley, 2006 #42]. One of the interacting proteins with 
5’LCR, the N-terminal 689 aa of cytLEK1, was identified as syntaxin 4. The plasmid was isolated 
from a colony that survived on QDO media and subsequently sequenced. The resulting sequence 
was identified as the C-terminal 144 aa of syntaxin 4, termed Y2HS4. The C-terminal 474 aa of 
cytLEK1, 5’LSD, was further characterized as being the region of cytLEK1 sufficient for syntaxin
4 interaction by Y2H. B) Positive associations grew on QDO media and exhibited blue color upon 
β-Gal testing. As a positive control, growth was indicated by yeast transformed with pGBKT7-53 
and pGADT7-T. Also used as a positive control, 5’LSD interacts with SNAP-25 as seen before 
[Pooley, 2006 #42]. The negative control utilized yeast expressing pGBTK-53 and the empty 
vector pGADT7 and demonstrated no growth on the media. The test interaction clearly 
demonstrates that 5’LSD does associate with the Y2HS4 portion of syntaxin 4 in yeast.
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Figure 20. Transfected 5’LSD redistributes in COS-7 cells expressing GFP-syntaxin 4.
COS-7 cells singly transfected with 5’LSD (A) show a cytoplasmic distribution of the protein 
with a high perinuclear distribution. Cells singly tansfected with GFP-syntaxin 4 (B) show a 
significantly different distribution at defined foci throughout the cell. When cells are
cotransfected with syntaxin 4 and 5’LSD (C-E), syntaxin 4 remained at the multiple 
intracellular foci, but 5’LSD demonstrated a significant redistribution to the same foci occupied 
by GFP-syntaxin 4 as seen in the merged image (E). 5’LSD is indicated in red, while GFP-
syntaxin 4 is shown in green. Dapi (blue) is used to visualize the nucleus. F) COS-7 cells were
transfected with 5’LSD and GFP-syntaxin or with GFP-syntaxin 4 alone for a negative control. 
An immunoprecipitation was conducted with α-myc antibody, and blots were probed with α-
GFP antibody. Input lanes show transfected protein expression in the lysate. GFP-syntaxin 4 
was precipitated in the presence of 5’LSD. The control shows there was no spurious binding of 
GFP-syntaxin 4 to the beads.
Transient protein expression reveals cytLEK1-syntaxin 4 interaction 
We next examined cytLEK1-syntaxin 4 protein association and localization 
in COS-7 cells. As we reported previously (Pooley et al., 2006), 5’LSD 
overexpression in COS-7 cells localizes to the perinuclear region of cells and 
extends more diffusely to the cell periphery (Figure 20A). Overexpression of 
chimeric GFP-syntaxin 4 localizes to multiple foci located throughout the cell 
(Figure 20B). Interestingly, in cells expressing both proteins, 5’LSD redistributed 
to GFP-syntaxin 4-positive foci (Figure 20C-E). These data suggest a direct 
association between cytLEK1 and syntaxin 4. 
To determine whether the two proteins interacted within these cells, a 
coimmunoprecipitation was conducted with lysates containing transiently 
expressed 5’LSD and GFP-syntaxin 4 proteins. As seen in Figure 20F, we were 
able to co-precipitate GFP-syntaxin 4 utilizing 5’LSD, while control experiments 
demonstrated no spurious GFP-syntaxin 4 association with the beads. Taken 
together, these results demonstrate that the 5’LSD region of cytLEK1 is 
responsible for syntaxin 4 association and confirm our Y2H results. 
 
Endogenous cytLEK1 and syntaxin 4 associate in mammalian cells 
Figure 21A demonstrates the association of cytLEK1 with the microtubule 
network. We next examined the endogenous colocalization and expression of 
cytLEK1 and syntaxin 4 in murine cell lines. Initially, C2C12 myoblasts were 
utilized since both cytLEK1 and syntaxin 4 are expressed in these cells (Pooley 
et al., 2006; Soukoulis et al., 2005; Tortorella and Pilch, 2002). As seen in Figure
 83
84
Figure 21. Endogenous cytLEK1 and syntaxin 4 colocalize in murine cells. A) COS-7 cells 
were transfected with full-length cytLEK1 and immunolabeling was conducted. A transfected
cell is labeled with FLAG and demonstrates a fibrous distribution of cytLEK1 (green) when 
processed in Histochoice. β-tubulin in the transfected cell is labeled in red. The merged image 
shows a significant colocalization of cytLEK1 on the microtubule network, therefore supporting 
a role for cytLEK1 with the microtubule network. Cells could not be pre-extracted, as too much
immunoreactivity was lost after processing. B) CytLEK1 and syntaxin 4 demonstrated 
significant overlap in expression throughout the cytoplasm in C2C12 myoblasts (merge).  They 
share a high degree of colocalization in the perinuclear region, but cytLEK1 has a broader 
distribution extending further into the cell periphery. C) 3T3-L1 preadipocytes also demonstrate 
a similar expression patterns of cytLEK1 and syntaxin 4 to that seen in C2C12 cells. 
Interestingly, both endogenous proteins demonstrate a higher expression pattern at the cell 
periphery than that seen in C2C12 myoblasts. D) 3T3-L1 cells were differentiated as described 
in methods. Both endogenous cytLEK1 and syntaxin 4 appear to have high localization 
throughout the cells. All images are from confocal microscopy. (Bar, 10 μm). E) CytLEK1 
forms an endogenous complex with syntaxin 4. Endogenous protein complexes were analyzed 
using C2C12 cell lysates for coimmunoprecipitation analysis with, Sepharose beads alone, α-
SNAP-25 antibody, syntaxin 4 antiserum, or IgG antibody alone. After precipitation, elution, 
and western blotting, the blot was probed with α-cytLEK1 antibody. Lane 1 demonstrates the 
presence of cytLEK1 in the lysate.  Lane 2 demonstrates the absence of precipitation with beads 
alone. Lane 3 is a positive control that demonstrates cytLEK1 precipitation with SNAP-25. 
Lane 4 shows that cytLEK1 precipitates with syntaxin 4.  Lanes 5 demonstrate the lack of 
precipitation with non-immune IgG.
21B, confocal analysis demonstrated significant colocalization in the perinuclear 
region of the cell extending into the cell periphery. In this cell line, overlap was 
not absolute, as the staining pattern of cytLEK1 extended further in the cell 
periphery than that of syntaxin 4. This is to be expected, because both proteins 
have been shown to bind other proteins and function in multiple pathways.  
Analysis of syntaxin 4 function has been established in 3T3-L1 apipocytes 
(Cain et al., 1992; Pessin et al., 1999; Volchuk et al., 1996). Therefore, in prelude 
to our functional studies of their interaction, we next examined for coexpression 
and colocalization of cytLEK1 and syntaxin 4 in this cell line. The intense 
perinuclear staining and colocalization of both cytLEK1 and syntaxin 4 mirrored 
the cytoplasmic expression observed in C2C12 cells, but both proteins 
demonstrated more significant staining at the cell periphery as compared to 
C2C12 myoblasts (Figure 21C). Interestingly, differentiated 3T3-L1 adipocytes 
demonstrated a high degree of endogenous cytLEK1 and syntaxin 4 throughout 
the cell with significant colocalization (Figure 21D). Protein expression is broader 
in the differentiated cells and appears to have a higher distribution throughout the 
cell extending to the cell periphery. It should be noted that previous studies of 
3T3 cells have also demonstrated the cytoplasmic localization of syntaxin 4 as 
observed here (Band et al., 2002). 
Next, we probed for the presence of endogenous complexes containing 
both cytLEK1 and syntaxin 4 using immunoprecipitation in lysates from C2C12 
cells. As seen in Figure 21E, lane 4, cytLEK1 was co-precipitated with syntaxin 4, 
while beads only (lane 2) and non-immune IgG (lane 5) were negative. As a 
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positive control (lane 3), cytLEK1 was co-precipitated from the same lysate using 
an antiserum against the syntaxin 4 binding partner SNAP-25 (Pooley et al., 
2006). Taken together, these data support the hypothesis that cytLEK1 and 
syntaxin 4 interact endogenously. 
 
Overexpression of 5’LSD and syntaxin 4 redistributes proteins of the 
membrane trafficking network 
 
The current data demonstrate that cytLEK1 and syntaxin 4 interact, while 
previous studies have determined that exogenously-expressed syntaxins 
accumulate in the Golgi (James et al., 2004; Rowe et al., 1999; Takuma et al., 
2002; Washbourne et al., 2001). We confirmed this result utililizing the trans-
Golgi network (TGN) marker golgin-97 in COS-7 cells cotransfected with GFP-
syntaxin 4 and 5’LSD (Figure 22A). 
We have previously demonstrated that VAMP2 forms a complex with 
5’LSD and SNAP-25 (Pooley et al., 2006). VAMP2 is also well-documented for its 
role with syntaxin 4 in intracellular vesicle trafficking (Chamberlain and Gould, 
2002; Cheatham et al., 1996; Kawanishi et al., 2000; Martin et al., 1996). 
Therefore, we examined whether VAMP2 localized to the TGN with 5’LSD and 
syntaxin 4. As seen in Figure 22B, VAMP2 localized with the transfected proteins 
at the TGN. VAMP3 is also a syntaxin 4 binding protein, but appears to have a 
role with endosomal populations (Galli et al., 1994; Kay et al., 2006; Mallard et 
al., 2002; McMahon et al., 1993; Polgar and Reed, 2003). Interestingly,
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Figure 22. Transient 5’LSD and syntaxin 4 colocalize at the TGN in COS-7 cells. COS-7 cells 
were cotransfected with 5’LSD and GFP-syntaxin 4, and only those expressing both transient 
proteins were analyzed. A) 5’LSD and GFP-syntaxin 4 colocalize with the TGN marker golgin-
97. B) VAMP2 also demonstrates a high degree of colocalization with 5’LSD and GFP-syntaxin
4. C) VAMP3 does not demonstrate any significant redistribution to 5’LSD-GFP-syntaxin 4 foci. 
D) Rab11a, a marker of recycling endosomes, does not demonstrate noticeable colocalization. E)
Early endosomes, stained by EEA1, also show no significant relocalization with 5’LSD-GFP-
syntaxin 4 foci. Therefore, the 5’LSD-GFP-syntaxin 4 complex is specific for localization at the 
TGN. 5’LSD staining is indicated in blue, GFP- syntaxin 4 in green, and the third marker, as 
indicated, is in red (Bar, 10 μm).
immunostaining for VAMP3 showed no discernable relocalization to the TGN foci 
(Figure 22C).  
We next examined whether this localization was specific to Golgi or was 
the result of nonspecific accumulation of plasma membrane networks. Therefore, 
we probed for localization of Rab11a, a Rab GTPase protein marker of the 
recycling endosome (Uhlig et al., 2005; Urbe et al., 1993). It should be noted that 
expression of 5’LSD and SNAP-25 results in accumulation in recycling 
endosomes (Pooley et al., 2006). Interestingly, Rab11a was not redistributed to 
the Golgi with transfection of 5’LSD and syntaxin 4 (Figure 22D) and early 
endosomes were not co-localized with the 5’LSD-GFP-syntaxin 4 foci (Figure 
22E). Thus, co-expression of syntaxin 4 and its cytLEK1 binding domain results 
in their accumulation specifically in the Golgi but does not result in redistribution 
of other endosomal compartments. 
 
Endogenous cytLEK1 redistributes with overexpression of syntaxin 4 
Co-expression of exogenous syntaxin 4 and the syntaxin 4 binding domain 
of cytLEK1 results in accumulation in the TGN. We next determined whether 
endogenous cytLEK1 localization was influenced by overexpression of GFP-
syntaxin 4. As seen in Figure 23A, in cells expressing the syntaxin 4 chimera, 
endogenous cytLEK1 overlapped significantly with transiently expressed syntaxin 
4 (Figure 23A). In fact, most endogenous cytLEK1 expression appeared to be at 
the syntaxin 4 foci. In addition, endogenous SNAP-25 redistributed and 
colocalized at the GFP-syntaxin 4 foci, just as its binding partner cytLEK1 (Figure
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Figure 23. Endogenous cytLEK1, SNAP-25, and VAMP2 colocalize with GFP-syntaxin 4.
C2C12 myoblasts were tansfected with GFP-syntaxin 4 and analyzed for endogenous protein 
localization. A) CytLEK1 demonstrated significant colocalization at the foci that contained 
GFP-syntaxin 4. B-C) Endogenous SNAP-25 and VAMP2 demonstrate localization with GFP-
syntaxin 4 D) VAMP3 does not demonstrate any significant relocalization with expression of 
GFP-syntaxin 4. E-F) Rab11a, a marker for recycling endosomes, and EEA1, a marker for early
endosomes, do not redistribute with transient syntaxin 4 expression, demonstrating specific 
localization to the TGN. GFP-syntaxin 4 is shown in green, while the endogenous markers are 
in red. Nuclei are visualized with Dapi (blue) (Bar, 10 μm).
23B). Interestingly, endogenous VAMP2 was also localized at the GFP-syntaxin 
4 foci (Figure 23C) while VAMP3, a SNARE protein functionally implicated with 
syntaxin 4 (Olson et al., 1997), did not (Figure 23D). Again, Rab11a did not show 
any noticeable relocalization or colocalization with the transient syntaxin 4 
expression (Figure 23E). Overexpression of syntaxin 4 also had no notable effect 
on the early endosome network as seen by Figure 23F. Therefore, we conclude 
that overexpression of the syntaxin 4 chimera results in accumulation in the Golgi 
network and concomitant redistribution of cytLEK1, VAMP2, and SNAP-25. No 
noticeable redistribution of recycling and early endosome networks was 
observed. 
 
5’LSD accumulates with endogenous SNAP-25 and syntaxin 4 
Previous and current data show that 5’LSD, the syntaxin 4 binding domain 
of cytLEK1, interacts with both syntaxin 4 and SNAP-25 (Pooley et al., 2006). 
Here, studies overexpressing 5’LSD and its binding partners show that 5’LSD 
accumulates at either the TGN or at recycling endosomes (Figures 22 and 23). 
We next examined distribution of 5’LSD in singly transfected C2C12 myoblasts.  
As seen in Figure 24, 5’LSD localizes throughout the cell, but it also has 
unique expression patterns at multiple distinct perinuclear foci. Overexpressed 
5’LSD and SNAP-25 proteins accumulated at a single perinuclear focus resulting 
in the collapse and redistribution of the recycling endosome network (Pooley et 
al., 2006). Since syntaxin 4 also localizes to the same recycling endosome 
perinuclear focus as 5’LSD and SNAP-25, we examined endogenous syntaxin 4 
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localization in cells expressing only 5’LSD. Syntaxin 4 showed significant 
localization at the foci. Transiently expressed 5’LSD also colocalized with 
endogenous SNAP-25 (Figure 24B), a cytLEK1 binding partner (Pooley et al., 
2006). 
 Next, the subcellular compartment(s) that 5’LSD localizes to were further 
characterized. Since 5’LSD localizes to the TGN in cells overexpressing syntaxin 
4 (Figure 24), and 5’LSD colocalizes with transiently expressed SNAP-25 at 
recycling endosomes (Pooley et al., 2006), we tested TGN and Rab11a 
localization at cells expressing only 5’LSD. Interestingly, examination of markers 
for both the TGN and recycling endosomes demonstrated expression at the 
5’LSD foci. 5’LSD accumulated with both markers for the TGN and the recycling 
endosome compartments. 5’LSD also colocalized with cytLEK1 binding partners 
syntaxin 4 and SNAP-25, along with VAMP2. As demonstrated in previous 
experiments, EEA1 and VAMP3 did not localize with 5’LSD (data not shown). 
Together, these data demonstrate cytLEK1 association with syntaxin 4, SNAP-
25, and VAMP2 at distinct subcellular compartments that function in plasma 
membrane trafficking. 
 
Lek1 knock-down inhibits glucose transport 
Syntaxin 4 has a critical role in GLUT4 trafficking in insulin responsive 
tissues (Cain et al., 1992; Martin et al., 1998; Pessin et al., 1999; Volchuk et al., 
1996). Insulin stimulates the translocation of intracellular GLUT4 vesicle pools to 
the plasma membrane in target tissues, which include cardiac and skeletal
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Figure 24. 5’LSD localizes to foci containing both TGN and recycling endosomes. 5’LSD 
was transfected into C2C12 cells and marker for SNAREs, TGN, and recycling endosomes were
immunolabelled. A) Syntaxin 4 did colocalize with 5’LSD. B-E) SNAP-25, golgin, Rab11a, and 
VAMP2 did colocalize with 5’LSD. 5’LSD immunofluorescence is shown in green, while 
endogenous markers are in red. DAPI was used to visualize the nuclei (blue) (Bar, 10 μm). 
muscle and adipose tissue. Activation of the insulin receptors triggers a large 
increase of GLUT4 vesicle trafficking and exocytosis as compared to basal 
conditions. cytLEK1 is now known to form a complex with two proteins that 
function in GLUT4 trafficking, syntaxin 4 and Rab11a (Kessler et al., 2000; 
Larance et al., 2005; Millar et al., 1999; Uhlig et al., 2005). In order to test Lek1 
function in GLUT4 trafficking, we utilized the 2-Deoxy-D-Glucose transport assay 
(Kawanishi et al., 2000). Briefly, 3T3-L1 cells were differentiated, and Lek1 
function was inhibited using MO anti-sense oligomers, a method previously 
described by our group (Ashe et al., 2004; Pooley et al., 2006; Soukoulis et al., 
2005). Radio-labeled binding and internalization within the cell population was 
then measured. As expected, depletion of Lek1 significantly reduces GLUT4 
trafficking, as a ~53% reduction of 2-deoxy-D- [1,2-3H] glucose at the cell surface 
(p<0.01) was observed (Figure 25). All values were normalized against the SC 
cell populations since experiments were conducted on three consecutive days. 
These results further demonstrate that cytLEK1 function is critical for membrane 
trafficking. 
 
Discussion 
We have identified a novel interaction between cytLEK1 and syntaxin 4. cytLEK1 
also interacts with Nde1, a dynein and microtubule associated protein, and the 
SNARE protein SNAP-25. Taken together, these studies support our hypothesis 
that cytLEK1 is a regulator of and link between recycling endosomes and the 
microtubule network. Most importantly, depleting endogenous Lek1 severely
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Figure 25. Depletion of LEK1 alters GLUT4 trafficking. A) 3T3-L1 apipocytes were 
differentiated and depleted of Lek1 by addition of MO. 48 h post MO addition, cells were 
processed according to methods. Normalized to SC cell populations, cells with MO addition had a 
two-fold decrease in radio-labelled glucose trafficking to the plasma membrane as counted by 
disintegration per minute (dpm). Data are normalized against the SC counts and are shown as 
means + SE from three independent experiments. (*) one sample Student’s t-test, p<0.01 vs. SC 
control. B) Also shown previously [Pooley, 2006 #42; Soukoulis, 2005 #41; Ashe, 2004 #46], 
MO addition is specific to cytLEK1 depletion as demonstrated by Western blot. 
affects GLUT4 trafficking, a model pathway used to study syntaxin 4 function in 
membrane trafficking. To date, no Lek1 family proteins have demonstrated roles 
in vesicle trafficking, and these data are the first to reveal a potentially critical 
property for this family in regulation of plasma membrane trafficking.  
 
The LEK family has a role in microtubule-based processes 
The Lek1/CENP-F/mitosin family has demonstrated roles in cell cycle, 
division, and differentiation through microtubule based function (Ashe et al., 
2004; Dees et al., 2000; Pooley et al., 2006; Rattner et al., 1993; Soukoulis et al., 
2005; Zhu et al., 1995b). The human CENP-F/mitosin protein has been shown to 
bind the kinetochore and is highly expressed at the G1/S boundary (Zhu et al., 
1995a; Zhu et al., 1997; Zhu et al., 1995b). The kinetochore is located at the 
centromere of the chromosome and serves as the site for microtubule spindle 
attachment during mitosis (Cleveland et al., 2003; Rieder and Salmon, 1998). 
Dynein, a microtubule-based motor, is also important for chromosome positioning 
and segregation (Cleveland et al., 2003; Heald and Walczak, 2000; Sharp et al., 
2000). Silencing of CENP-F/mitosin results in misalignment of chromosomes 
during mitosis and premature cell death (Yang et al., 2005), thus defining a role 
for this protein in microtubule based processes. Mouse Lek1 has a defined 
association with a regulator of dynein and microtubules (Soukoulis et al., 2005). 
Taken together, the LEK family of proteins has diverse roles in organelle 
dynamics associated with microtubule-based processes. While it is clear that 
LEK family proteins are involved in organelle positioning and movement, to date, 
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the interacting proteins and regulators of such functions are largely unknown. 
Through a series of experiments to identify interacting proteins, we have 
determined that cytLEK1 provides a connection between the MT network and 
recycling endosomes. 
 
cytLEK1 associates with syntaxin 4 
Here, we determined through genetic, biochemical, and immunochemical 
data, that cytLEK1 has a direct interaction with syntaxin 4. Previous data have 
shown that cytLEK1 and SNAP-25 interact through the 5’LSD domain of 
cytLEK1. We now demonstrate that both transiently expressed 5’LSD and 
endogenous cytLEK1 associate with syntaxin 4 using biochemical and cytological 
analyses. In cotransfection studies, 5’LSD and syntaxin 4 colocalized specifically 
to the TGN, as markers for other cellular and endosomal compartments did not 
demonstrate significant colocalization. It should be noted that syntaxin proteins 
localize to the TGN in overexpression studies (James et al., 2004; Rowe et al., 
1999; Takuma et al., 2002; Washbourne et al., 2001), and these current data are 
in accord with previous studies. VAMP2, but not VAMP3, also localized to these 
foci.  
Studies performed in C2C12 myoblasts with single transfections 
corroborated our previous data that syntaxin 4 localized with cytLEK1 at recycling 
endosomes. Additionally, GFP-syntaxin 4 colocalized with endogenous cytLEK1, 
SNAP-25 and VAMP2 at the TGN. In turn, transient 5’LSD colocalized with 
syntaxin 4, SNAP-25, and VAMP2. We now show that cytLEK1 directly binds 
 96
both SNARE proteins SNAP-25 and syntaxin 4, and VAMP2 appears to be the 
prominent VAMP family member in this complex.  
 
cytLEK1-syntaxin 4 interaction is critical in regulation of the recycling 
endosome network 
 
cytLEK1 binds syntaxin 4 at recycling endosomes. Interestingly, the region 
of the protein responsible for this interaction is the same highly coiled binding 
region of cytLEK1 that associates with syntaxin 4 and SNAP-25. Here, we 
demonstrate that both endogenous and transiently expressed cytLEK1 colocalize 
with its transfected binding partner syntaxin 4. Rab11a, a protein cytLEK1 has 
been shown to associate with, at least indirectly, is a well-defined Rab GTPase 
that regulates plasma membrane recycling and delivery of proteins from the TGN 
to the plasma membrane. Rab11a has also been localized to GLUT4 positive 
vesicles (Kessler et al., 2000; Larance et al., 2005; Millar et al., 1999; Uhlig et al., 
2005). Importantly, 5’LSD transfection results in a redistribution of SNAP-25, 
VAMP2, Rab11a, and syntaxin 4 to the same foci as 5’LSD, indicating that this 
complex of proteins function at recycling endosomes. These data support our 
previous finding that this complex forms at the recycling endosome network. 
VAMP2 has also been identified at the Golgi apparatus (Chamberlain and Gould, 
2002; Cheatham et al., 1996; Kawanishi et al., 2000; Martin et al., 1998), and a 
function for Rab11a at the TGN has been described (Chen and Wandinger-Ness, 
2001; Crespo et al., 2004). This is most interesting when considering that 5’LSD 
localizes not only with Rab11a, but also golgin-97. 
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We propose that cytLEK1 is a key regulator of plasma membrane 
recycling. Since 5’LSD colocalizes with both the recycling marker Rab11a and 
the TGN marker golgin-97, cytLEK1 may be an important regulator of plasma 
membrane trafficking between these two compartments. Through the ability of 
cytLEK1 to bind Nde1 and at least two SNARE proteins directly, it may be a 
critical link for plasma membrane trafficking along the microtubule network. 
 To test the significance of cytLEK1-syntaxin 4 association, we used a 
GLUT4 translocation assay as a model of plasma membrane trafficking. Syntaxin 
4 is a SNARE protein that functions in GLUT4 vesicle trafficking. By depleting 
cells of Lek1, there was a significant decrease in the amount of labeled glucose 
in the cells. Not only does cytLEK1 localize with syntaxin 4 in the recycling 
endosome network, but our data demonstrate that cytLEK1 has a key role in this 
syntaxin 4 dependent pathway. We have now established roles for cytLEK1 in 
membrane trafficking. cytLEK1 has now been shown to have a function in two 
plasma membrane trafficking processes in the cell, the plasma membrane 
recycling system of transporting transferrin (Pooley et al., 2006), and GLUT4 
vesicle trafficking (present data). It remains to be determined whether cytLEK1 is 
specific to regulation of plasma membrane trafficking through recycling 
endosomes, or if it is a general regulator of vesicle movement along the 
microtubule network. In either case, the current study reveals an entirely new 
property of cytLEK1, and in addition places it in a molecular pathway through its 
interaction with multiple SNARE proteins. The identification of cytLEK1 as a 
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regulator of plasma membrane recycling is an entirely new property for any of the 
LEK family of proteins. 
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CHAPTER IV 
 
THE OTHER CYTLEK1 BINDING PARTNERS 
 
 
Introduction 
Lek1 undergoes a post-translational modification that produces nucLEK1 
and cytLEK1 peptides (Chapter I). Initial studies on nucLEK1 localization 
demonstrate that the protein is in proliferating cells of the developing embryo. 
Since nucLEK1 is highly expressed in the developing heart, we focused on its 
role during cardiomyocyte proliferation and differentiation (Ashe et al., 2004; 
Goodwin et al., 1999).  Specifically, Lek1 mRNA was detected in the heart from 
E9.5 and downregulated after neonatal day 4 and was not found in the adult 
(Goodwin et al., 1999). Coincidently, this is the same time when cardiomyocytes 
cease proliferation and undergo terminal differentiation. Future studies showed 
that nucLEK1, along with CENP-F/Mitosin and CMF1, binds to Rb family proteins 
(Rb, p107, and p130), which are critical for cellular proliferation and 
differentiation (Ashe et al., 2004; Redkar et al., 2002; Zhu et al., 1995b). Critical 
in vitro and in vivo data show that disruption and depletion of Lek1 inhibits 
myocyte proliferation and differentiation (Ashe et al., 2004; Dees et al., 2000; Wei 
et al., 1996). These data support a function for Lek1 as a regulator of cell 
proliferation and differentiation through its interaction, at least in part, with Rb 
proteins.  
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Our most recent data also show that the C-domain of cytLEK1 is 
responsible for interaction with Nde1, a member of the Lis1 pathway (see 
Chapter I). Proteins that are members of the Lis1 pathway function in dynein-
mediated processes of the MT network. Depletion of Lek1 causes a severe 
collapse of the MT network, further indicating a cytLEK1 function with the 
cytoskeleton (Soukoulis et al., 2005). We reported that cytLEK1 functions with 
the MT network through its interaction with Nde1. At that time, out of 2998 aa, we 
had functional data that accounted for less than 10% of Lek1. Therefore, we 
postulated that more unique associations exist through the other 
noncharacterized regions of the protein. 
In order to further characterize the function of cytLEK1 in molecular 
pathways, we developed the conditional Lek1 knock-out mouse (Chaper IV). Due 
to the large size of the Lek1 gene, we utilized the Cre-loxP system to delete the 
first five exons of Lek1 specifically in the heart. Postulating logical hypotheses on 
what phenotypes may result after ablating Lek1 in the heart and to give further 
insight into the function of the deleted region, we utilized this peptide as bait for a 
Y2H screen to identify novel Lek1 binding proteins. The bait was constructed to 
contain only the first five exons of Lek1, termed 5’LSD. Placing Lek1 within a 
pathway(s) in which this domain is responsible for Lek1 function is critical to 
characterize the conditional Lek1 knock-out and to determine its role in 
development.   
Through this Y2H screen, we identified and characterized two novel Lek1 
binding partners, SNAP-25 (Chapter II) and syntaxin 4 (Chapter III). Along with 
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these two proteins, the screen identified six other proteins that may associate 
with 5’LSD of Lek1. Characterizing these interactions is critical in our goal of 
understanding Lek1 function in its entirety. Results may clarify the roles of Lek1 
in proliferation and differentiation or its function with trafficking and the MT 
network. They may also demonstrate Lek1 function(s) in a completely new 
manner. 
 
Materials and Methods 
 
Yeast Two-Hybrid Screen 
 The Y2H screen was conducted utilizing the Matchmaker Y2H System 3 
(BD Biosciences Clontech). The bait construct, 5’ LSD, was constructed by PCR 
amplifying aa 1-474 from a full-length cytLEK clone (aa 1-2210). 5’LSD was 
cloned into the EcoRI/BamHI sites of the pGBKT7 vector. The bait plasmid was 
then transformed into AH109 yeast according to the manufacturer’s instructions. 
The AH109 yeast containing the bait vector were then mated to Y187 yeast 
containing a pretransformed whole mouse embryonic day 11 cDNA library. The 
matings were grown at 30oC overnight with gentle agitation (50 rpm). Mated 
colonies were plated onto QDO media (SD/-Ade/-His/-Leu/-Trp) and grown for 4 
days at 30oC. Positive and negative controls were also conducted according to 
manufacturer’s instructions. Colonies that grew on QDO were replica plated on 
QDO-α-gal to retest positive associations. Blue colonies were then streaked for 
segregation, and only blue colonies were analyzed. Bait and prey vectors were 
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isolated from positive yeast colonies utilizing the Yeastmaker Yeast Plasmid 
Isolation Kit (BD Biosciences Clontech). Plamids were then transformed into XL-
1 Blue E.coli (Stratagene), isolated, and then sequenced at the Vanderbilt 
University Sequencing Core Facility. The resulting sequences were identified 
using NCBI Blast (Altschul et al., 1990). To confirm and validate the interactions, 
each resultant vector was then put through a false positive screening process. 
Briefly, they were mated with yeast containing empty vectors or random proteins 
to examine for spurious protein interactions. Clones that only grew with the 
original bait construct containing 5’LSD were further analyzed.  
 
Cloning of hook2 
 The mouse hook2 full-length cDNA clone was obtained from Invitrogen 
(clone # 4211990). A PCR product was constructed utilizing primers that 
amplified the entire hook mRNA and then ligated the resulting product into the 
HindIII/KPN sites of pEGFP-C3 (BD Bioscences Clontech).  
5’ primer: TATAAAGCTTATGAGTGTGGACAAGGCCGAG. 
3’primer: TATAGGTACCGTGCTTGTCAGTGGGGCG. 
 
Cell Culture  
COS-7 and NIH 3T3 fibroblast cells (ATCC) were maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM; Cellgro) supplemented with 10% 
fetal bovine serum, 100 μg/ml penicillin/streptomycin, and L-glutamine. Cells 
were maintained in 5% CO2 at 37oC. 
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 Cell Transfections 
COS-7 and NIH3T3 fibroblasts were grown to 60-70% confluency and 
transfected using FuGENE6 (Roche) as per the manufacturer’s 
recommendations. For one four-well slide: FuGENE was added to a 1.5 ml 
eppendorf tube containing 100 μl OptiMEM (Gibco) and gently mixed. One μg of 
DNA was then added and mixed. It was then incubated at room temperature for 
20 min. Twenty-five μl of DNA mixture was added per well containing fresh 
medium. Cells were allowed to grow for at least 24 h before processing. 
 
Immunocytochemistry and Microscopy 
Cells were grown on glass chamber slides (Nalge Nunc), gently washed 
with 1X PBS, and fixed with Histochoice (Amresco) for 20 min. After fixation, cells 
were washed three times with 1X PBS, permeabilized with 0.25% Triton X-100 in 
PBS for 10 min., and blocked with 2% BSA in PBS for at least one h. Primary 
antibodies were applied overnight at 4oC. Cells were again washed three times in 
PBS. Secondary antibodies were added for one h at room temperature. Cells 
were washed three times with PBS and cover slips were attached to the slide 
with Aqua Poly/Mount (PolySciences). Cells were visualized by fluorescence 
microscopy on an AX70 (Olympus). Digital images were captured identically 
using Magnafire (Optronics) and processed identically with adobe Photoshop 
software.  
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Antibodies 
Monoclonal α-p50 antibody was purchased from BD Bioscience, while 
polyclonal myc antiserum was obtained from Novus, and monoclonal α-myc 
antibody was acquired from Clontech. 
 
Results 
 Lek1 functions in proliferation and differentiation, and it associates with the 
MT network through its Nde1 interaction (see Chapter I). To further define the 
function of Lek1 in these processes and to discover novel pathways for 
Lek1function, a Y2H screen was utilized. The region of cytLEK1, 5’LSD, was 
chosen because it is the same region that is being ablated in the Lek1 knock-out 
mouse, and a function for this region was unknown. It is predicted to have two 
leucine zippers in this region of cytLEK1, structures that generally play a role in 
protein-protein and protein-DNA interactions (O'Shea et al., 1989). 5’LSD 
consisted of the N-terminal 474 aa of cytLEK1 and was used as bait to screen a 
whole mouse embryonic day 11 cDNA library. This screen yielded eight clones 
that passed the false screening process. 
 
Dynamitin/p50 
 Dynamitin/p50 is a subunit protein of the dynactin complex. Eleven 
different complex subunits have been identified in the complex, with some 
subunits appearing more than once. Dynactin is composed of 20 individual 
polypepetide subunits (Figure 26). Dynactin is a complex that is required for
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Figure 26. Dynactin. Schematic illustrating the approximate location of the 11 unique 
subunits of the dynactin complex, including the p50/dynamitin protein. Note that some 
subunits appear more than once. Figure from Schroer et al., 2004.
most, if not all, dynein functions. They are considered to be intimate partners in 
MT based functions. Studies indicate that dynactin participates in a wide range of 
functions with cellular structure, many of which are roles in transporting cargos 
by the dynein motor. It appears that movement of cargo by dynein requires 
dynactin as the bridge between dynein and the cargo. Dynactin is also required 
for mitosis and cell proliferation by its association with centrosomes (Quintyne et 
al., 1999). Each dynactin molecule contains four p50 subunits. It appears to have 
a central role in linking the cargo-binding region of the dynactin complex with the 
dynein and microtubule-binding arm of the dynactin molecule (Figure 26). The 
p50 protein localization has been shown at the organelles, centrosomes, and 
kinetochores (Karki and Holzbaur, 1999). Since cytLEK1 and dynactin function 
with the MT network and are involved in organelle transport, preliminary studies 
were done examining cytLEK1 and p50 colocalization. 
 Three different mammalian cell lines were utilized to examine endogenous 
cytLEK1 and p50 localization: C2C12 myoblast, NIH3T3 fibroblas, and purified 
primary neonatal day 4 myocytes (Goodwin et al., 1999; Pooley et al., 2006; 
Soukoulis et al., 2005). They shared similar distribution patterns in each cell line. 
In all three cell types, cytLEK1 had a high of cytoplasmic localization, while p50 
also had a similar distribution. In merged images (Figure 27), the proteins share 
a high degree of colocalization in cells. It is also of great interest to note that in 
C2C12 cells, both proteins demonstrated a speckled nuclear distribution. The 
p50 protein has a known function and associates with kinetochores (Echeverri et 
al., 1996). Another LEK family member, CENP-F/Mitosin, has a described
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Figure 27. cytLEK1 and p50 endogenous protein localization. As shown previously in 
Chapters II and III, cytLEK1 (green) has a cytoplasmic distribution with high perinuclear
localization. There is a strong overlap of p50 (red) staining demonstrated by the merged images. 
C2C12 myoblast (A), NIH3T3 fibroblast (B), and primary myoblast (C) cells were examined for
colocalization of endogenous proteins. Interestingly, NIH3T3 cells show endogenous protein 
localization of both cytLEK1 and p50 in an area in the nucleus that could be at the kinetochores
(arrowheads). 
interaction with the kinetochore (Zhu, 1999). There may also be a population of 
cytLEK1 that resides at the kinetochore (Soukoulis and Bader, unpublished 
data), thus defining their localization and function with the kinetochore is critical 
in characterizing this association. cytLEK1 and p50 have both been separately 
shown to function in cell division and to have roles in organelle transport and MT 
based processes while displaying similar colocalization. Further characterization 
of the cytLEK1-p50 interaction will give great dividends in defining cytLEK1 
functions with the cytoskeleton. 
 
Hook2 
 The Hook family of proteins is an emerging class of proteins that bind 
microtubules and membranes. Studies on the D. melanogaster homolog indicate 
a function for the protein in multivesicular body trafficking (Kramer and Phistry, 
1996; Kramer and Phistry, 1999; Sunio et al., 1999), while the C. elegans 
homolog appears to function in attachment of the centrosome to the nucleus 
(Malone et al., 2003). The three human members, Hook1-3, have conserved N-
termini that bind MTs, while the C-termini are more divergent and contain the 
vesicle membrane-binding domain. Hook1 interacts with Rab proteins and 
functions in routing proteins through the endosomes network. Hook3 has been 
shown to affect Golgi stabilization and distribution (Walenta et al., 2001). No 
published studies of Hook2 function exist at this time. Because of similar 
characteristics shared with cytLEK1 in MT association and function in vesicle 
transport, preliminary overexpression studies were conducted with Hook2.  
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 Hook2 was identified as a cytLEK1 interacting protein in our Y2H screen. 
COS-7 cells were utilized to examine exogenous expression and localization of 
transient 5’LSD and GFP-hook2. As seen in previously published reports (Pooley 
et al., 2006), 5’LSD expression has a high perinuclear expression pattern and 
extends into the cell periphery. Interestingly, the Hook2 chimera had a pinpoint 
localization at the centrosome. In cells that were cotransfected with 5’LSD and 
GFP-hook2, there was an obvious and dramatic relocalization of 5’LSD to the 
same focus that contained GFP-hook2 (Figure 28), and both proteins localize at 
the centrosome (Moynihan and Bader, unpublished data). Interestingly, it 
appears that 5’LSD expression is actually less in cotransfected cells compared to 
singly 5’LSD transfected cells. This is only visualized by immunofluorescence to 
date, but further characterization will be conducted. Our genetic and transient 
protein expression data support a direct cytLEK1-Hook2 interaction, making 
studies defining the function of this association essential.  
 
Discussion 
 Even though all the results here are preliminary, it is worthwhile to further 
speculate and discuss the significance of our Y2H results. Examining these 
associations and characterizing their possible interactions is fundamental in 
understanding cytLEK1 and its function in different molecular pathways. It is 
essential that we understand cytEK1 function, since the protein appears to be 
important for basic cell processes, such as cell proliferation and differentiation 
and intracellular movement of proteins. 
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Figure 28. Coexpression of transient 5’LSD and GFP-hook2. COS-7 cells were singly
transfected (A-B) or cotransfected with 5’LSD and GFP-hook2 (C-E). As seen, 5’LSD (red) has 
a cytoplasmic distribution (A), while GFP-hook2 (green) has a pinpoint localization in the area of 
the centrosome (B). In cotransfected cells (C-E), 5’LSD has a dramatic relocalization to the same 
foci as GFP-hook2. We have identified this focus as being at the centrosome (Moynihan and 
Bader, unpublished data).
A B
C D E
cytLEK1-p50 interaction 
Endogenous cytLEK1 and p50 have a similar distribution in mammalian 
cells and appear to have significant colocalization. Dynactin is a multimeric 
complex that contains 11 different subunits, one of which is p50. The p50 protein 
is 551 aa and forms an α-helical structure that appears to be the critical protein 
link by interacting with itself and the dynactin subunits p150glued, p24/22, and 
Arp 1 rod. The middle portion of p150glued interacts with MT based motors, 
while p24/22 and Arp 1 are important in cargo recognition (reviewed in Schroer, 
2004). Arp1, or Actin related protein, can hydrolyze ATP and form filaments 
(Bingham and Schroer, 1999). In relation to cytLEK1, Arp1 binds spectrin-family 
proteins (Holleran et al., 2001), which allows one to speculate that this 
association between cytLEK1 and dynactin could be a mechanism utilized by 
dynein to bind a variety of subcellular structures, refer to model in Figure 26.  
 Subcellular localization of dynactin has shown that it is present in many 
different regions of the mammalian cell. Dynactin has distinct localization at 
centrosomes and spindle pole bodies, similar to that seen with cytLEK1 (Clark 
and Merer, 1992; Gill et al., 1991; Paschal et al., 1993; Soukoulis et al., 2005), 
and Soukoulis and Bader, unpublished data). Studies indicate that dynactin 
governs microtubule anchoring during mitosis. Cells with overexpression of the 
p50 subunit or other dynactin subunits displayed irregular spindle morphology. 
As a result, dynactin was mislocalized at the centrosome, and the MTs were in 
unfocused arrays (Quintyne et al., 1999). Centrosomal component transport was 
also inhibited after disruption of the dynactin complex (Quintyne et al., 1999). 
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Along with dynactin localization at the centrosome and spindle appparatus, p50 
is located specifically at the kinetochore. The protein associates with the 
kinetochore proteins Rod, Zw10, and Zwilch, which are essential for mitotic 
checkpoint signaling (Karess, 2005). CLIP-170, another protein associated with 
dynactin, relocalizes to and functions in spindle-kinetochore attachment during 
the onset of mitosis (Tanenbaum et al., 2006). Dynactin also has been localized 
to the cell cortex. It is speculated that dynactin’s binding of microtubules allows a 
force to be generated that orients the spindles in the proper arrangement 
(Busson et al., 1998). Dynactin is an integral regulator of mitosis in its key roles 
with dynamics of centrosomes, spindles, and kinetochores.  
Pertinent to our studies, dynactin has been localized at a number of 
intracellular membranes, because most organelles, if not all, are capable of 
microtubule-based movement. As would be expected, there are a number of 
studies describing dynactin regulation of organelle trafficking. Originally identified 
as a kinetochore protein during mitosis and a p50 binding protein, ZW10 is 
localized at the ER and throughout the cytoplasm during interphase (Hirose et 
al., 2004). Overexpression and knockdown assays of ZW10 revealed its 
involvement in membrane trafficking between the endoplasmic reticulum and 
Golgi. We have also described a role for cytLEK1 in membrane trafficking at the 
recycling endosomes network (see Chapters II and III). Along with dynactin 
localization at the Golgi, dynactin has been localized to numerous other organelle 
structures. Overexpression of p50 causes accumulation of Golgi, early and late 
endosomes, and lysosomal structures at the cell periphery. Therefore, these 
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results indicate that p50 and dynactin are required for proper plus-ended 
transport of organelles (Burkhardt et al., 1997; Deacon et al., 1997; Presley et al., 
1997; Valetti et al., 1999). These studies may indicate that cytLEK1 not only 
functions in recycling endosome movement, but it is a more broad regulator of 
intracellular movement. Alternatively, p50-cytLEK1 interaction may have a critical 
role specifically in plasma membrane recycling. 
Protein members of the Lis1 pathway bind the dynein heavy chain through 
Nde1 and also the dynactin complex indirectly (Sasaki et al., 2000; Smith, 2000). 
Nde1, a cytLEK1 binding protein (see Chapter I), has been localized to the cell 
cortex and centrosomes, where it has roles in mitosis and spindle assembly. 
Studies conducted in A. nidulans indicate a direct interaction of Nde1 with the 
Arp1 subunit of dynactin. However, direct or indirect associations between Nde1 
and the dynactin complex are lacking. cytLEK1 may provide the first identified 
link between the p50 subunit of dynactin and Nde1. 
A number of factors are responsible for recruitment of dynactin and dynein 
to Golgi membranes. The Arp1 subunit binds directly with the Golgi-specific 
spectrin β-III spectrin. Rab6 appears to regulate the binding of dynactin to the 
TGN. BICD, a binding partner of Rab6, also has the ability to bind p50, implying a 
regulatory mechanism of dynactin localization and function at the Golgi (Matanis 
et al., 2002; Young et al., 2005). These proteins assist in tethering the dynactin-
dynein motor to the MT network. Similarly, Rab7 is proposed to be the link 
between dyanctin and endosomes (Cantalupo et al., 2001). It is now quite 
evident that dynactin is a key regulator of organelle and membrane transport of 
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several intracellular pathways along the MT network. These data show that p50 
and dynactin have a broad role in organelle movement. cytLEK1 has an 
emerging role with SNAP-25 and Rab11a in the recycling endosome pathway. 
Therefore, future studies need to address whether or not cytLEK1 has a broad 
role in membrane transport throughout the cell or if it is specific to recycling 
endosomes. cytLEK1 may be the key regulator of p50 and dynactin association 
with the plasma membrane recycling pathway.  
 
cytLEK1-hook2 interaction 
Hook2 is a member of an emerging family of proteins that associates with 
the MT network and membranous cargo, which are thought to be nonmotor MT 
linkers for cellular components. There are three mammalian hook homologs that 
have nearly identical N-termini but differ in their C-terminal cargo binding 
domains. The central region consists of a coiled-coil domain, similar to cytLEK1 
and its other binding partners. Interestingly, northern blot analysis reveals that 
Hook1 is found only in the testes. RT-PCR shows hook1 transcript expression at 
very low levels in adult tissues. Hook1 maps to chromosome 4 in the mouse and 
is in the same locus as the previously identified azh mutation (Mendoza-Lujambio 
et al., 2002). The azh/azh mouse is a mutant that displays abnormal sperm head 
morphology and looping at the midpiece of sperm flagellum (Cole et al., 1988; 
Meistrich et al., 1990). RT-PCR analysis shows that deletion of exons 10 and 11 
from the 22 exon hook1 gene results in a premature stop codon and then 
translation of a non-functional protein. Hook1 is located at MT structures located 
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throughout the developing spermatids. From these studies, it is speculated that 
Hook1 is responsible for MT and associated protein localization in the 
differentiating spermatid. Truncation of the wild-type protein results in altered 
sperm morphology and may be a cause of male infertility (Mendoza-Lujambio et 
al., 2002). In vitro cell culture data show that Hook1 localizes to unidentified 
discrete punctuate subcellular structures that appear to be associated with MTs 
(Walenta et al., 2001). 
 Hook3 is a more ubiquitous protein than Hook1. It is expressed in all 
tissues, 293 cells, human, and monkey cells tested thus far. Examination of 
Hook3 localization in Hep2 cells shows that it has a perinuclear distribution and 
colocalizes significantly with Golgi and the microtubule organizing center. Similar 
to all Hook proteins, Hook3 binds MTs, and MT integrity is required for proper 
localization of Hook3. Overexpression of Hook3 disrupts the Golgi complex 
(Walenta et al., 2001).  
 Hook2 is also a widely expressed family member, as it is expressed in all 
rodent tissues tested. It is the family member that we identified in our Y2H 
screen. Interestingly, protein expression peaks in the developing brain at a time 
when most neuronal precursors cease division and undergo differentiation. This 
is in striking similarity to what is observed with cytLEK1 expression in the 
developing heart. Lek1 is expressed at high levels during cardiomyocyte 
proliferation and is drastically down-regulated as cells terminally differentiate 
(Ashe et al., 2004; Goodwin et al., 1999). Hook2 protein is distributed throughout 
the cytoplasm, but has more intense staining at the centrosome. Y2H analysis 
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utilizing Hook2 as bait identified the centrosomal protein CEP110. Furthermore, 
overexpression analyses demonstrated altered centrosome localization and 
function and retarded MT aster formation (Personal communication, H. Kramer).  
 As one can see, the overriding theme of the Hook family’s functions 
appears to be organelle transport along the MT network. In separate studies, we 
have identified a cytLEK1 function with the MT network and a role for cytLEK1 in 
vesicular transport in recycling endosomes (Pooley et al., 2006; Soukoulis et al., 
2005). Similar to Hook2, cytLEK1 also has a high localization in a focus 
juxtaposed to the nucleus that coincides with centrosome localization (Soukoulis 
et al., 2005; Soukoulis and Bader, unpublished data). The interaction between 
cytLEK1 and Hook2 needs to be further characterized for obvious reasons. We 
identified Hook2 in our Y2H screen as a cytLEK1 interacting protein 
demonstrating interaction between the proteins, while both have a similar protein 
subcellular localization patterns at the centrosome. It could be speculated that 
Hook2 and cytLEK1 regulate function at the centrosome. In separate studies, 
overexpressing proteins phenocopy one another in the retardation of microtubule 
polymerization at the centrosome (Soukoulis et al., 2005; personal 
communication, Helmut Kramer). Further clarification is needed as to whether 
cytLEK1-Hook interaction is specific for only Hook2, or if other Hook members 
are able to associate with cytLEK1.  
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Other proteins identified in the Y2H screen 
Along with p50 and Hook2, the Y2H screen identified four other proteins 
as preliminary cytLEK1 interacting proteins. Because no further data has been 
generated characterizing the association, they will only be briefly discussed. 
Keratins, identified in the screen, are members of the intermediate filament family 
of proteins. Keratins have been shown to exist in high copy numbers in 
pretransformed libraries and have been shown to be prone to giving false-
positive results in Y2H. As a result, cytLEK1-keratin interaction is unlikely, as 
previous colcalization experiments have shown sparse colocalization between 
the proteins (Pooley, Soukoulis, and Bader, unpublished data).  
Oligophrenin was identified and is a protein that encodes a RhoGAP 
protein involved in X-linked mental retardation (Zanni, 2005). It may modulate 
Rho GTPase activity in neuronal morphogenesis by regulating the actin 
cytoskeleton. The only common characteristic that oligophrenin shares with 
cytLEK1 is its association with the cytoskeleton, however oligophrenin has only 
been identified to  interact with actin. To date, cytLEK1 has no known function 
with actin. 
 Structural maintenance of chromosome (SMC) proteins are chromosomal 
GTPases that function in chromosome organization, segregation, and dynamics, 
especially during mitosis. SMC4 was also identified in our Y2H screen as a 
cytLEK1 interacting protein. It forms a condensing complex with other accessory 
proteins that bind to chromosome arms during mitosis and help maintain 
chromosome architecture. Emerging data suggests that SMC proteins play a vital 
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role in assembling centromeric heterochromatin and orienting sister kinetochores 
to allow spindle attachment (Losada and Hirano, 2005). Even though cytLEK1 
and SMC4 have different localization patterns and are quite divergent in their 
known functions, there may be a population of cytLEK1 that localizes to the 
kinetochore (Soukoulis and Bader, unpublished data). cytLEK1 may bind SMC4 
at the kinetochore during mitosis and help in spindle attachment, a MT-based 
process. 
 Lastly, laminin B1 was recognized in the Y2H screen. Since laminins are 
part of the extracellular matrix, a functional role with cytLEK1 appears obscure 
and should not be pursued. We hypothesize that this is not a true interaction and 
may be a false-positive from our screen. 
The N-terminal portion of cytLEK1 used for the bait construct in our Y2H 
screen contains two leucine zippers. Leucine zippers are generic motifs that drive 
protein-protein interaction (O'Shea et al., 1989). It is logical for us to characterize 
cytLEK1 functions with proteins that have a similar expression pattern, 
subcellular localization, and demonstrated roles in shared cellular processes (i.e. 
interaction with the MT network and/or involvement in vesiclar transport, since 
these are two pathways of known cytLEK1 function). Hook2 and p50 have well-
defined functions with the MT network and in vesicle trafficking and positioning. 
Therefore, it would be of most interest for us to pursue these interactions.  
According to published reports, it appears that keratin, oligophrenin, and 
SMC4 have no known function with the cytoskeleton. It may be that these 
proteins are inherently “sticky” and had a spurious interaction with our bait 
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construct, even though they passed a false-positive screen and appear to be 
legitimate cytLEK1 interacting proteins according to our initial Y2H analysis. It 
should also be noted that we have done multiple Y2H screens with various 
regions of cytLEK1, and these proteins were never identified in other screens.  
To date, it appears that cytLEK1 may have multiple functions with the 
microtubule network. It is possible that the C-domain of cytLEK1 binds MTs while 
the more N-terminal 5’LSD arm of cytLEK1 associates with proteins that link to 
the MT network. cytLEK1 has a broad expression pattern with a high expression 
pattern around the nucleus. We have demonstrated that cytLEK1 is at the 
kinetochore, the centrosome, and with recycling endosomes. cytLEK1 may in fact 
interact with numerous proteins at given organelles, and the underlying role of 
cytLEK1 is in associating structures with the MT network. It may be a protein that 
is a general regulator of association between organelles and the MT network, or 
it may be specific to certain organelles (for example, recycling endosomes and 
the kinetochore). I propose that cytLEK1 may be a general link for organelles to 
the cytoskeleton.  
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CHAPTER V 
 
DEVELOPMENT OF THE CONDITIONAL LEK1  
KNOCK-OUT ALLELE 
 
 
Introduction 
To date, study of the LEK family of proteins has remained confined to 
overexpression and knock-down studies with exogenous factors, such as with 
RNAi and Morpholino oligomers. Overexpression of dominant-negative proteins 
in chicken cell lines demonstrates a CMF1 function in muscle cell proliferation 
and differentiation (Dees et al., 2000; Wei et al., 1996). The human CENP-
F/mitosin associates with the kinetochore and mitotic spindles in a cell cycle 
dependent manner (Liao et al., 1995; Zhu et al., 1995a; Zhu et al., 1995b). 
Several studies have examined CENP-F/mitosin knock-down in human cell lines 
utilizing RNAi. All studies have varying results and conclusions, but knock-down 
of CENP-F/mitosin implicate roles for the protein in kinetochore assembly, 
regulation of chromosome behavior, and control of the spindle assembly 
checkpoint during mitosis (reviewed in Varis et al., 2006). While RNAi is a useful 
tool in studying protein knock-down in cell lines, critical in vivo studies utilizing 
protein ablation are completely lacking, particularly in organogenesis. 
The Cre-loxP system is a widely used tool for genetic tailoring of the 
mouse genome. Cre recombinase from the P1 bacteriophage efficiently 
recombines DNA located between consensus 34 base pair recognition loxP sites. 
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By utilizing this system, DNA can be altered in such a way that it becomes 
inverted, excised, or recombined between two different DNA templates. It can 
then be manipulated so the gene of interest is activated or inactivated after 
recombination. Numerous transgenic mouse lines have been created that 
express Cre recombinase in tissue and temporal specific manners. One is now 
able to create global knock-out or conditional knock-outs depending on which 
Cre line is utilized. Conditional lines are especially useful when a traditional 
knock-out results in early embryonic-lethality preventing study of later functions, 
or when the gene of interest has roles in multiple tissues (reviewed in Kwan, 
2002; Nagy, 2000).  
No studies have been conducted on any of the LEK proteins that examine 
complete loss-of-function. Groups have used RNAi and Morpholino technology 
with some success. The major drawbacks with these technologies is that one 
never knows if the protein is completely diminished in every cell, and they cannot 
be utilized in vivo in mice. The holy grail of knock-down/knock-out technology is 
the creation of a conditional allele of the gene of interest, and in our case, Lek1. 
We have now created the conditional Lek1 allele and initial studies characterizing 
the conditional knock-out in the heart have been completed.  
Our pilot studies utilizing the Lek1loxP/loxP mouse line have utilized the 
cardiomyocyte specific cardiac troponin-T Cre line (cTnT-Cre) to conditionally 
ablate Lek1 function specifically in cardiomyocytes early in heart organogenesis. 
Our pilot studies indicate a “small heart” phenotype that includes a reduction in 
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myocyte layer thickness and overall heart size in mutant hearts with significant 
alterations in their functional capabilities. 
 
Materials and Methods 
 
Labeling of Probes for BAC Screening 
The Rediprime II Random Prime Labeling System was obtained from 
Amersham. After PCR amplification of the Lek1 fragment used as a template for 
the probe, 25ng template DNA was diluted in 45 μl of TE. The DNA was 
denatured at 95oC for 5 min and centrifuged briefly. The denatured DNA was 
then added to the tube supplied by the kit. To the tube, 5 μl 32P-dCTP (Sigma) 
was added to the reaction mixture, pipetted up and down 12 times, and 
incubated at 37oC for 15 min. The reaction was column purified (Quick Spin 
Column (TE), Roche). The flow-through was boiled for 15 min, centrifuged briefly, 
and mixed. Labeled probe (14 μ) was used in 5 ml hybridization buffer. 
 
PreHyb Solution 
To 1M NaPO4, 20% filtered SDS, 0.5M EDTA, fresh Poly A/PolyC solution 
(Sigma, # P9403 and P4903) was added. Poly A/Poly C stock solution was 
maintained at 10 mg/ml. To 1ml of TE, 12.5 μl of each was added and boiled for 
10 min, quenched on ice, and added to PreHyb solution. 
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Hybridization Buffer 
1 M NaPO4, 20% filtered SDS, and 0.5M EDTA  
 
Erase Solution 
5 ml 20X SSC, 5 ml 20% SDS, and 490 dH2O 
 
Wash Solution 
For 1L: 5 ml 20X SSC, 2 ml 0.5M EDTA, 50 ml 20% SDS, and 943 ml of dH2O 
 
Probing of BAC Filters 
PreHyb solution was added to the filter membranes (CHORI), and they 
were incubated at 65oC for 2 h. PreHyb solution was replaced with prewarmed 
hybridization solution. The labeled probes were boiled and then added overnight 
at 65oC. Filters were washed with 1X SSC with 0.1% SDS for 30 min for a total of 
six times. The labeled membranes were placed in a Kodak Biomax cassette with 
film for 24-48 h, and the film was then developed. 
 
Labeling of Southern Probes to Screen ES Cells 
The Prime-It II Random Primer Labeling Kit was obtained from 
Stratagene. With some modifications, PCR fragments were amplified and then 
purified using the QIAquick Gel Extraction Kit (Quigen). After purification, 2 μl of 
DNA (25 ng total) was added to a microcentrifuge tube. To the reaction tube, 17 
μl dH2O and 10 μl of random oligonucleotide primers were added, and the tubes 
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were heated at 95oC for 5 min and briefly centrifuged. In order, 10 μl of 5X buffer, 
5X dCTP primer buffer, 5 μl of labeled 32P-dCTP (Sigma), and 1 μl Exo(-) Klenow 
enzyme (5 U/μl) were added and then mixed and incubated at 37oC for 45 min. 
The reaction was stoped with 2 μl of stop mix.  
 
Southern Blotting 
DNA was digested with EcoRI or BsaWI for a minimum of 8 h during the 
day. The digested DNA was run on a 0.8% agarose gel overnight without EtBr at 
25 V in 1X TBE. The gel was stained in 4 μg/ml EtBr for 15 min and briefly rinsed 
three times with H2O and photographed. Dilute HCl (10 ml HCl+490 ml H2O) was 
added for 15 min and rinsed with H2O three times. The gel was washed with 
0.5M NaOH for 40 min on shaker at room temperature. DNA was transferred 
overnight in 0.5M NaOH in transfer apparatus (Altec Labs) to a Hybond-N+ 
(Amersham) membrane. The next day, the membrane was washed with 2X SSC 
for 10 min and then Stratalinked (Stratagene) for 30 min. Erase solution (500ml) 
was added to the blot at room temperature with shaking for 20 min. PreHyb (10 
ml) solution was added for 2 h at 65oC. The PreHyb solution was removed and 
the boiled probe was added to 10 ml hybridization solution preheated to 65oC. 
The probe and blot were incubated overnight at 65oC. The following day, the 
hybridization mixture was discarded. Preheated wash solution (100ml) was 
added to the container with blot for 30 min at 65oC, for a total of three times. The 
labeled blots and film were placed in a Biomax cassette (Kodak) for at least 24 h, 
depending on the affinity of the probe, and developed.  
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 Modified BAC DNA Midiprep (Qiagen) 
A single BAC clone was obtained from CHORI and one colony was 
isolated and used to inoculate a 5 ml starter culture with chlorophenicol. To 
inoculate 100 ml of selective LB medium, 0.5 ml of starter culture was added and 
then grown at 37oC overnight with vigorous shaking. The cells were harvested by 
centrifugation. Pellets were suspended in 10 ml of P1 buffer. Buffer 2 (10 ml) was 
added to the tubes. It was mixed thoroughly by inverting six times and then 
incubated at room temperature for 5 min. Chilled P3 buffer (10 ml) was added 
and immediately mixed by inverting six times and incubated on ice for 15 min. 
The slurry was centrifuged at >20,000 x g for 15 min at 4oC. The supernatant 
was removed containing the BAC DNA. It was re-centrifuged as before and the 
supernatant with the DNA was removed. A Qiagen-tip 100 was equilibrated by 
applying 4 ml of Buffer QBT and then allowed to empty by gravity flow. The tip 
was washed two times with 10 ml Buffer QC. The DNA was eluted with 
prewarmed (65oC) 5 x 1ml Buffer QF. The DNA was precipitated by addition of 
3.5 ml room temperature isopropanol. It was mixed with gentle inversion and 
centrifuged immediately at >15,000 x g for 30 min at 4oC. The supernatant was 
removed from the DNA pellet, and the pellet was washed with 2 ml of room-
temerature 70% EtOH. Centrifugation was then conduted at >15,000 x g for 10 
min. The pellet was air-dried and redissolved in TE. 
 
 
 126
Primers Used to Construct Probe for BAC Membrane Screen 
5’: AGCTGGGCCCTGGAAGAATGG,  
3’: AGCGCAGCTTCGAGAGAGTC 
 
Primers for PCR Screening of BAC Clones  
3.1: 5’ CGAGTTGTCCTTTGAGTCCCTG, 
 3’ GAACCTACCGTCTGAGAACCACTG;  
3.2: 5’ TGGAAGAATGGAAGGAAGGTCTC,  
3’ CACAGGCAGGCAGCAATAAAG;  
3.3: 5’ GGGTGAACTCTGTAACCATTGACC,  
3’ CGGCTTTCCTTTGTCTGTCTTG;  
3.4: 5’ GAATGCTTGCGTGTAGTTTGGG,  
3’ TGCTCTAAGACAATGGTTCCTTCC;  
3.5: 5’ TTGTATGTGGCGTTCAGTAGATGG,  
3’ TGACTTGCTGTAACTCCTGGGTAAG;  
3.6: 5’ AGCAGTGAGGTATGTGAGCAGGAG,  
3’ TTTTGGACCAGGGAGATGACTTAG;  
4.1: 5’ GCAGTTTGAATCGCTCGTGC,  
3’ TACGGAACAACCTGTCAGCCAC;  
4.2: 5’ CTCTGAGAAGGGAAGGTGTTTGTG,  
3’ AAGCAAGGGAATCCAGCAGG 
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Primers for Cloning Lek1 into pFRT.loxP 
SA: 5’ ATCGATGGACTGGGATCACAGGCAGAAG,  
3’ ATCGATTTCTTTCTGTCTTGTTTTGTCAATTGTG;  
5’ DEL fragment: 5’ TTAATTAACAGTTGGGTCTGAGTGACAGTGGCAG,  
3’ CTTTTGCTCCATCGACAGAAATTAC;  
3’ DEL fragment: 5’ CGGTAACTGTCTGAGGAACAGTCCTGT,  
3’ TTAATTAAGCAACAGTGTAAACCTCTACTACT;  
5’ LA fragment: 5’ TATAGGATCCTCTTCAGTGGAGACAGAGCT,  
3’ GCAATGTCAGCAAAACACTTAACAA;  
3’ LA fragment: 5’ ATTCCTCCAGGTCCTTAAGATTTG,  
3’ ATATAGGATCCCATGCCCACCTCATAAAGA 
 
Primers Used for Screening ES Cells by Southern 
Probe 4.1-1: 5’ GCAGTTTGAATCGCTCGTGC,  
3’ TACGGAACAACCTGTCAGCCAC;  
Probe 11.1-5: 5’ TTAGCTGCCTTCCTGGGGAA,  
3’ AAATCTGGATATGCGATTCGC;  
Probe 5.7: 5’ AATCACTAGGCCAGTATCACTGC,  
3’ CATTTCACAATGTGTGCATGG 
 
Primers for PCR Screening of ES Cells and Mice  
Across loxP site: 5’ AATAATGAAGCTGACACCAAAAACT,  
3’ GAACCTACCGTCTGAGAACCACTG;  
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Across FRT site: 5’ CCAAAGAACGGAGCCGGTT,  
3’ AATGTCTTACTCGCGTCTTCACGGA;  
Neomycin cassette: 5’ CGATCCCATATTGGCTGCAG,  
3’ AACCGGCTCCGTTCTTTGG;  
LA recombination: 5’ TTGGAGGCATGTCTGTGTGTGGCT,  
3’ CATTTCACAATGTGTGCATGG 
 
Results 
 
Isolation of Lek1 gene 
Our laboratory had previously constructed the nucLEK1 and cytLEK1 
constructs separately. As a result, the entire gene with exons and introns needed 
to be cloned. To inititially screen the high density mouse BAC library filter set, a 
140 bp fragment from exon 1 of Lek1 was amplified by PCR. This fragment of 
Lek1 was then randomly labeled to create a radioactive probe. The probe was 
then utilized to screen the filter set with 11 potential clones being identified in the 
screen. 
 Individual BAC clones were received and further analyzed. DNA was 
purified from each individual clone, and a PCR-based strategy was developed to 
screen for ones that contained Lek1 (Figure 29). Initially, PCR was used to 
amplify a 140 bp product located in exon 1 (primer set 3.2). The screen identified 
two potential BAC clones that may have contained Lek1, clones 535-I18 and
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Figure 29. BAC screen. Eight unique primer sets were utilized to screen BAC clones that may 
have contained Lek1. In clone 335-N19, approximately 3 KB of 5’UTR and at least 17 KB of 
Lek1 was identified in the PCR screen.
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Figure 30. PCR screen with Lek1 primer sets. Refer to Figure 27 to see where the unique 
Lek1 primer sets amplify. Fragments from all the primer sets were amplified in clone 335-N19, 
while clone 535-I18 appears to have a region of Lek1 missing from the BAC. A and C are PCR 
screens utilizing 335-N19 as template DNA and B uses 535-I18. From these screens, we 
determined that 335-N19 has at least 3 KB of 5’UTR and 17 KB of Lek1 in the clone. Positive 
control reactions (+) utilized Lek1 primer sets previously shown to amplify fragments of the 
gene.
100 bp
500 bp
335-N19. These two clones were then characterized to determine exactly which 
portion of Lek1 they contained.  
 Again, a PCR-based analysis was utilized to further characterize how 
much of Lek1 was present in each BAC clone. The clones were screened by 
eight unique primer sets that amplified different regions of Lek1 (Figure 29). 
Clone 535-I18 was not found to have the entire gene and appeared to have a 
region missing between the first and fifth exons, while clone 335-N19 was found 
to have no such deletion (Figure 30). Further analysis showed that the 335-N19 
BAC clone contained at least 3 KB of the 5’UTR and at least 17 KB after the 
translation start site (Figures 29 and 30). The BAC clone may contain more of 
Lek1; it has not been further characterized. In order to amplify the BAC clone, a 
modified Midiprep was used (see Materials and Methods). 
 
Cloning of Lek1 into knock-out vector 
The knock-out vector, pFRT.loxP, was a gift of Dr. Mark Magnuson 
(Figure 31; Vanderbilt University). It contains the loxP sites, the neomycin 
resistance positive selection gene, the thymidine kinase negative selection 
marker utilized for random vector integration events, and FRT sites used to 
delete the neomycin resistance cassette. To construct the final knock-out Lek1 
vector, three fragments of Lek1 had to be ligated into different sites. The Lek1 
short arm (SA) and long arm (LA) were required for recombination in ES cells. 
Lastly, the fragment of Lek1 to be floxed and excised (DEL) from the 
endogenous Lek1 locus needed to be cloned (Figure 32). 
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Figure 31. Cloning of Lek1 targeting construct. The pFRT.loxP vector is depicted in the upper left 
corner of the figure. Shuttle vectors had to be constructed utilizing the pGEM T-easy system that 
were then used in intermediate steps to ligate the SA (1 KB), LA (6 KB), and DEL (1.4 KB)into
pFRT.loxP. First, the BamHI digested vector and AvaI and BamHI digested LA5’ and LA3’
fragments were triple ligated to construct pFRT.loxP-LA. Then, BsrGI and PacI digested DEL5’ and 
DEL3’ fragments were triple ligated into PacI digested pFRT.loxP-LA. This construct, pFRT.loxP-
LA-DEL was then digested with ClaI and a shuttle vector containing the SA was also digested with
ClaI. The cut vector and SA fragment were ligated together to form the final pKOLEK1-5 targeting 
construct.
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Figure 32. Lek1 targeting. A) The 5’UTR was utilized for the SA, the first five exons, DEL, are 
to be excised, and a 3’ region after DEL was used for the LA. B) After successful recombination,
loxP sites will flank the first five exons of Lek1, and the positive selection cassette Neomycin 
resistance with corresponding FRT sites will also be integrated into the Lek1 locus. C) Once the 
conditional Lek1 mouse line carrying the Neo resistance cassette is identified, it will be crossed 
with a line expressing FlpE to delete the Neo resistance cassette. D) The line carrying the floxed
Lek1 allele without the Neo resistance cassette will be mated to Cre lines to delete the first five
exons of Lek1, therefore ablating Lek1 function.
 The Lek1 gene is relatively large in size, 8994 bp, and contains 17 exons. 
Therefore, it was not feasible to flox the entire gene. We developed a strategy 
that floxed the first five exons of Lek1 and included the translation start site. This 
corresponds to the first 788 bp Lek1 mRNA. By deleting the first five exons of 
Lek1, we postulated that since the translation start site is absent, Lek1 will not be 
translated. It must be noted that our laboratory has detected neither alternative 
start sites nor alterantive splice variants. However, there are several methionines 
located in frame throughout the remainder of the mRNA. If a truncated mRNA is 
transcribed, it is theoretically possible that a truncated Lek1 could be translated. 
Also, no consensus Kozac sequences would be present if a  shortened mRNA is 
transcribed. 
 If a truncated Lek1 protein were to be translated, we have the necessary 
reagents to screen for the presence of the mutated protein. We have several 
antibodies that recognize different epitopes located throughout the protein. If a 
peptide was translated without the floxed region present (also termed 5’LSD), we 
have antibodies that recognize six epitopes after 5’LSD (see Figure 4). In the 
event that a truncated protein was produced, it was most likely that it would not 
function properly. Since a large region would be absent, it is quite possible that 
the protein would be misfolded or degraded, rendering it nonfunctional. The first 
five exons of Lek1 correspond to the same region, 5’LSD, which was used in the 
Y2H screen (review chapters II and III). This is the region that is responsible for 
Lek1 interaction with SNAP-25 and syntaxin 4 in the plasma membrane recycling 
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pathway. In the scenario that a truncated Lek1 transcript is translated, we can 
test the consequences of Lek1 loss-of-function in these pathways. 
 In order for our laboratory to target ES cells and ablate Lek1 early in 
development, we constructed a Lek1 knock-out vector. Unique restriction 
enzyme sites were required for each of the ligations, and each of the ligations 
had to be performed in a sequential manner. First, we utilized site directed 
mutagenesis to obtain a unique PacI restriction site in pFRT.loxP that was 
utilized for placement of DEL.  
Second, a triple ligation strategy was used to ligate the LA into pFRT.loxP, 
since it is relatively large and difficult to PCR amplify. The LA contains a unique 
AvaI site that is found only once in the LA and not found in pGEM T-easy vector.  
Shuttle vectors were made that contained a 5’ and 3’ half of the LA (Figure 31). 
These shuttle vectors were then digested with BamHI and AvaI, purified, and 
ligated into the BamHI cut pFRT.loxP. After numerous attempts at the triple 
ligation, the LA was successfully ligated into pFRT.loxP, termed pFRT.loxP-LA. 
Third, a similar triple ligation strategy was developed to place the DEL 
region into pFRT.loxP-LA. 5’ and 3’ halves were PCR amplified, placed into the 
shuttle vector, digested with PacI and BsrGI, and triple ligated into pFRT.loxP-
LA. After several attempts, pFRT.loxP-LA-DEL was developed. 
Lastly, the ClaI site of pFRT.loxP-LA-DEL was utilized to ligate the SA into 
the Lek1 knock-out targeting vector. The SA was PCR amplified, placed into the 
shuttle vector, digested, and ligated into the construct. This was relatively easier 
than the prior triple ligations. The targeting construct, pKOLEK1-5, was finished 
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after 11 months of ligation attempts. The vector was sequenced fully, and no 
mutations were present. 
 
Development of conditional Lek1 knock-out mouse line 
No Lek1 family protein has been ablated in vivo. Figure 32 diagrams the 
wild type and targeted loci of Lek1. All ES cell electroporations were performed 
by the Vanderbilt Transgenic Mouse/ Embryonic Stem Cell Shared Core 
Resource Facility (Dr. Cathleen Pettepher, director) utilizing our pKOLEK1-5 
targeting vector. Our laboratory also developed a Southern probe strategy to 
screen injected ES cell clones.  
 We obtained DNAs from 711 129/SvEv ES cell clones that survived 
positive and negative selections. Our initial screen used the radioactively labeled 
4.1-1 probe of 545 bp (Figure 33). We identified four potential ES cell clones that 
had targeted recombination at the Lek1 locus. In order to confirm these results, 
all clones were re-probed with 11.1-5, and these data supported the previous 
screen. We identified clones 1D-5, 5-C9-1, 6A7-1, and 8-D9 as potential clones 
containing the targeted Lek1 locus. A third probe using the LA as a template, 
probe 5.7, confirmed our results.  
 Next, a PCR-based strategy was utilized to verify that the targeting 
construct recombined properly in the ES cell clones and that the entire construct 
was present in the floxed Lek1 locus. As seen in Figure 33, four primer sets were 
used to identify a loxP site, a FRT site, the neomycin resistance cassette, and a 
primer set to identify proper LA recombination. Results from the PCR screen
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Figure 33. ES cell screening strategies. DNA was isolated from 711 ES cell clones and a 
Southern blot strategy was employed to screen the clones. To initially test for recombination at 
the SA, DNAs were digested at EcoRI sites (*) and the digested DNA was labeled with probe 
4.1-1. The wild type Lek1 band was 7.7 KB, while a targeted floxed allele would label a 
fragment of 3.6 KB. To confirm our initial results, probe 11.1-5 was also utilized on EcoRI
digested DNA and gave the same results. DNA samples were then digested with BsaWI (+) to 
test for recombination at the LA. Wild type fragments were 13 KB, while targeted alleles 
showed fragments of 8.8 KB. After Southern blot screening, clones demonstrating targeted 
recombination at the Lek1 locus were also PCR screened. Primer sets (arrows) were designed to 
produce fragments that varied in size between wild type and floxed alleles. Primer sets were 
designed that showed the presence of a loxP site, the inclusion of the Neo resistance cassette, an 
FRT site, and recombination at LA locus.
showed that clones 1-D5 and 8-D9 had the correctly targeted Lek1 locus. By 
utilizing both Southern blotting and PCR-based strategies, we were able to 
identify two ES cell clones containing the correct targeted Lek1 locus that floxed 
the first five exons of the Lek1.  
Both ES cell clones 1-D5 and 8-D9 were injected into blastocysts and then 
placed into foster mothers by the Core. All litters had pups demonstrating >80% 
levels of chimerism (as seen by coat color), and therefore, germ line transmission 
was probable in one or more of these chimeras. One chimeric pup derived from 
the 1-D5 injected blastocyst demonstrated germline transmission and became 
the founder. Chimeras were crossed to the ICR background. 
 
Preliminary studies characterizing conditional Lek1 knock-out mice 
Mice carrying floxed Lek1 on both alleles, Lek1 loxP/loxP, have now been 
generated. We removed the neomycin resistance cassette gene by utilizing the 
FlpE deleter strain, and as a result, phenotypes characterized after Lek1 excision 
can be based solely on Lek1 loss-of-function (Rodriguez et al., 2000). By utilizing 
the cTnT-Cre mouse line (a gift from Dr. H. Scott Baldwin; Jiao et al., 2003) and 
establishing cTnT-Cre; Lek1 loxP/+, we were able to ablate Lek1 function 
specifically in cardiomyocytes early in heart development, beginning at E7.5. To 
date, normal Mendelian distributions have been obtained, indicating that it is not 
an embryonic lethal phenotype. Lek1 is not required for cardiac specification or 
commitment and is not required for initial cardiac differentiation as we once 
speculated (Ashe et al., 2004). It must be noted that we would prefer to establish 
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a null Lek flox/- mouse line by utilizing the E2A-Cre (Lakso et al., 1996) line that 
expresses Cre ubiquitously, but the F1 generations have only demonstrated 
mosaic expression with no germ line Cre transmission. Attempts to develop a null 
Lek1 allele are ongoing.  
PCR analysis of mice carrying a floxed allele confirms the presence of a 
loxP site before the first exon, which contains the translation start site, and a site 
after the fifth exon. These mice also carry the cardiomyocyte specific cTnT-Cre, 
therefore ablation of the first five exons is expected. A truncated protein may or 
may not be present, as previously described.  
 In our pilot studies, we initially examined three time points in cardiac 
development to characterize Lek1 loss-of function in cardiomyocytes. E12.5 is 
the time when the heart chambers become apparent and the heart wall 
cardiomyocytes are undergoing proliferation; trabeculae are becoming 
prominent. As seem in Figure 34, no outward structural defects were present 
when examining the entire organ at this timepoint. Histological analysis displayed 
distinct differences between mutant hearts and those from their heterozygous 
littermates. The ventricular walls, atrial walls, and epicardium appear highly 
thinned in the mutant hearts. Interestingly, epicardial thinning may result from 
signaling defects between the myocardium and the epicardium in the developing 
heart (Crispino et al., 2001). Some areas in the mutant hearts have only one 
myocyte thickness in the developing ventricles and the differences in 
nontrabeculated regions of the heart appear significant (Figure 34). Also, 
ventricular wall trabeculation is significantly reduced in the cTnT-Cre; Lek1 loxP/loxP
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Figure 34. E12.5 mutant hearts. Wild-type (WT) and mutant cTnT-Cre; Lek1loxP/loxP mice were compared at 
E12.5 by histological analysis by H and E staining. Hearts isolated from mutant animals demonstrate significant 
structural defects as compared to the littermates. Right ventricular (RV) and left atrial (LA) wall thickness are 
reduced in mutant hearts. Trabeculation in the developing chambers also appears to be significantly reduced and 
blunted in mutant hearts. 
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Figure 35. E17.5 mutant hearts. Control littermates and mutant cTnT-Cre; Lek1loxP/loxP mice 
were compared at E17.5 by histological analysis by H and E staining. Serial sections are depicted 
(1-5). As seen with E12.5 mutant hearts, a decrease in wall thickness is observed in ventricles. A 
25-40% reduction in heart wall thickness is observed throughout. The decrease is most apparent 
in the right ventricle. Mutant hearts also show more blunted trabeculae, indicating that there may 
be a delay in heart wall compaction as compared to heterozygous littermates.
hearts as compared to heterozygous littermates. The developing atria also 
appear to have similar thinning and trabeculation defects.  
 We also compared E17.5 mutant and heterozygous hearts by 
immunohistochemical analyses.  Heart walls should be thickened at this timpoint 
and trabeculae should be undergoing compaction. Hearts from the mutant mice 
have the same characteristics seen earlier at E12.5 with defects in myocardium 
thickness and blunted trabeculation (Figure 35). Mutant hearts demonstrate a 25-
40% decrease in heart wall thickness compared to Lek1flox/+ control littemates. 
The decrease is most apparent in the right ventricle. Interestingly, the walls are 
thinner in the mutant hearts, and it appears that trabeculae are more apparent in 
mutant hearts. This may indicated a delay in trabeculae compaction. Gross 
examination of the mutant E17.5 heart reveals that the mutant heart is 
significantly more angular and thinner than the control littermates, and they also 
appear to pool blood in both their atria and ventricles (Figure 36). 
 Lek1 loss-of-function results in a “small heart” phenotype in P4 hearts. 
Mutant cTnT-Cre; Lek1 loxP/loxP hearts are consistently smaller than control 
littermate hearts, as there was a 30-40% reduction in heart size in mutant hearts 
(Figure 37), yet there was no significant body size difference between the 
animals at this timepoint.  Mutant hearts have a more globular appearance and 
the ventricular apex is not as angular. Interestingly, studies examining valves, 
great vessels, epicardium, and endocardium show no distinct variations in these 
structures. The atrial and ventricular myocardium still appear to be significantly 
thinned in P4 hearts. 
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Figure 36. E17.5 mutant whole hearts. As compared to heterozygous littermates, mutant hearts 
are consistently thinner and more angular. Function also appears to be compromised in mutant 
hearts as blood is trapped in the atria and ventricles.
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Figure 37. “Small Heart”. Mutant hearts are 30-40% smaller than control littermates. Mutant 
hearts have a more globular shape and the ventricular apex is less angular than heterozygous 
littermates.
The first litters were not sacrificed, but instead were analyzed for cardiac function 
beginning at four weeks of age with the help of the Vanderbilt University Murine 
Cardiovascular Core (Dr. Jeff Rothman, director). After four weeks of age, major 
differences in heart function became apparent. Control and mutant mice were 
analyzed by serial conscious transthoracic echocardiography until 26 weeks of 
age. At 12 weeks, control (n=11) and mutant (n=5) subjects did not differ in terms 
of body weight or heart rate. However, Lek1 mutant mice developed progressive 
dilated systolic cardiomyopathy with age (Figure 38 and 39), demonstrating 
increased diastolic and systolic left ventricular dimension and decreased systolic 
function reflected in diminished fractional shortening defect. At 26 weeks, left 
ventricular dimension was markedly increased in mutant mice (LVIDs 0.19+0.03 
vs 0.13+0.01 cm, p<0.01, FS% 44+1.9 vs 54+1.9, p<0.001; cTnT-Cre; Lek1 
loxP/loxP vs control littermates). In other words, contractile performance was 
significantly diminished and the heart had become enlarged by 26 weeks of age. 
Also, some mice demonstrated alterations in ventricular contraction, thus 
suggesting conducting abnormalities. Analyses of long-term electrocardiographic 
(EKG) recordings show differences in mutant mice. Mutant mice demonstrated 
prolonged PR intervals, low QRS complex amplitude and prolonged duration, 
and evidence of sinus node dysfunction or sino-atrial exit block (Figure 40). 
Ventricular arrhythmias or higher grade block may progress rapidly in the near-
terminal stages of cardiomyopathy (Kozlov et al., 2005). Our EKG results may 
indicate deficiencies in the electrical coupling and alterations at the intercalated 
disk. Interestingly, when mice were allowed to age to 9 months, mutant mice 
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Figure 38. M-mode echocardiograph. Images of conscious cTnT-Cre; Lek1 flox/flox (a) and wt 
(b) mice at the mid-papillary level. The diastolic (thin line) and systolic (thick line) chords are 
indicated next to the images. The cTnT-Cre; Lek1 flox/flox mice show marked ventricular dilatation 
(~2x increase in left ventricular end-diastolic dimension) and moderate ventricular systolic 
dysfunction (decreased FS% at comparable afterload). 
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Figure 39. Longitudinal echocardiography of WT and cTnT-Cre; Lek1 flox/flox hearts. 
Progressive dilation of cTnT-Cre; Lek1 flox/flox hearts is seen as compared to wt hearts (left) 
while decreased fractional shortening is observed with age of knockout mice. Dysfunction is 
observed at all time points after birth. Contractile performance was significantly diminished and 
the size of the heart has become enlarged.
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Figure 40. Ambulatory mouse electrocardiogram. Ambulatory murine electrocardiogram 
from a cTnT-Cre; Lek1 flox/flox mouse (Mouse Holter) showing erratic sinus node function. P-P 
(and R-R) intervals range from 100ms (normal) to 410ms (markedly prolonged). QRS 
complex annotation is performed on arbitrarily long recordings, which can then be searched 
using a logical command structure. 
have a 20% mortality rate during this time period. All surviving mutant mice had 
irregular P-to-P intervals (the time between successive cardiac impulses), 
consistent with sino-atrial exit block (Figure 40), while control mice appear 
normal and no deaths occured. Lek1 mutant hearts show structural, but most 
importantly, functional defects. 
 Mutant mice have altered electroconducivity in their myocardium shown by 
their EKG. As a result, we utilized an in vitro technique developed by our 
collaborator, Cecilia Lo (NIH), to measure cell coupling between NIH3T3 
fibroblasts. Her laboratory has demonstrated that NIH3T3 fibroblasts form gap 
junctions and therefore couple in culture. Microelectrode impalements of a cell 
with dye allow one to measure coupling between cells. A single cell is impaled 
and loaded with dye. Then, the numbers of cells containing dye are counted that 
surround the injected cell.   
 For our experiment, the results depicted in Figure 41, two different 
experimental cell populations were transfected with two different dominant 
negative complexes. One population was transfected with 5’LSD and GFP-
syntaxin 4. In chapter III, we show that these proteins form a dominant negative 
complex. The second cell population was transfected with 5’LSD and GFP-
SNAP-25. This complex was shown to retard endosomal recycling (Chapter II). 
These data shown in Figure 41 demonstrate that coupling is inhibited in dominant 
negative cells as compared to the control cell population that was transfected 
with EGFP only. In control cells that express EGFP, coupling is not inhibited and 
dye transfers to numerous second tier cells. Whereas in both experimental cell 
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Figure 41. Coupling is inhibited. As a control, NIH3T3 fibroblasts were transfected with EGFP. 
One transfected cell was injected with dye and dye transfer was visualized. As seen, eight 1st and 
ten 2nd tier cells were observed containing dye.  Then, a 5’LSD-GFP-syntaxin 4 cell was also 
loaded with dye. Only five 1st tier cells and one 2nd tier cell had dye transfer. Also, a 5’LSD-GFP-
SNAP-25 cell was examined. Five 1st tier cells and two 2nd tier cells had dye transfer. The 
experimental cell populations have reduced dye transfer and therefore have significantly less 
coupling between the transfected cell and its surrounding cells.
populations, coupling is significantly inhibited.  As demonstrated, one second tier 
cell contains dye when a cell expressing 5’LSD and GFP-syntaxin 4 is loaded 
with dye. Two second tier cells contain dye when a cell expressing 5’LSD and 
GFP-SNAP-25 is injected with dye. These results show that coupling is inhibited 
in a cell autonomous manner, and protein localization at gap junctions may be 
abnormal. 
 
Discussion 
 Lek1 is a 8994 bp gene that contains 17 exons and the intervening 
introns. Since it a relatively large gene, it was determined that deleting the first 
five exons, including the translation start site, would be the most feasible way to 
ablate Lek1 function. At least three KB of the 5’ UTR and at least 17 KB of the 
gene were identified in a BAC clone. Utilizing this clone, we were able to 
construct a targeting vector that was successfully recombined into ES cells. 
Southern blot and PCR-based analyses allowed us to identify two unique ES cell 
lines that demonstrated proper recombination at the Lek1 locus. ES cells from 
both clone lines were injected into blastocysts and placed into foster mothers, 
and only one founder was obtained that showed germ line transmission. 
Homozygous floxed Lek1 mice without the neomycin resistance cassette are now 
available and initial studies characterizing mutant hearts are on-going. We have 
identified a “small heart” phenotype. Importantly, mutant hearts are altered in 
function, demonstrating a requirement for Lek1 in proper heart function. 
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 Lek1 loss-of-function had never been demonstrated in vivo. We have not 
had any success with RNAi, but we have had much success with MO in vitro. 
Cell culture based techniques have obvious short-comings. MO technology is 
more of a protein knock-down approach rather than complete ablation, and MO 
entry into every cell can not be tested. For the first time, we are now able to study 
Lek1 ablation in a tissue-specific and temporal manner in the developing mouse. 
We have chosen to study Lek1 ablation in terms of heart development utilizing a 
transgenic cTnT-Cre mouse line. Lek1 has demonstrated associations with Rb 
family members and has been implicated in having a function in myocyte cell 
proliferation and differentiation (Ashe et al., 2004). Our most recent data show 
that Lek1 interacts with Nde1 and the MT network (Soukoulis et al., 2005). A 
unique interaction between SNAP-25 and syntaxin 4 with the plasma membrane 
recycling system has also now been identified (Chapters II and III).  
 Cardiac-TnT is expressed early in mouse heart development. Jiao et al. 
(2003) isolated the rat TnT promoter and used it to drive Cre expression in a 
transgenic line. By crossing these mice with the ROSA26 reporter mice (R26R), it 
was determined that the cTnT-Cre line induced recombination early in 
cardiomyocyte lineage. Expression was determined to initiate as early as E7.5 
and was restricted to the hearts until E10.5. They demonstrated high levels of 
recombination at E10.5. Interestingly, skeletal muscles also express cTnT during 
fetal muscle development (Sabry and Dhoot, 1991). Lek1 has functions in muscle 
cell proliferation and differentiation, at least in vitro. As a result, Lek1 loss-of-
function may also demonstrate a muscle development defect. Creating the cTnT-
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Cre;Lek1 loxP/loxP is an invaluable tool needed to study Lek1 function in the 
developing heart by ablating the protein early in heart development. 
It is of interest to note that in the conditional Lek1 knock-out early in heart 
development, a functional heart still develops. We initially postulated that a 
mutant may not develop properly, since it functions with Rb family members and 
has roles in proliferation and differentiation. Therefore, we speculated it may 
result in early embryonic lethality. These initial hypotheses were based on the 
only known interacting partners of Lek1 at that time, Rb family proteins. Rb 
proteins function in regulating the cell cycle, differentiation, and apoptosis. Our 
data demonstrate that Lek1 may bind and inhibit the fuctions of Rb proteins in 
these processes. Since cardiomyocytes continually proliferate and differentiate in 
the developing heart, and Lek1 was central in these critical cellular processes, it 
was not incorrect to postulate that normal heart organogenesis would have been 
delayed or mutated in such a way that resulted in early lethality. However, this is 
not the case. A mutated, but functional heart develops, and pups are born at 
expected Mendelian ratios. Lek1 is not required for cardiac specification or 
commitment, and it is therefore not required for initial cardiac differentiation.  
 Ablation of the first five exons of Lek1 results in the “small heart” 
phenotype. It must be noted that we have yet to determine if a truncated protein 
is translated, but protein characterization is on-going with our available 
antibodies. Our pilot studies examined E12.5, E17.5, and P4 hearts. At all time 
points, there was a reduction in myocardium thickness and blunted trabeculae 
existed. As seen in hearts isolated at P4, there is a significant reduction in overall 
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heart size and variations in heart structure. Thinning of the myocardial layer may 
be the result in a block of Lek1 function in proliferation and differentiation. Mutant 
hearts may not be able to compensate for the loss, resulting in alterations of the 
cell cycle and a reduction in cell numbers, which are also defined roles of Lek1. 
We also speculate that since trabeculae are more apparent in the E17.5 mutant 
hearts, there may be a delay in trabeculae compaction, which results in the 
reduction of wall thickness in the adult heart. 
Lek1 has functions with Rb proteins, the MT network, and in vesicle 
transport. Therefore, it appears that these Lek1 functions are critical for proper 
heart development. Mutant adult mice demonstrate progressive dilated systolic 
cardiomyopathy, altered conducting function, and deficiencies in electrical 
coupling. Loss of Lek1 function in vesicle transport and membrane trafficking is 
likely to be responsible, at least in part, for these results. 
Again, we utilized the cTnT-Cre line to induce recombination early in heart 
development and excise the first five exons of Lek1 in cardiomyocytes. Our most 
recent data show Lek1 to be important for heart function. Within the cardiac 
muscle, two types of myocytes exist: cells of the working myocardium, in both the 
atria and ventricles, and the conduction cells (Moorman et al., 1998). The 
conduction system has separate components that have distinct functions in the 
adult heart. They primarily function in the generation and conduction of electrical 
impulses in the heart. The myocytes of the working myocardium and conduction 
system perform four basic functions: contraction, autorythmicity, intracellular 
conduction, and electromechanical coupling. Coupling between myocytes occurs 
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through intercalated disks. Intercalated discs are formed at the junction between 
myocytes. It is through the gap junctions of the intercalated disks that electrical 
impulses pass through from cell to cell for myocyte contraction. Proteins that 
have been shown to be important at intercalated discs include connexin43, 
catenins, cadherins, vinculin, and ZO-1. 
cytLEK1 has direct association with SNAP-25 and syntaxin 4. All three 
proteins have been localized to myocytes (Ashe et al., 2004; Bryant et al., 2002; 
Goodwin et al., 1999; Jagadish et al., 1996; Ma et al., 2005; Pessin et al., 1999; 
Pooley et al., 2006; Sevilla et al., 1997; Soukoulis et al., 2005). Therefore, 
studying Lek1 ablation in the heart is an excellent model to define their functions. 
The ability of cytLEK1 to bind SNAP-25 is important for plasma membrane 
recycling. We do not know if cytLEK1 has a more broad role in plasma 
membrane trafficking along the MT network, or if it is specific to Rab11a positive 
recycling endosomes.  Needless to say, plasma membrane recycling is important 
for every cell type, including myocytes, in trafficking and placement of proper 
proteins and ion channels to the cell surface, such as Tf and its receptor. 
cytLEK1 has now been shown to function in membrane trafficking in two 
pathways. First, cytLEK1-SNAP-25 association functions in Tf uptake. Second, 
syntaxin 4 was also found to associate directly with cytLEK1. In vitro knock-down 
of Lek1 severley retards GLUT4 trafficking, a well-defined function of syntaxin 4. 
For increased glucose uptake, GLUT4-containing vesicle transport is critical after 
insulin stimulation. GLUT4 is trafficked through recycling endosomes. We 
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postulate that cytLEK1 is a critical link between recycling vesicles and the MT 
network, and specifically functions with Tf and GLUT4- containing endosomes.  
When considering the preliminary data on Lek1 loss-of-function in the 
heart, it is very interesting to postulate that alterations to normal plasma 
membrane recycling are present in mutant cardiomyocytes. If further evidence  
support our pilot studies, vesicle and protein trafficking may be responsible, at 
least in part, for decrease function in mutant cells. Intercalated disks form 
between the junctions of myocytes, and proteins need to be properly trafficked to 
the cell membrane for electrical current to pass through cells and tissues of the 
heart. Our EKG data indicate that cells may not couple properly and electrical 
conduction in affected. Our in vitro data shows that altering cytLEK1 function 
alters coupling. Therefore, protein trafficking to the intercalated disks may be 
affected. It is logical to postulate that mutant cells have an inability to traffic 
proteins to the cell membrane properly, therefore heart function would be 
severely altered. 
In conclusion, the conditional Lek1 mouse line is now available. Our 
preliminary studies indicate that Lek1 function is critical for proper heart 
organogenesis, as mutant Lek1 hearts have decreased function and contractile 
ability. Coronary heart disease is the leading cause of death in Americans; over 
28% of Americans die from diseases of the heart every year (American Heart 
Association). Initially, it appears that Lek1 functions with Rb family proteins may 
be important in myocardial wall development, and/or Lek1 function with plasma 
membrane transport and vesicle associations with the MT network may be just 
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as critical. We are now able to test Lek1 loss-of function during development for 
the first time. 
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CHAPTER VI 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Conclusions 
Entering these studies, we identified nucLEK1 as being involved in cell 
proliferation and differentiation, while the initial cytLEK1 data show that the C 
domain interacts and functions with Nde1 and the microtubule network. In my 
studies, I describe novel functions for cytLEK1 in intracellular trafficking. Chapter 
II characterizes the interaction between cytLEK1 and SNAP-25. We show that 
the endogenous proteins share a strikingly similar cytoplasmic distribution pattern 
in cultured myocytes and fibroblasts with little, if any, localization at the cell 
membrane. This is important because in most cell types, neurons for example, 
SNAP-25 is mostly cell membrane bound. As a result, most studies focus on 
neurotransmitter release in neurons, but intracellular roles for SNAP-25 are 
emerging. Furthermore, CoIPs utilizing endogenous and transfected cytLEK1 
and SNAP-25 show that these proteins interact directly. The most intriguing part 
of the study identifies this association as being critical for Rab11a and recycling 
endosome function. Rab11a is a marker for recycling endosomes and has a 
perinuclear distribution similar to cytLEK1 and SNAP-25. In contrast, cytLEK1 
and SNAP-25 also have a wider distribution in cytoplasm further towards the cell 
membrane. This indicates that the association between cytLEK1 and SNAP-25 
may regulate other intracellular pathways or other endosomal compartments. 
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In chapter III, a direct interaction between cytLEK1 and syntaxin 4 is 
characterized. As with SNAP-25, cytLEK1 and syntaxin 4 colocalize in the 
cytoplasm, especially in undifferentiated 3T3-L1 cells (preadipocytes). This cell 
line is a model for syntaxin 4 function and GLUT4 trafficking which are both 
important for glucose uptake. GLUT4 movement is dependent, at least in part, on 
Rab11a and the recycling endosome network. For the first time, we have 
identified a membrane localized cytLEK1 in differentiated 3T3-L1 adipocytes and 
in neuronal cell lines, another model cell line used to study syntaxin 4 function. 
Chapters II and III show that cytLEK1 can associate with both syntaxin 4 and 
SNAP-25 in the same complex. In order for the SNARE complex to form, a 
VAMP family member is also required, and in each study VAMP2 was identified. 
From our initial studies characterizing cytLEK1 function in plasma 
membrane trafficking, we put foward the following model (Figure 42). We 
propose that cytLEK1 is a link between recycling endosomes and the MT 
network. Previous data show that the MTs are important to recycling endosome 
movement as nocodazole treated cells halt endosome recycling (Apodaca et al., 
1994; Casanova et al., 1999). However, no proteins have yet been identified that 
function linking endosomes to the MT network. Actin has long been known to 
have a role in endosomes trafficking through myosin Vb, but we have now 
identified a possible link to the MT cytoskeleton.  
As shown previously, the C-domain of cytLEK1 associates with the MT 
network (see Chapter I). This should not be of surprise, since this region of 
cytLEK1 has a spectrin repeat, a domain that has been shown to function with
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Figure 42. Our cytLEK1 model. We propose that cytLEK1 links recycling endosomes with 
the microtubule network. CytLEK1 has now been shown to associate with SNAP-25, and 
previously with Nde1 (Soukoulis et al., 2005), a protein of the Lis1/dynein complex that 
associates with the microtubule network. Rab11a, myosin Vb, and VAMP2 have been 
localized to recycling endosomes. CytLEK1 associates with SNAP-25 and syntaxin 4, and 
through this complex, recycling vesicles are linked to Nde1 and thus Lis1 and microtubules.
the cytoskeleton. Now through our most recent studies, we have demonstrated 
that cytLEK1 functions with the recycling endosome network through the 5’LSD 
domain. By combining these known functions of cytLEK1, we hypothesize that 
our protein is a key link between recycling endosomes and MTs. In order for 
organelles to move throughout the cytoplasm, one would postulate that interplay 
is required between the three networks that make up the cytoskeleton: MTs, actin 
filaments, and intermediate filaments. In our model, recycling endosomes can 
interact with two of the systems. First, they associate with the MT network by 
association with cytLEK1 and the Lis1 pathway. Second, they interact with the 
actin network by their association with Rab11a and myosin Vb. We further 
speculate that cytLEK1 is a key player in regulating trafficking between these two 
networks of the cytoskeleton. 
Chapter V describes our initial characterization of the Lek1 conditional 
knock-out. Since Lek1 is expressed at high levels in the developing heart, and 
most of our previous studies focused on its role in cardiomyocytes, we ablated 
the protein early in heart development. Deletion of Lek1 leads to alterations in 
heart structure early in development and has severe effects to adult heart 
function. Interestingly, Lek1 is not absolutely required for cardiac specification 
and commitment as we once postulated. This hypothesis was solely based on 
our understanding of nucLEK1 function in the key processes of proliferation and 
differentiation, a shared function with CMF1 (see Chapter I). Our initial 
characterizations show that Lek1 has an important role in the regulation of heart 
development. At this point, it appears that any of the Lek1 functions may be 
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responsible for the small heart. Altered cardiomyocyte proliferation and 
differentiation may result in the thinning of the myocardium and changes in 
normal trabeculation and compaction during heart development. Retarding 
endosomal recycling could also be a factor responsible for the mutant phenotype.  
Structuaral analyses and physiological tests conducted on mutant mice 
are quite revealing. Immunohistochemical anlalyses of heart sections from 
different stages of embryonic heart development demonstrate that the maturing 
heart wall is thinner and the trabeculae are blunted and not as pronounced in 
mutant mice. We initially speculate that this is the result of Lek1 loss-of-function 
in the regulation of proliferation and differentiation. This would also help explain 
the “small heart” phenotype. 
Interestingly, we observed that mutant adult hearts have dilated 
cardiomyopathy, which results in a dilated heart wall and diminished heart wall 
function. So as mutant hearts gets older, they actually increase in size. 
Additionally, EKG recordings demonstrate that the periodicity of heart contraction 
is significantly altered in mutant hearts. This allows us to postulate that not only 
are proliferation and differentiation compromised in mutant hearts, but coupling of 
cardiomyocytes is also affected. Therefore, electroconductivity through the heart 
wall is altered. Our initial in vitro data support these results and show that 
inhibiting Lek1 function retards coupling.  
Recently, it has become evident that dilated cardiomyopathy is mainly due 
to mutations in cytoskeletal proteins (reviewed in Perriard et al., 2003). It is 
characterized by the thinning of the ventricular wall and its impared contraction, 
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both of which are altered in our mutant mice. It is unknown what causes the 
thinning of the wall, but our data indicate that altering Lek1 function may result in 
reduced myocyte numbers in the myocardial wall. 
Relevant to our studies on cytLEK1 function in membrane trafficking and 
its association with the microtubule network, architecture and composition at 
intercalated disks may be a major contributing factor the dilated cardiomyopathy. 
Changes at contact sites between myocytes may diminish electroconductivity 
between cells (Ehler et al., 2001). Intercalated discs are comprised of three 
different types of cell-cell connections: gap, adheren, and desmosomal junctions. 
EKG recordings show that mutant hearts have altered electroconductivity, a 
function of gap junctions. As a result, it would be most informative to examine 
protein trafficking, such as connexin 43, to gap junctions. But, trafficking of any, 
or all, proteins to the intercalated disks may be inhibited or upregulated, as 
indicated by both studies in mice and humans (Perriard et al., 2003). Throughout 
development, it is of most interest to compare intercalated disk formation at the 
cell membrane. Mice suffering from dilated cardiomyopathy have shown 
significant changes in cardiomyocyte shape and intercalated disk localization. 
Cells isolated from diseased hearts have shown a more rounded shape and a 
broad intercalated disk localization (reviewed in Perriard et al., 2003). 
Cardiomyocytes are not able to make the normal bipolar connections with its 
surrounding cells.  
Thus far, our studies have not addressed the compaction of the 
myocardium (see Chapter I). It is quite logical to hypothesize that Lek1 may also 
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function during this event in heart wall maturation. Compaction events have not 
been well-studied, but it is easy to postuate that protein and membrane trafficking 
are critical for compaction. In order for myocytes to make proper contacts and to 
function appropriately, protein localization to the cell surface must be 
unrestrained. It appears that Lek1 is a critical factor that functions in the basic 
pathways that are the foundation for proper heart development and function.  
This leads us to the following question: What do all the known functions 
mean in terms of the global role of Lek1 in development? Even though we have 
chosen to characterize Lek1 function in terms of heart development, the protein 
is expressed throughout the developing embryo. I speculate that cytLEK1 has a 
critical function regulating organelle positioning and movement at the perinuclear 
region of cells. Examining the localization and distribution of endogenous 
proteins juxtapose to the nucleus allows me to hypothesize that it has a key 
function in this area of the cell. Studies looking at the C-domain demonstrate its 
localization at centrosomes. 5’LSD localizes to the recycling endosome network, 
a function primarily located in the perinuclear region. If the hook2-cytLEK1 
association is validated, this is yet another line of evidence suggesting that 
cytLEK1 has an important role regulating organelles in the perinuclear region. 
We also need to define whether or not Lek1 only has a role early in 
development, or if it does have some capacity to function in adult cells. The first 
possible explanation is that we have simply not examined adult tissues closely 
enough. It may be found at low levels in adult cells, just as SNAP-25, and we 
have not utilized assays sensitive enough to detect the protein. Also, now that we 
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have a better understanding of cytLEK1 function, it may be worthwhile to 
reexamine adult expression of the protein in certain cell types. SNAP-25 has 
well-documented functions in neurons. Syntaxin 4 has functions in adipocytes 
and neurons (see Chapter I). Recent reports show that SNAP-25 and syntaxin 4 
function in insulin release in β-cells of the pancreas (Spurlin and Thurmond, 
2006). These are tissues that may demonstrate cytLEK1 function in the adult. 
Lastly, stem cell proliferation and differentiation is a critical area of research 
today. It is imperative that we examine Lek1 function in embryonic and adult 
stem cell populations since it has roles in proliferation and differentiation.  
Another explanation for cytLEK1 function in development is that another 
protein replaces Lek1 functions in the adult. This point appears to be the weaker 
of the two at this time. In vitro protein knock-down has a detrimental effect on cell 
proliferation and differentiation, as a result it appears that no proteins are able to 
compensate in cell culture with the loss of Lek1 function. Creation of the 
conditional knock-out may help alleviate this debate. With the inducible systems 
now available, cytLEK1 function in the adult can be further characterized. 
In summary, we have now shown that cytLEK1 functions in plasma 
membrane recycling. Along with what was previously known about cytLEK1, we 
have developed a model that depicts cytLEK1 being a key regulator that bridges 
recycling endosomes with the MT network. This would be the first time such a  
protein has been identified. Also, the conditional Lek1 mouse line has been 
developed and pilot studies characterizing Lek1 function are ongoing. Lek1 
appears to have a significant role in heart organogenesis. Even though we have 
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made great strides in defining the function of Lek1, additional studies are needed 
to fully understand its role in such key cellular processes. 
 
Future Directions 
 
Define cytLEK1, SNAP-25, and syntaxin 4 complexes  
We have now shown that cytLEK1 binds both SNAP-25 and syntaxin 4 
independently by Y2H. SNAP-25 function is best characterized in the brain, while 
syntaxin 4 is best defined in adipocytes, even though both proteins have a 
broader expression pattern and are found in numerous cell types. In fact, we 
have demonstrated that cytLEK1, SNAP-25, and syntaxin 4 form an intracellular 
complex in NIH3T3 fibroblasts and in C2C12 myoblasts. It remains to be 
determined whether or not a complex exists that contains all three proteins. 
 The SNARE complex is composed of a SNAP, syntaxin, and VAMP family 
member. SNAP-25 is mostly characterized with syntaxin 1 and 2 in the brain, 
while syntaxin 4 is best characterized with SNAP-23. We have strong evidence 
that cytLEK1 interacts with both SNAP-25 and syntaxin 4 in a complex. In all 
transfection experiments conducted thus far (see Chapters II and III), all three 
proteins are found at the perinuclear foci, and CoIPs demonstrate the presence 
of both SNAP-25 and syntaxin 4 with cytLEK1. To date, these data are only 
indirect evidence for their association. It is possible in such experiments that 
there are populations of cytLEK1-SNAP-25 complexes interspersed with cytLEK-
1-syntaxin 4 populations. To address this question, biochemical competition 
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binding assays are necessary and would give the most insight. Further use of 
CoIP assays would also be a valuable tool. A series of pull-downs and 
immunoblots could be performed to identify which proteins are present in a 
complex.  
 It is of interest to examine the binding domains of the proteins. cytLEK1 
binds the N-terminal region in SNAP-25. This is the same region in which 
syntaxins also bind SNAP-25. cytLEK1 binds syntaxin 4 at its C-terminus, again 
the same region that binds SNAP-25. It may be that cytLEK1 is a regulator of 
SNAP-25-syntaxin 4 binding. If all proteins do not form a complex, cytLEK1 may 
be a negative regulator of membrane fusion and deter complex formation, similar 
to Munc-18 binding of syntaxin 4 (Yang et al., 2000). Defining cytLEK1 binding in 
the SNARE complex is critical in understanding the role of cytLEK1 in 
intracellular transport. 
 We have identified cytLEK1 as being important in Tf and GLUT4 
trafficking, which are both plasma membrane recycling processes. Future studies 
also can be conducted to determine the importance of cytLEK1 for other protein 
recycling pathways. To date, numerous proteins have been identified that traffic 
through Rab11 and recycling endosomes. These proteins include EGFR 
(Lapierre and Goldenring, 2005), p120 (Ducharme et al., 2006), apoE (Braun et 
al., 2006), NK1R (Roosterman et al., 2004), CXCR2 (Fan et al., 2004), and PAR2 
(Roosterman et al., 2003), among many others. The recycling system has critical 
functions in protein localization to the cell surface in a wide variety of cell types. It 
is worthwhile to define the function of cytLEK1 beyond that of Tf and GLUT4 
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trafficking and to identify the roles of cytLEK1 in these protein trafficking 
pathways. 
 
Further define Lek1 expression pattern and localization  
To date, we have examined Lek1 function in vitro by utilizing fibroblast and 
myoblast cell lines. We now have a mouse line that conditionally ablates Lek1 in 
the developing heart. Interestingly, SNAP-25 and Lis1 pathway proteins are most 
highly expressed in the brain, while syntaxin 4 is also highly expressed in 
adipocytes. To gain further insight into cytLEK1 function, we need to examine its 
function in these cell types.  
Even though our initial expression studies show cytLEK1 localization in 
the brain, further detailed expression studies need to be conducted. It would be 
of great interest to determine whether cytLEK1 is highly expressed in proliferating 
cells of the brain and whether or not it is localized to the membrane, since this is 
where SNAP-25 functions in neurotransmitter release. We have begun to define 
cytLEK1 function in myocyte proliferation and differentiation. Since we have 
shown that Lek1 function is critical for heart development and function, it is also 
of interest to examine expression in postnatal hearts and determine if there is a 
proliferating population that expresses Lek1. Because syntaxin 4 is also highly 
expressed in adipocytes, studies need to commence on cytLEK1 localization and 
function in these cells. Additionally, further analysis in tumors would be of great 
interest to examine Lek1 function. One family member, CENP-F/Mitosin, is highly 
expressed in human tumors (de la Guardia et al., 2001), and since Lek1 has a 
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role in proliferation, characterizing Lek1 function in mouse tumor cells is of 
interest. Interestingly, one of the only cell populations to express both SNAP-25 
and syntaxin 4 is β-cells in the regulation of insulin release (Spurlin and 
Thurmond, 2006). cytLEK1 expression and function should also be examined in 
these cells. Finally, stem cell research is an emerging field of research today. 
Lek1 may be expressed and function in various stem cell populations, since they 
are populations that retain their ability to proliferate and differentiate. Detailed 
studies on proliferating cells in the adult need further characterization to 
determine if cytLEK1 is definitively expressed and functions only during 
development.  
To address these issues, we have undertaken several projects. We have 
produced several monoclonal antibodies that recognize unique epitopes in 
cytLEK1 and nucLEK1. Monoclonal antibodies have not previously been 
available. Once they are available, we will be able to look at nucLEK1 and 
cytLEK1 peptides concurrently. This will help to determine if a cleavage event 
exists that produces two peptides or whether two populations of full-length 
proteins reside in different compartments. Also, the conditional Lek1 mouse will 
help define Lek1 function in different cell types. We now have the ability to 
specifically ablate Lek1 function in specific organs or at various developmental 
time points. This will allow us to define the broader role of Lek1 in proliferation, 
differentiation, and membrane trafficking with the MT network. 
Lastly, we propose that Lek1 undergoes a cleavage event by an unknown 
enzyme at an unknown site. Mass spectrometry analysis and protein sequencing 
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techniques have been unsuccessful in determing the site of Lek1 cleavage if it 
exists (Ashe, Price, and Bader, unpublished data). To fully understand the 
function of Lek1 in such basic cellular processes, the full-length clone needs to 
be generated. However, our efforts in creation of the clone remain elusive, as no 
ligation strategy has been feasible. Development of the full-length clone by RT-
PCR is required. Not only would it be beneficial in defining the cleavage event, 
but it would also allow us to perform overexpresion and rescue experiments. In 
summary, these experiments will allow us to define Lek1 expression in key cell 
types that have not been examined in detail thus far. 
 
Characterize novel Lek1 binding partners  
Thus far, we have identified and begun to characterize three novel protein 
associations initiated by Y2H screens. These screens were conducted with 
regions that account for less than 20% of Lek1. This technique has been 
invaluable in initiating studies in Lek1 function and should not cease. Structural 
analysis provides evidence that several leucine zippers are present throughout 
Lek1, which indicates regions for other potential protein-protein associations. 
 First, several interacting proteins have already been found through our 
Y2H analyses that have not been characterized. Besides Nde1, the Y2H screen 
conducted with the C domain also identified dysbindin as a cytLEK1 interacting 
protein (Soukoulis and Bader, unpublished data). This association is of interest 
because of its high expression in cardiac muscle, skeletal muscle, and the brain. 
One of its functions appears to be involved in lysosome-related processes (Li et 
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al., 2003). As previously discussed in Chapter V, proteins identified as interacting 
with 5’LSD need to be further addressed, especially p50 and Hook2. Studies 
examining these interactions previously identified by Y2H would be of great 
benefit in determining the function of Lek1 in intracellular processes with the MT 
network. Secondly, we have used the Y2H system with great success. Additional 
screens with other Lek1 bait constructs should be undertaken to identify Lek1 
binding partners.  
 Once binding partners are identified, biochemical analyses will be of 
interest to support interaction and can also be used to define the binding 
domains within the proteins. Candidate approaches can then be used to identify 
the protein members that reside in the complex. From these data, hypotheses 
can be made on their functions in biological processes. In vitro MO protein 
knock-down can then be utilized to determine the ramifications to such 
complexes when Lek1 is no longer able to function in the cell. Lek1 may enhance 
or decrease complex formation. Once new associations are discovered, 
colocalization and dominant-negative studies should be undertaken. 
 
Examination of Lek1 function in the mouse 
First, analysis of cell proliferation in the heart needs to be conducted in our 
conditional Lek1 knock-out mouse by BrdU incorporation studies. Our most 
recent data suggest that Lek1 ablation results in a hypoplastic heart and the 
“small heart” phenotype. The phenotype may be due to decreases in myocyte 
number that would result in a decrease in wall mass. This phenotype is 
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supported by the ability of nucLEK1 to function in cell proliferation and 
differentiation. If there is a reduction in cell numbers, standard BrdU and PCNA 
analyses can demonstrate if a premature withdrawal from the cell cycle is 
present or if mutant cells undergo earlier differentiaton. By conducting these 
studies, it can be determined if the phenotype observed in the mutant heart is a 
result of altered cell proliferation and/or differentiation. 
Second, further analyses of differentiation and protein trafficking are 
required. We have demonstrated that cytLEK1 associates with recycling 
endosomes and the microtubule network. We will apply the findings from our pilot 
studies on the conditional Lek1 knock-out to help define the “small heart” 
phenotype at the molecular level. Myocyte protein markers can be analyzed for 
both proper expression and localization in knock-out cells. To demonstrate 
consequences of altered protein trafficking, primary cardiac myocyte cultures can 
be purified and electrophysiological analysis can be conducted to measure gap 
junction mediated coupling in mutant cells. SNAP-25 and syntaxin 4 localization 
needs to be examined in these cells. This will demonstrate whether or not altered 
Lek1 function in protein trafficking is responsible for the “small heart” phenotype, 
at least in part. 
 Standard marker gene expression should be analyzed by 
immunofluorescence, PCR, and Northern blot assays to determine whether the 
overall pattern of myocyte differentiation is altered when Lek1 expression is 
disrupted. Analysis of contractile protein expression levels of myosin heavy and 
light chain, actinin, and cardiac troponin can be conducted (Ashe et al., 2004; 
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Gonzalez-Sanchez and Bader, 1984; Gonzalez-Sanchez and Bader, 1990). 
Changes in myocyte reshaping, movement, and adhesion during trabeculation 
and compaction should be visualized by immunohistological labeling with 
antibodies for N-cadherin, connexin 43, and other intercalated disc-specific 
proteins (Mikawa et al., 1992; Radice et al., 1997). Cardiac myocytes can be 
isolated to evaluate adhesive and migratory characteristics, and PCNA/BrdU will 
demonstrate mitotic capability in vitro. 
 Relatively little is known about the molecular regulation of cardiomyocyte 
proliferation and differentiation during trabeculation and maturation of the heart. 
Examining protein trafficking during heart organogenesis is a novel concept. The 
demonstrated roles for Lek1 in the regulation of cell division and movement, its 
high level of expression in the early heart, and its consequences to heart 
development in the conditional Lek1 knock-out indicate that this gene is a key 
regulator of cardiac organogenesis. In the future, this conditional Lek1 mouse 
line in combination with other Cre-expressing mice, such as α-MHC to ablate 
Lek1 function later in heart development (Sohal et al., 2001), will allow us to 
further define the role of Lek1 in heart organogenesis.  
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